KR20180032527A - Compound and organic electroluminescent device - Google Patents

Compound and organic electroluminescent device Download PDF

Info

Publication number
KR20180032527A
KR20180032527A KR1020177034684A KR20177034684A KR20180032527A KR 20180032527 A KR20180032527 A KR 20180032527A KR 1020177034684 A KR1020177034684 A KR 1020177034684A KR 20177034684 A KR20177034684 A KR 20177034684A KR 20180032527 A KR20180032527 A KR 20180032527A
Authority
KR
South Korea
Prior art keywords
group
compound
substituted
unsubstituted
synthesis
Prior art date
Application number
KR1020177034684A
Other languages
Korean (ko)
Other versions
KR102592175B1 (en
Inventor
홍타오 판
샹후이 장
수앙 샤오
쉐옌 런
Original Assignee
베이징 이터널 머터리얼 테크놀로지 씨오., 엘티디
구안 이터널 머터리얼 테크놀로지 씨오., 엘티디
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201510472766.4A external-priority patent/CN106433614B/en
Priority claimed from CN201510472703.9A external-priority patent/CN106432242B/en
Application filed by 베이징 이터널 머터리얼 테크놀로지 씨오., 엘티디, 구안 이터널 머터리얼 테크놀로지 씨오., 엘티디 filed Critical 베이징 이터널 머터리얼 테크놀로지 씨오., 엘티디
Publication of KR20180032527A publication Critical patent/KR20180032527A/en
Application granted granted Critical
Publication of KR102592175B1 publication Critical patent/KR102592175B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • H01L51/0072
    • H01L51/5012
    • H01L51/5056
    • H01L51/5088
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/15Hole transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/17Carrier injection layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom

Abstract

본 발명은 일반식(Ⅰ)로 표시되는 유기 전계 발광 화합물 및 이의 유기 전계 발광 소자를 제조함에 있어서의 용도를 제공한다. 제공하는 유기 전계발광 화합물은 유기 전계 발광 소자의 작업 전압을 저하시키고, 발광 효율을 향상시킨다.The present invention provides an organic electroluminescent compound represented by the general formula (I) and its use in the production of the organic electroluminescent device. The organic electroluminescent compound provided decreases the working voltage of the organic electroluminescent device and improves the luminous efficiency.

Description

화합물 및 유기 전계 발광 소자Compound and organic electroluminescent device

본 발명은 새로운 화합물에 관한 것으로, 또한 상기 화합물을 사용한 유기 전계 발광 소자에 관한 것이다.The present invention relates to a novel compound and also relates to an organic electroluminescent device using the compound.

유기 발광 다이오드(OLED)기술이 조명과 디스플레이 두 분야에서 끊임없이 발전함에 따라, 사람들은 고효율 유기 재료의 연구에 더 많은 관심을 가지게 되고, 효율적이고 수명이 긴 유기 전계 발광 소자는 통상적으로 소자 구조와 여러 가지 유기 재료가 최적화되어 조합된 결과인데, 흔히 재료의 작용이 더 현저하므로, 재료가 유기 발광 다이오드(OLED) 기술의 근본이라고 말할 수 있다. 유기 발광 다이오드(OLED) 분야에서의 유기 재료는 주로 정공 주입 재료, 정공 수송 재료, 정공 차단 재료, 전자 주입 재료, 전자 수송 재료, 전자 차단 재료 및 발광 호스트 재료와 발광 게스트(염료) 등을 포함한다.As organic light emitting diode (OLED) technology continues to evolve in both light and display, people are becoming more interested in the study of high-efficiency organic materials, and efficient, long- Organic light emitting diodes (OLEDs) are the basis of OLED technology, because organic materials are optimized and combined. Organic materials in the field of organic light emitting diodes (OLEDs) mainly include a hole injecting material, a hole transporting material, a hole blocking material, an electron injecting material, an electron transporting material, an electron blocking material and a light emitting host material and a light emitting guest .

현재, 유기 전계 발광 소자에서 사용되는 정공 주입 재료는 일반적으로 트리아릴아민 구조를 구비한 유도체(출광 특허: 공개 번호CN1152607C; 호도가야 특허: EP0650955A1과 케미프로(Chemipro) 특허: JPH09301934 등)이고, 하기와 같이 표시된다.Currently, the hole injecting material used in the organic electroluminescent device is generally a derivative having a triarylamine structure (Ex. Patent: Publication No. CN1152607C; Hodogaya patent: EP0650955A1 and Chemipro patent: JPH09301934) As shown in FIG.

Figure pct00001
Figure pct00001

정공 수송 재료로서, 재료 분자 구조 중에 통상적으로 트리아릴아민, 카르바졸 또는 티오펜 등 구조를 가지고 있다. 출광 특허(공개 번호는 CN 101506191A이고, 공개일은 2009년 8월 12일임)에서 티에닐기를 함유한 재료를 보호하였고; 출광 특허(공개 번호는 CN102334210 A이고, 출원일은 2012년 1월 25일이며; 공개 번호는 WO 2010/114017 A1이고, 공개일은 2010년 10월 7일임)에서 카르바졸과 디벤조푸란 구조를 구비한 정공 수송 재료를 보호하였으며, 일부 대표적인 화합물은 하기와 같다.As the hole transporting material, it usually has a structure such as triarylamine, carbazole or thiophene in the molecular structure of the material. Protected thienyl group-containing material in the outbreak patent (publication number CN 101506191A, publication date August 12, 2009); (The disclosure number is CN102334210 A, the filing date is Jan. 25, 2012; the publication number is WO 2010/114017 A1, and the disclosure date is October 7, 2010), which has carbazole and dibenzofuran structures The hole transport material was protected, and some typical compounds are as follows.

Figure pct00002
Figure pct00002

현재 공지된 정공 수송 재료와 정공 주입 재료의 성능이 이상적이지 못하므로, 업계에서 새로운 정공 수송 재료와 정공 주입 재료의 개발이 시급히 필요로 한다.The hole transporting material and the hole injecting material, which are currently known, are not ideal in performance, and it is urgently required in the industry to develop a new hole transporting material and a hole injecting material.

이 외에, 자주 상용되는 발광 호스트 재료 CBP(일본 특허공개공보 특개 2001-313178호 공보)로서, 우수한 정공 수송 성능을 구비하지만, 전자 수송 성능 측면이 비교적 떨어져, 캐리어 수송 불균일을 초래한다. 그러나, TAZ를 호스트 재료(일본 특허공개공보 특개 2002-352957호 공보)로 하면 반대로, 전자 수송 능력이 우수하지만, 정공 수송 능력이 비교적 떨어질 수 있어, 마찬가지로 균일한 캐리어 수송을 실현할 수 없다. 우수한 발광 호스트 재료를 개발하는 것도 업계에서 시급히 해결하여야 하는 문제이다.In addition to this, as a frequently used light emitting host material CBP (Japanese Patent Application Laid-Open No. 2001-313178), although having excellent hole transporting performance, the electron transporting performance is comparatively deteriorated, leading to carrier transport unevenness. However, when TAZ is a host material (Japanese Unexamined Patent Application Publication No. 2002-352957), the electron transporting ability is excellent, but the hole transporting ability is comparatively low, and uniform carrier transport can not be realized. It is also an urgent problem in the industry to develop a superior luminescent host material.

Figure pct00003
Figure pct00003

상기 문제를 해결하기 위하여, 본 발명은 유기 전계 발광 소자에 사용되는 신규한 화합물을 제공한다. 상기 화합물은 신규한 벤조시클로옥타테트라엔디인돌 구조를 도입하여, 우수한 호스트 재료 성능 및 정공 주입, 수송 성능을 실현하였다. 본 발명의 화합물은 하기 일반식(Ⅰ)으로 표시된다.In order to solve the above problems, the present invention provides a novel compound for use in an organic electroluminescent device. This compound introduced a novel benzocyclooctatetraendiindole structure and realized excellent host material performance and hole injection and transport performance. The compound of the present invention is represented by the following general formula (I).

Figure pct00004
Figure pct00004

여기서, 고리A는

Figure pct00005
고리이고, 점선은 시클로옥타테트라엔과 이어지는 위치이며;Here, ring A is
Figure pct00005
And the dotted line is the position following the cyclooctatetraene;

바람직하게, Ar는 수소, C6 내지 C30인 아릴아미노기 또는 헤테로아릴아미노기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C2 내지 C30 헤테로아릴기이고;Preferably, Ar is hydrogen, C 6 to C 30 aryl group or a heteroaryl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 2 to C 30 heteroaryl group;

바람직하게, R1 내지 R12는 각각 독립적으로 수소, 할로겐, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C2 내지 C30 알케닐기, 치환 또는 비치환된 C2 내지 C30 알키닐기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C2 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C2 내지 C30 헤테로아릴기이며; 또는, R1 내지 R4 및/또는 R5 내지 R8은 각각 고리를 형성한다.Preferably, R 1 to R 12 each independently represent hydrogen, halogen, a substituted or unsubstituted C 1 to C 30 alkyl group, a substituted or unsubstituted C 2 to C 30 alkenyl group, a substituted or unsubstituted C 2 to C 30 alkynyl group, a substituted or unsubstituted C 3 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heterocycloalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 2 to C 30 heteroaryl group; Or R 1 to R 4 and / or R 5 to R 8 each form a ring.

본 발명의 화합물은 정공 주입 재료로 사용 가능하여, 정공을 인듐주석 산화물(ITO) 양극으로부터 유기 재료에 효과적으로 주입시킬 수 있으며, 정공 수송 재료로도 사용 가능하여, 발광층 호스트 재료의 호모(HOMO) 에너지 준위와 더욱 잘 매치됨으로써, 소자 작업 전압을 효과적으로 저하시키고 소자 발광 효율을 향상시킨다. 이 외에, 본 발명의 화합물은 발광층의 호스트 재료로도 사용 가능하고, 이는 상대적으로 비교적 균일한 전자와 정공 수송 성능을 가지며, 인접한 전자 및 정공 수송층 재료와 매치되는 에너지 준위를 구비하여, 발광재료에 충분한 에너지를 전달하여 높은 발광 효율을 실현함으로써, 소자 라이트와 작업 전압을 저하시키고, 소자의 효율을 향상시키며, 소자의 수명을 연장할 수 있어, 유기 전계 발광 소자의 제조 중에서 매우 중요한 실질적 의의가 있다.The compound of the present invention can be used as a hole injecting material, effectively injecting holes from an anode of indium tin oxide (ITO) into an organic material, and can also be used as a hole transporting material. HOMO energy Level, thereby effectively reducing the device working voltage and improving the device luminous efficiency. In addition, the compound of the present invention can be used also as a host material of a light emitting layer, which has relatively relatively uniform electron and hole transporting ability, has an energy level matched with adjacent electron and hole transporting layer materials, There is a substantial significance in manufacturing the organic electroluminescent device because it is possible to realize a high luminous efficiency by transmitting sufficient energy to lower the device light and the working voltage, to improve the efficiency of the device, and to extend the lifetime of the device .

본 발명에서, Ca 내지 Cb의 표현 방식은 상기 기가 갖고 있는 탄소 원자수가 a 내지 b인 것을 나타내고, 다른 설명이 없으면, 일반적으로 상기 탄소 원자수는 치환기의 탄소 원자수를 포함하지 않는다.In the present invention, the expression system of C a to C b means that the number of carbon atoms of the group is a to b, and unless otherwise stated, the number of carbon atoms does not include the number of carbon atoms of the substituent group.

본 발명에서, 화학 원소의 표현은 화학적 성질이 동일한 동위 원소의 개념을 포함하고, 예를 들어 "수소"의 표현은 화학적 성질이 동일한 "중수소", "삼중수소"의 개념도 포함한다.In the present invention, the expression of a chemical element includes the concept of an isotope having the same chemical nature, and for example, the expression "hydrogen" includes the concept of "deuterium" or "tritium" having the same chemical nature.

본 발명에서의 헤테로 원자는, 통상적으로 B, N, O, S, P, P(=O), Si와 Se에서 선택되는 원자 또는 원자단을 지칭한다.The hetero atom in the present invention usually refers to an atom or atomic group selected from B, N, O, S, P, P (= O), Si and Se.

본 발명의 화합물은 하기 일반식(Ⅰ)으로 표시되는 구조를 구비하고,The compound of the present invention has a structure represented by the following general formula (I)

Figure pct00006
Figure pct00006

여기서, 고리A는

Figure pct00007
이며, 점선은 이어지는 위치이고;Here, ring A is
Figure pct00007
And the dotted line is the following position;

Ar는 수소, C6 내지 C30인 아릴아미노기 또는 헤테로아릴아미노기, 치환 또는 비치환된 C6 내지 C30인 아릴기, 치환 또는 비치환된 C2 내지 C30인 헤테로아릴기일 수 있으며;Ar is hydrogen, C 6 to C 30 aryl group or a heteroaryl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 2 to C 30 heteroaryl which may be an;

R1 내지 R12는 각각 독립적으로 수소, 할로겐, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C2 내지 C30 알케닐기, 치환 또는 비치환된 C2 내지 C30 알키닐기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C2 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C2 내지 C30 헤테로아릴기이고;R 1 to R 12 are each independently hydrogen, halogen, a substituted or unsubstituted C 1 to C 30 alkyl group, a substituted or unsubstituted C 2 to C 30 alkenyl group, a substituted or unsubstituted C 2 to C 30 alkynyl group , A substituted or unsubstituted C 3 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heterocycloalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 2 to C 30 heteroaryl group;

이 외에, R1 내지 R4 및/또는 R5 내지 R8은 이러한 기들 사이에 서로 연결되어 고리 모양 구조를 형성할 수 있으며, 이러한 고리 구조는 지방족 단일 고리 또는 다중 고리, 방향족의 단일 고리 또는 융합 고리일 수 있고, 이러한 고리들은 모두 헤테로 원자를 포함할 수 있다. 지방족 단일 고리의 예로서, 예를 들어, R1 내지 R4 또는 R5 내지 R8 중 임의의 인접한 두 개의 기가 연결되어 지방족의 5원 고리, 6원 고리를 형성할 수 있고, 이러한 고리의 구성 원자는 탄소 원자 외에 헤테로 원자일 수도 있으며, 이러한 고리는 치환기를 구비할 수 있고, 고리를 구성하는 탄소 원자는 케톤기를 형성할 수도 있다. 이러한 고리의 예로서, 시클로펜탄 고리, 시클로헥산 고리, 디시클로펜텐 고리, 테트라히드로피롤 고리, 테트라히드로푸란 고리, 피페리딘 고리 및 시클로펜탄 고리와 시클로헥산 고리 중의 탄소 원자가 케톤기에 의해 치환되어 얻어진 에스테르 고리 등을 들 수 있다. 방향족의 단일 고리 또는 융합 고리로서, 바람직하게는 C6 내지 C30인 단일 고리 또는 융합 고리이고, 예로서 벤젠 고리, 나프탈렌 고리 등을 들 수 있으며; 헤테로 원자를 포함하는 단일 고리 또는 다중 고리로서, 바람직하게는 피롤 고리, 피리딘 고리, 인돌 고리, N-페닐기로 치환된 인돌 고리이다. 상기 지방족 고리와 방향족 고리, 헤테로 방향족 고리에 다중 고리로 조합될수 있으며, 예를 들어, 벤조피롤 고리, 벤조푸란 고리, 벤조티오펜 고리, 플루오렌 고리 등이 있다.In addition, R 1 to R 4 and / or R 5 to R 8 may be connected to each other to form a cyclic structure, which may be an aliphatic single ring or multiple rings, a single ring of aromatic rings, And these rings may all contain heteroatoms. Examples of aliphatic monocyclic rings include, for example, any two adjacent groups of R 1 to R 4 or R 5 to R 8 may be connected to form an aliphatic five-membered ring or a six-membered ring, The atom may be a hetero atom in addition to the carbon atom, and the ring may have a substituent, and the carbon atom constituting the ring may form a ketone group. Examples of such rings include cyclopentane rings, cyclohexane rings, dicyclopentene rings, tetrahydropyrrole rings, tetrahydrofuran rings, piperidine rings, and cyclopentane rings, in which the carbon atoms in the cyclohexane ring are substituted by a ketone group Ester rings, and the like. Aromatic single ring or fused ring, preferably a single ring or fused ring of C 6 to C 30 , examples being benzene ring, naphthalene ring and the like; A single ring or multiple rings containing a hetero atom, preferably an indole ring substituted with a pyrrole ring, a pyridine ring, an indole ring, or an N-phenyl group. The aliphatic ring may be combined with an aromatic ring or a heteroaromatic ring in multiple rings, for example, a benzopyrrole ring, a benzofuran ring, a benzothiophene ring, a fluorene ring, or the like.

상기 치환 또는 비치환된 C1 내지 C30알킬기로서, 바람직하게는 C1 내지 C10인 알킬기이고, 더 바람직하게는 C1 내지 C6인 알킬기이며, 예를 들어, 메틸기, 에틸기, n-프로필기, 이소프로필기, n-부틸기, n-헥실기, n-옥틸기, 이소부틸기, t-부틸기, 시클로펜틸기, 시클로헥실기 등을 예로 들 수 있다.The substituted or unsubstituted C 1 to C 30 alkyl group is preferably a C 1 to C 10 alkyl group, more preferably a C 1 to C 6 alkyl group, and includes, for example, a methyl group, An isopropyl group, an n-butyl group, an n-hexyl group, an n-octyl group, an isobutyl group, a t-butyl group, a cyclopentyl group and a cyclohexyl group.

상기 치환 또는 비치환된 C2 내지 C30 알케닐기로서, 바람직하게는 C2 내지 C10인 알케닐기이고, 이의 예로서, 예를 들어, 바이닐기, 프로필렌기, 부테닐기, 펜테닐기, 헥세닐기, 헵테닐기, 옥테닐기, 시클로헥세닐기 등을 예로 들 수 있다.The substituted or unsubstituted C 2 to C 30 alkenyl group is preferably a C 2 to C 10 alkenyl group, and examples thereof include a vinyl group, a propylene group, a butenyl group, a pentenyl group, a hexenyl Group, a heptenyl group, an octenyl group, a cyclohexenyl group and the like.

상기 치환 또는 비치환된 C2 내지 C30알키닐기로서, 바람직하게는 C2 내지 C10인 알키닐기이고, 이의 예로서, 예를 들어, 에티닐기, 1-프로피닐기, 부티닐기, 펜티닐기, 헥시닐기, 헵티닐기, 옥티닐기, 시클로헥실에티닐기 등을 예로 들 수 있다.The substituted or unsubstituted C 2 to C 30 alkynyl group is preferably an alkynyl group having 2 to 10 carbon atoms, and examples thereof include an ethynyl group, a 1-propynyl group, a butynyl group, a pentynyl group, A heptynyl group, an octynyl group, a cyclohexylethynyl group and the like.

상기 치환 또는 비치환된 C3 내지 C30시클로알킬기로서, 바람직하에 C3 내지 C10인 시클로알킬기이고, 예를 들어, 시클로프로필기, 시클로부틸기, 시클로펜틸기, 시클로헥실기 등을 예로 들 수 있다.The substituted or unsubstituted C 3 to C 30 cycloalkyl group is preferably a C 3 to C 10 cycloalkyl group, and examples thereof include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, and a cyclohexyl group .

상기 치환 또는 비치환된 C2 내지 C30헤테로시클로알킬기로서, 바람직하게는 3 내지 10개 고리 골격을 구비한 원자이고 O, S 및 N 중에서 적어도 하나를 포함하는 헤테로시클로알킬기이며, 바람직한 예로서 테트라히드로푸란, 피롤리딘과 테트라히드로티오펜 등을 예로 들 수 있다.The substituted or unsubstituted C 2 to C 30 heterocycloalkyl group is preferably a heterocycloalkyl group having an atom having 3 to 10 ring skeletons and containing at least one of O, S and N, Pyrrolidine, tetrahydrothiophene, and the like.

상기 치환 또는 비치환된 C6 내지 C30아릴기로서, 바람직하게는 6 내지 20개의 골격을 이루는 탄소 원자를 갖고 있고, 바람직한 상기 아릴기는 페닐기, 바이페닐기, 터페닐기, 나프틸기, 안트릴기, 페난트릴기, 인데닐기, 플루오레닐기 및 이의 유도체, 플루오란테닐기, 트리페닐렌기, 피레닐기, 페릴렌기, 크리세닐기와 나프타센기로 이루어진 군으로부터 선택되는 기이다. 상기 바이페닐기는 2-바이페닐기, 3-바이페닐기와 4-바이페닐기로부터 선택되고, 상기 터페닐기는 p-터페닐-4-일, p-터페닐-3-일, p-터페닐-2-일, m-터페닐-4-일, m-터페닐-3-일과 m-터페닐-2-일을 포함하며; 상기 나프틸기는 1-나프틸기와 2-나프틸기로 이루어진 군으로부터 선택되는 기이고; 상기 안트릴기는 1-안트릴기, 2-안트릴기와 9-안트릴기로 이루어진 군으로부터 선택되는 기이며; 상기 플루오레닐기는 1-플루오레닐기, 2-플루오레닐기, 3-플루오레닐기, 4-플루오레닐기와 9-플루오레닐기로 이루어진 군로부터 선택되는 기이고; 상기 플루오레닐기 유도체는 9,9’-디메틸플루오렌, 9,9’-스피로바이플루오렌과 벤조플루오렌으로부터 이루어진 군으로부터 선택되는 기이며; 상기 피레닐기는 1-피레닐기, 2-피레닐기와 4-피레닐기로 이루어진 군으로부터 선택되는 기이고; 상기 나프타센기는 1-나프타센기, 2-나프타센기와 9-나프타센기로 이루어진 군으로부터 선택되는 기이다.The substituted or unsubstituted C 6 to C 30 aryl group preferably has 6 to 20 skeleton carbon atoms. Preferable examples of the aryl group include a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, an anthryl group, A phenanthryl group, an indenyl group, a fluorenyl group and derivatives thereof, a fluoranthenyl group, a triphenylene group, a pyrenyl group, a perylene group, a chrysenyl group and a naphthacene group. The biphenyl group is selected from a 2-biphenyl group, a 3-biphenyl group and a 4-biphenyl group, and the terphenyl group is selected from the group consisting of p-terphenyl-4-yl, p- Yl, m-terphenyl-4-yl, m-terphenyl-3-yl and m-terphenyl-2-yl; The naphthyl group is a group selected from the group consisting of a 1-naphthyl group and a 2-naphthyl group; The anthryl group is a group selected from the group consisting of a 1-anthryl group, a 2-anthryl group and a 9-anthryl group; The fluorenyl group is a group selected from the group consisting of a 1-fluorenyl group, a 2-fluorenyl group, a 3-fluorenyl group, a 4-fluorenyl group and a 9-fluorenyl group; The fluorenyl group derivative is a group selected from the group consisting of 9,9'-dimethylfluorene, 9,9'-spirobifluorene and benzofluorene; The pyrenyl group is a group selected from the group consisting of a 1-pyrenyl group, a 2-pyrenyl group and a 4-pyrenyl group; The naphthacene group is a group selected from the group consisting of a 1-naphthacene group, a 2-naphthacene group and a 9-naphthacene group.

치환 또는 비치환된 C2 내지 C30 헤테로아릴기로서, 바람직하게는 5 내지 20개의 골격을 이루는 탄소 원자를 갖고 있고, 바람직하게 상기 헤테로아릴기는 푸라닐기, 티에닐기, 피롤릴기, 벤조푸라닐기, 벤조티에닐기, 이소벤조푸라닐기, 인돌릴기, 디벤조푸라닐기, 디벤조티에닐기, 카르바졸릴기 및 이의 유도체 또는 벤조디옥솔기이며, 여기서, 상기 카르바졸릴기 유도체는 바람직하게 9-페닐카르바졸, 9-나프틸카르바졸벤조카르바졸, 디벤조카르바졸, 또는 인돌로카르바졸이다.The substituted or unsubstituted C 2 to C 30 heteroaryl group preferably has 5 to 20 skeleton carbon atoms. Preferably, the heteroaryl group is a furanyl group, a thienyl group, a pyrrolyl group, a benzofuranyl group, A carbazolyl group and derivatives thereof or a benzodioxolyl group, wherein the carbazolyl group derivative is preferably a 9-phenylcarbazolyl group, an isobenzofuranyl group, an indolyl group, a dibenzofuranoyl group, a dibenzothienyl group, 9-naphthylcarbazole benzocarbazole, dibenzocarbazole, or indolocarbazole.

C6 내지 C30인 아릴아미노기 또는 헤테로아릴아미노기로서, 디(헤테로)아릴아미노기, 트리(헤테로)아릴아미노기를 예로 들 수 있고, 여기서 “(헤테로)아릴기”의 표현 방식은 아릴기와 헤테로아릴기 두가지를 포함하며, 구체적인 예로서 디페닐아미노기, 페닐나프틸아미노기, 4-트리페닐아미노기, 3-트리페닐아미노기, 4-[N-페닐-N-(디벤조푸란-3-일)]페닐아미노기, 4-[N-페닐-N-(디벤조티오펜-3-일)페닐아미노기로 이루어진 군으로부터 선택되는 기를 예로 들 수 있다.Examples of the "(hetero) aryl group" used herein include an aryl group and a heteroaryl group having from 6 to 30 carbon atoms such as a di (hetero) arylamino group and a tri (hetero) arylamino group as an arylamino group or a heteroarylamino group, Specific examples thereof include a diphenylamino group, a phenylnaphthylamino group, a 4-triphenylamino group, a 3-triphenylamino group and 4- [N-phenyl-N- (dibenzofuran- , And 4- [N-phenyl-N- (dibenzothiophen-3-yl) phenylamino group.

본 발명의 바람직한 화합물로서, 상기 화합물은 하기 일반식(II)과 같은 구조를 갖는다.As a preferred compound of the present invention, the compound has a structure represented by the following general formula (II).

Figure pct00008
Figure pct00008

여기서, Ar1, Ar2는 동일하거나 상이하며, 각각 독립적으로 C1 내지 C10알킬기, C6 내지 C30인 아릴아미노기 또는 헤테로아릴아미노기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C2 내지 C30 헤테로아릴기이고;Here, Ar 1, Ar 2 are the same or different, each independently represent a C 1 to C 10 alkyl group, C 6 to C 30 aryl group or a heteroaryl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted Or an unsubstituted C 2 to C 30 heteroaryl group;

여기서, R1 내지 R12는 동일하거나 상이하며, 각각 독립적으로 바람직하게 수소, 할로겐, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C2 내지 C30 알케닐기, 치환 또는 비치환된 C2 내지 C30 알키닐기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C2 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C2 내지 C30 헤테로아릴기, C6 내지 C30인 아릴아미노기 또는 헤테로아릴아미노기이고; 또는, R1 내지 R4의 인접한 기는 서로 연결되어 고리 모양 구조를 형성할 수 있으며, 이러한 고리 구조는 지방족 단일 고리 또는 다중 고리, 방향족의 단일 고리 또는 융합 고리일 수 있고, 이러한 고리에는 헤테로 원자를 포함할 수 있으며, 여기서, 지방족 단일 고리의 예로서, 예를 들어, R1 내지 R4 중 임의의 인접한 두 개의 라디칼이 연결되어 형성된 지방족의 5원 고리, 6원 고리가 있고, 이러한 고리의 구성 원자는 탄소 원자 외에 헤테로 원자일 수도 있으며, 이러한 고리는 치환기를 구비할 수 있고, 고리를 구성하는 탄소 원자는 케톤기를 형성할 수도 있다. 이러한 고리의 예로서, 시클로펜탄 고리, 시클로헥산 고리, 디시클로펜텐 고리, 테트라히드로피롤 고리, 테트라히드로푸란 고리, 피페리딘 고리 및 시클로펜탄 고리와 시클로헥산 고리 중의 탄소 원자가 케톤기에 의해 치환되어 얻어진 에스테르 고리 등을 들 수 있다. 방향족의 단일 고리 또는 융합 고리로서, 바람직하게는 C6 내지 C30인 단일 고리 또는 융합 고리이고, 예로서 벤젠 고리, 나프탈렌 고리 등을 예로 들수 있으며; 헤테로 원자를 포함하는 단일 고리 또는 다중 고리로서, 바람직하게는 피롤 고리, 피리딘 고리, 인돌 고리, N-페닐기에 의해 치환된 인돌 고리이다. R5 내지 R8 또는 R9 내지 R12 중의 인접한 기는 서로 연결되어 고리 모양 구조를 형성할 수 있고, 이러한 고리 구조의 예로서 상기 R1 내지 R4의 인접한 기로 형성된 고리 구조의 예와 동일하며, 바람직한 예도 동일하다.Here, R 1 to R 12 are the same or different and each independently preferably represents hydrogen, halogen, a substituted or unsubstituted C 1 to C 30 alkyl group, a substituted or unsubstituted C 2 to C 30 alkenyl group, hwandoen C 2 to C 30 alkynyl group, a substituted or unsubstituted C 3 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heterocycloalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, A substituted or unsubstituted C 2 to C 30 heteroaryl group, a C 6 to C 30 arylamino group or a heteroarylamino group; Alternatively, the adjacent groups of R 1 to R 4 may be connected to each other to form a cyclic structure, which may be an aliphatic single ring or multiple rings, a single ring or a fused ring of aromatic rings, Examples of the aliphatic single ring include an aliphatic five-membered ring and a six-membered ring formed by connecting any two adjacent radicals of R 1 to R 4 , The atom may be a hetero atom in addition to the carbon atom, and the ring may have a substituent, and the carbon atom constituting the ring may form a ketone group. Examples of such rings include cyclopentane rings, cyclohexane rings, dicyclopentene rings, tetrahydropyrrole rings, tetrahydrofuran rings, piperidine rings, and cyclopentane rings, in which the carbon atoms in the cyclohexane ring are substituted by a ketone group Ester rings, and the like. Aromatic single ring or fused ring, preferably a single ring or fused ring of C 6 to C 30 , examples being benzene ring, naphthalene ring and the like; A single ring or multiple rings containing a hetero atom, preferably an indole ring substituted by a pyrrole ring, a pyridine ring, an indole ring, or an N-phenyl group. Adjacent groups in R 5 to R 8 or R 9 to R 12 may be connected to each other to form a cyclic structure, and examples of such cyclic structure are the same as examples of the cyclic structure formed by adjacent groups of R 1 to R 4 , The preferred example is also the same.

구조식II에서, Ar1, Ar2는 각각 독립적으로 치환 또는 비치환된 C6 내지 C30아릴기이고, 바람직하게는, Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 C6 내지 C20 아릴기이며; 상기 아릴기는 더욱 바람직하게는 페닐기, 바이페닐기, 터페닐기, 나프틸기, 안트릴기, 페난트릴기, 인데닐기, 플루오레닐기 및 이의 유도체, 플루오란테닐기, 트리페닐렌기, 피레닐기, 페릴렌기, 크리세닐기와 나프타센기로 이루어진 군으로부터 선택되는 기이다. 상기 바이페닐기는 2-바이페닐기, 3-바이페닐기와 4-바이페닐기로부터 선택되고, 상기 터페닐기는 p-터페닐-4-일, p-터페닐-3-일, p-터페닐-2-일, m-터페닐-4-일, m-터페닐-3-일과 m-터페닐-2-일을 포함하며; 상기 나프틸기는 1-나프틸기와 2-나프틸기로 이루어진 군으로부터 선택되고; 상기 안트릴기는 1-안트릴기, 2-안트릴기와 9-안트릴기로 이루어진 군으로부터 선택되는 기이며; 상기 플루오레닐기는 1-플루오레닐기, 2-플루오레닐기, 3-플루오레닐기, 4-플루오레닐기와 9-플루오레닐기로 이루어진 군으로부터 선택되는 기이고; 상기 플루오레닐기 유도체는 9,9’-디메틸플루오렌, 9,9’-스피로바이플루오렌과 벤조플루오렌으로 이루어진 군으로부터 선택되는 기이며; 상기 피레닐기는 1-피레닐기, 2-피레닐기와 4-피레닐기로 이루어진 군으로부터 선택되는 기이고; 상기 나프타센기는 1-나프타센기, 2-나프타센기와 9-나프타센기로 이루어진 군으로부터 선택되는 기이다.In the structural formula II, Ar 1 and Ar 2 are each independently a substituted or unsubstituted C 6 to C 30 aryl group, preferably Ar 1 and Ar 2 are each independently a substituted or unsubstituted C 6 to C 20 An aryl group; The aryl group is more preferably a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, an anthryl group, a phenanthryl group, an indenyl group, a fluorenyl group and derivatives thereof, a fluoranthenyl group, a triphenylene group, a pyrenyl group, , A group selected from the group consisting of a chrysenyl group and a naphthacene group. The biphenyl group is selected from a 2-biphenyl group, a 3-biphenyl group and a 4-biphenyl group, and the terphenyl group is selected from the group consisting of p-terphenyl-4-yl, p- Yl, m-terphenyl-4-yl, m-terphenyl-3-yl and m-terphenyl-2-yl; The naphthyl group is selected from the group consisting of a 1-naphthyl group and a 2-naphthyl group; The anthryl group is a group selected from the group consisting of a 1-anthryl group, a 2-anthryl group and a 9-anthryl group; The fluorenyl group is a group selected from the group consisting of a 1-fluorenyl group, a 2-fluorenyl group, a 3-fluorenyl group, a 4-fluorenyl group and a 9-fluorenyl group; The fluorenyl group derivative is a group selected from the group consisting of 9,9'-dimethylfluorene, 9,9'-spirobifluorene and benzofluorene; The pyrenyl group is a group selected from the group consisting of a 1-pyrenyl group, a 2-pyrenyl group and a 4-pyrenyl group; The naphthacene group is a group selected from the group consisting of a 1-naphthacene group, a 2-naphthacene group and a 9-naphthacene group.

구조식II에서 Ar1과 Ar2는 치환 또는 비치환된 C3 내지 C30 헤테로아릴기일 수 있고, 상기 헤테로아릴기 중의 헤테로 원자로서, 바람직하게 하나 또는 다수의 O, S 및 N으로부터 선택되는 헤테로 원자이며, 상기 헤테로아릴기로서, 바람직하게 치환 또는 비치환된 C5 내지 C20 헤테로아릴기이고, 여기에서의 헤테로아릴기의 바람직한 예로서, 푸라닐기, 티에닐기, 피롤릴기, 벤조푸라닐기, 벤조티에닐기, 이소벤조푸라닐기, 인돌릴기, 디벤조푸라닐기, 디벤조티에닐기, 카르바졸릴기 및 이의 유도체와 벤조디옥솔기로 이루어진 군으로부터 선택되는 적어도 하나를 예로 들 수 있으며, 여기서, 상기 카르바졸릴기 유도체는 9-페닐카르바졸, 9-나프틸카르바졸벤조카르바졸, 디벤조카르바졸와 인돌로카르바졸 중의 적어도 하나를 포함하지만 이에 한정되지 않는다.In Structure II, Ar < 1 > and Ar < 2 > may be a substituted or unsubstituted C 3 to C 30 heteroaryl group and heteroatoms in the heteroaryl group preferably contain one or more heteroatoms selected from O, S and N and, as the heteroaryl group, preferably a substituted or unsubstituted C 5 to C 20 heteroaryl ring, as a preferable example of heteroaryl groups herein, furanyl group, thienyl group, pyrrolyl group, benzofuranyl group, benzo At least one selected from the group consisting of a thienyl group, an isobenzofuranyl group, an indolyl group, a dibenzofuranyl group, a dibenzothienyl group, a carbazolyl group and derivatives thereof, and a benzodioxole group can be exemplified, The benzyl group derivatives include, but are not limited to, 9-phenylcarbazole, 9-naphthylcarbazole benzocarbazole, dibenzocarbazole and indolocarbazole The.

구조식II에서, Ar1과 Ar2는 C6 내지 C30인 아릴아미노기 또는 헤테로아릴아미노기일 수 있고, 이의 구체적인 예로서, 디(헤테로)아릴아미노기, 트리(헤테로)아릴아미노기를 들 수 있으며, 여기서 “(헤테로)아릴기”의 표현 방식은 아릴기와 헤테로아릴기 두가지를 포함하고, 더욱 구체적인 예로서, 디페닐아미노기, 페닐나프틸아미노기, 4-트리페닐아미노기, 3-트리페닐아미노기, 4-[N-페닐-N-(디벤조푸란-3-일)]페닐아미노기, 4-[N-페닐-N-(디벤조티오펜-3-일)페닐아미노기로 이루어진 군으로부터 선택되는 기를 들 수 있다.In the structural formula II, Ar 1 and Ar 2 may be an arylamino group or a heteroarylamino group having 6 to 30 carbon atoms, and specific examples thereof include a di (hetero) arylamino group and a tri (hetero) arylamino group, The "(hetero) aryl group" includes two types of aryl groups and heteroaryl groups, and more specific examples thereof include a diphenylamino group, a phenylnaphthylamino group, a 4-triphenylamino group, a 3- Phenyl-N- (dibenzofuran-3-yl)] phenylamino group, and 4- [N-phenyl-N- (dibenzothiophen-3-yl) phenylamino group .

본 발명의 바람직한 화합물로서, 상기 화합물은 하기 일반식(III)과 같다.As a preferred compound of the present invention, the compound is represented by the following general formula (III).

Figure pct00009
Figure pct00009

여기서, Ar3, Ar4가 동일하거나 상이하고, 각각 독립적으로 C1 내지 C10 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C2 내지 C30 헤테로아릴기, C6 내지 C30인 아릴아미노기 또는 헤테로아릴아미노기이며;Wherein Ar 3 and Ar 4 are the same or different and each independently represents a C 1 to C 10 alkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 2 to C 30 heteroaryl group, An arylamino group or a heteroarylamino group having 6 to 30 carbon atoms;

여기서, R13 내지 R24는 동일하거나 상이하고, 각각 독립적으로 바람직하게는 수소, 할로겐, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C2 내지 C30 알케닐기, 치환 또는 비치환된 C2 내지 C30 알키닐기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C2 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C2 내지 C30 헤테로아릴기, C6 내지 C30 아릴아미노기 또는 헤테로아릴아미노기이며; 또는, R13 내지 R16의 인접한 기 서로 연결되어 고리 모양 구조를 형성할 수 있고, 이러한 고리 구조의 예는 상기 R1 내지 R4 중의 인접한 기로 형성된 고리 구조의 예와 동일하며, 바람직한 예도 동일하고; R17 내지 R20 중의 인접한 기는 서로 연결되어 고리 모양 구조를 형성할 수 있으며, 이러한 고리 구조의 예는 상기 R1 내지 R4의 인접한 라디칼로 형성된 고리 구조의 예와 동일하고, 바람직한 예도 동일하다.Here, R 13 to R 24 are the same or different and each independently preferably represents hydrogen, halogen, a substituted or unsubstituted C 1 to C 30 alkyl group, a substituted or unsubstituted C 2 to C 30 alkenyl group, An unsubstituted C 2 to C 30 alkynyl group, a substituted or unsubstituted C 3 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heterocycloalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group , A substituted or unsubstituted C 2 to C 30 heteroaryl group, a C 6 to C 30 arylamino group or a heteroarylamino group; Alternatively, adjacent groups of R 13 to R 16 may be connected to form a cyclic structure. Examples of such cyclic structure are the same as those of the cyclic structure formed of adjacent groups in R 1 to R 4 , and preferable examples are the same ; The adjacent groups in R 17 to R 20 may be connected to each other to form a cyclic structure. Examples of such cyclic structure are the same as those of the cyclic structure formed by adjacent radicals of R 1 to R 4 , and preferable examples are also the same.

구조식III에서, Ar3, Ar4는 각각 독립적으로 치환 또는 비치환된 C6 내지 C30 아릴기일 수 있고, 바람직하게는, Ar3과 Ar4는 각각 독립적으로 바람직하게는 치환 또는 비치환된 C6 내지 C20 아릴기, 치환 또는 비치환된 C3 내지 C30 헤테로아릴기, C6 내지 C30인 아릴아미노기 또는 헤테로아릴아미노기이며, 여기서의 아릴기, 헤테로아릴기, 아릴아미노기 또는 헤테로아릴아미노기의 구체적인 예와 바람직한 예로서, 상기 구조식II 중 대응되는 기에서 예로 든 대표적인 예, 바람직한 예와 동일하다.In the structural formula III, Ar 3 and Ar 4 may each independently be a substituted or unsubstituted C 6 to C 30 aryl group, and preferably Ar 3 and Ar 4 each independently preferably represent a substituted or unsubstituted C A C 6 to C 20 aryl group, a substituted or unsubstituted C 3 to C 30 heteroaryl group, a C 6 to C 30 arylamino group or a heteroarylamino group, wherein the aryl group, the heteroaryl group, the arylamino group or the heteroarylamino group Are the same as the representative and preferred examples exemplified in the corresponding groups in the structural formula II.

본 발명 화합물은 벤조시클로옥타테트라엔디인돌 구조를 모핵으로 하고, 대표적인 예로서, Ar을 페닐기로 하는 디벤조시클로옥타테트라엔디인돌 구조의 화합물의 삼중항 에너지 준위는 약 2.8(하기 도면 참조)이며, 이 외에, 인돌 구조 자체가 비교적 강한 정공 주입 능력을 가지고 있어, 이러한 특정된 전자 구름 밀도와 분포에 기반하면, 본 발명은 유기 전계 발광 소자의 발광층 호스트 재료, 정공 주입 재료와 정공 수송 재료에 특히 적합하게 사용된다.The compound of the present invention has a trinuclear energy level of about 2.8 (see the following drawing) of a dibenzocyclooctatraendienediindole structure compound having a benzocyclooctatetraendiindole structure as a parent nucleus and having a phenyl group as a representative example, In addition, the indole structure itself has a relatively strong hole injection capability. Based on this specified electron cloud density and distribution, the present invention is particularly suitable for a host material for a light emitting layer of an organic electroluminescent device, a hole injecting material and a hole transporting material Lt; / RTI >

Figure pct00010
Figure pct00010

이 외에, 특정된 치환기로 개질하여, 본 발명의 화합물의 호모(HOMO)및 루모(LUMO) 에너지 준위를 조절할 수 있고, 시클로옥타테트라엔의 공액계는 각각의 라디칼을 효과적으로 연결시킬수 있으므로, 고효율의 정공 주입과 정공 수송 성능을 실현하는 동시에, 비교적 높은 삼중항 에너지 준위를 보장하여, 일련의 고효율의 정공 주입과 수송 재료를 제공하고; 한편, 전자 끄는 기에 의해, 바람직하게는 피리딜기, 트리아진, 퀴나졸린, 퀴놀릴기, 옥사졸릴기 등 기의 개질에 의해, 재료 분자가 전자와 정공 수송성을 동시에 구비하도록 하며, 또한 여러 가지 기의 수량과 치환기의 위치를 조절하여, 높은 성능의 발광층 호스트 재료를 얻을 수 있는데, 일부 바람직한 화합물은 심지어 0에 접근하는 ΔEST의 에너지 차이를 나타내므로, 본 발명의 화합물을 호스트 재료로 하는 인광 발광의 유기 발광 다이오드(OLED) 소자의 작업 전압을 현저하게 저하시키고 긴 작업 수명을 실현할 수 있다.In addition, it is possible to modify the HOMO and LUMO energy levels of the compounds of the present invention by modifying with a specified substituent, and the conjugated system of cyclooctatetraene can effectively link each radical, Realizing hole injection and hole transporting performance and ensuring a relatively high triplet energy level to provide a series of high efficiency hole injection and transport materials; On the other hand, by electron-withdrawing groups, the material molecules are preferably provided with both electrons and holes transporting properties by modifying groups such as pyridyl group, triazine, quinazoline, quinolyl group and oxazolyl group, and the adjusting the position of the quantity and the substituent, there can be obtained a high performance of the light emitting layer host material, some preferred compounds are even exhibits an energy difference ΔE ST approaching zero, phosphorescent, which the compounds of the present invention as a host material The operation voltage of the organic light emitting diode (OLED) device of the present invention can be remarkably reduced and a long working life can be realized.

이 외에, 본 발명의 화합물의 식(II)과 (III)의 화합물의 가장 주요한 구별점은 대칭 관계가 상이한 것이다. 대칭 관계는 전자 구름의 배열, 막 형성 시의 결정 성장에 현저한 영향을 미친다. 이를 기초로하여, 본 발명자들은 예의 연구한 결과, 대칭 관계를 조절하고, 적합한 치환기를 선택하는 것을 통해, 본 발명의 화합물의 삼중항 에너지 준위, 공정 주입 수송 능력을 미세하게 조절할 수 있음을 발견하였고, 진일보로 필요에 따라 전기 성능을 최적화 하였으며, 다음과 같은 규칙을 귀납 하였다.In addition, the main distinguishing feature of the compounds of formulas (II) and (III) of the compounds of the present invention is that the symmetric relationships are different. The symmetric relationship has a significant influence on the electron cloud arrangement and crystal growth during film formation. Based on this finding, the present inventors have conducted intensive studies and have found that the triple energy level of the compound of the present invention, the process injection transport ability can be finely adjusted by controlling the symmetry relationship and selecting a suitable substituent , Further optimization of electrical performance as necessary, and the following rules were derived.

구체적으로, 본 발명의 화합물로서, 더욱 바람직하게는 일반식 II, III 중 Ar1 내지 Ar4, R1 내지 R24를 수소 원자 또는 중성(여기서 중성은 전자 주기와 전자 끌기 성능이 명확하지 않은 것을 지칭하고, 이하 동일하다)인 아릴기의 화합물로 하고, 중성인 아릴기로서, 예를 들어, 페닐기, 톨릴기, 바이페닐기, 나프틸기, 페난트릴기, 트리페닐렌기, 플루오란테닐기, 크리세닐기, 플루오레닐기, 인데노플루오레닐기 등을 들 수 있다. 구체적인 화합물의 예로서, 아래 A-1 내지 A-24의 화합물을 들지만, 이들 화합물에 한정되지 않는다.More specifically, as a compound of the present invention, Ar 1 to Ar 4 and R 1 to R 24 in the general formulas II and III are preferably a hydrogen atom or a neutral And the same shall apply hereinafter), and examples of the neutral aryl group include a phenyl group, a tolyl group, a biphenyl group, a naphthyl group, a phenanthryl group, a triphenylene group, a fluoranthenyl group, A decenyl group, a decenyl group, a decenyl group, a decenyl group, a decenyl group, a decenyl group, a decenyl group, Specific examples of the compound include the following compounds A-1 to A-24, but are not limited to these compounds.

Figure pct00011
Figure pct00011

Figure pct00012
Figure pct00012

Figure pct00013
Figure pct00013

Figure pct00014
Figure pct00014

Figure pct00015
Figure pct00015

Figure pct00016
Figure pct00016

Figure pct00017
Figure pct00017

상기 바람직한 화합물로서, 치환기가 중성 기이므로, 원래 전구물질 비스인돌릴시클로옥타테트라엔기의 전자 구름 밀도 및 분포를 현저하게 변경하지 않아, 치환기의 변화로 분자의 분자량을 변화시키는 것을 아주 잘 발휘하고 분자의 스태킹 방식을 조절할 수 있어, 소자 제조 과정에서 증착 성막의 공정 조건, 설비 종류의 상이한 요구에 따라 성막 분자의 물리 화학적 성질을 조절할 수 있고, 공정 자유도를 대폭 상승시키며; 분자의 대칭성, 결정성 등을 조절하여 더욱 좋은 증착막을 얻음으로써, 유기 전계 발광 소자의 발광 효율을 향상시키고, 구동 전압을 낮춘다.As the preferable compound, since the substituent is a neutral group, the electron cloud density and distribution of the original precursor bis-indolylcyclooctatetraene group are not remarkably changed, and the change of the molecular weight of the molecule by the change of the substituent is exhibited very well It is possible to control the stacking manner of the molecules, and it is possible to control the physicochemical properties of the film-forming molecules according to the process conditions of the deposition film formation and the different requirements of the equipment type in the device manufacturing process, By improving the symmetry of the molecules, the crystallinity, and the like to obtain a better evaporated film, the luminous efficiency of the organic electroluminescent device is improved and the driving voltage is lowered.

본 발명의 화합물로서, 더욱 더 바람직한 하기 일반식II, III 중 Ar1 내지 Ar4, R1 내지 R24은 수소 원자 또는 전자 주는 성질을 띤 헤테로아릴기의 화합물이고, 이러한 헤테로아릴기가 모핵과 상호작용함으로써, 본 발명의 화합물의 호모(HOMO) 에너지 준위를 미세하게 조절할 수 잇다. 본 발명자들은 연구를 통하여, 유기 전계 발광 소자에서, 정공 수송층으로서의 재료가 만약 호모(HOMO) 에너지 준위가 5.4eV 또는 이상이면, 발광층 호스트 재료의 호모(HOMO), 에너지 준위와 더욱 잘 매칭될 수 있으므로, 발광 효율을 향상시킨다는 것을 발견하였다. 일반식II, III 중 Ar1 내지 Ar4, R1 내지 R24가 전자 주는 성질을 띤 헤테로아릴기의 화합물임을 이용하여, 형성된 화합물의 호모(HOMO) 에너지 준위를 5.4 내지 5.7 내외로 할 수 있어, 정공 수송 재료로서의 사용에 아주 유익하다. 전자 주는 성질을 띤 헤테로아릴기로서, 카르바졸릴기, 디벤조푸라닐기, 디벤조티에닐기, 인돌로카르바졸릴기, 벤조푸라닐카르바졸릴기, 벤조티에노카르바졸릴기 등을 예로 들 수 있다. 구체적인 화합물의 예로서, 아래 B-1 내지 B-30의 화합물을 예로 들 수 있지만, 이들 화합물에 제한되지 않는다.As further preferred compounds of the present invention, Ar 1 to Ar 4 and R 1 to R 24 in the following general formulas II and III are compounds of a heteroaryl group having a hydrogen atom or electron donating property, The HOMO energy level of the compounds of the present invention can be finely controlled. Through research, the present inventors have found through research that if a material as a hole transporting layer has a HOMO energy level of 5.4 eV or more in an organic electroluminescent device, the HOMO energy level of the light emitting layer host material can be better matched , Thereby improving the luminous efficiency. Using the fact that Ar 1 to Ar 4 and R 1 to R 24 in the general formulas II and III are electron-donating heteroaryl groups, the HOMO energy level of the formed compound can be adjusted to about 5.4 to 5.7 , It is very useful for use as a hole transporting material. Examples of the electron-donating heteroaryl group include a carbazolyl group, a dibenzofuranyl group, a dibenzothienyl group, an indolocarbazolyl group, a benzofuranylcarbazolyl group, a benzothienocarbazolyl group and the like . Examples of specific compounds include, but are not limited to, the following compounds B-1 to B-30.

Figure pct00018
Figure pct00018

Figure pct00019
Figure pct00019

Figure pct00020
Figure pct00020

Figure pct00021
Figure pct00021

Figure pct00022
Figure pct00022

Figure pct00023
Figure pct00023

Figure pct00024
Figure pct00024

Figure pct00025
Figure pct00025

Figure pct00026
Figure pct00026

Figure pct00027
Figure pct00027

본 발명의 화합물로서, 더욱 더 바람직한 하기 일반식II, III 중 Ar1 내지 Ar4, R1 내지 R24는 수소 원자 또는 아릴아미노기의 화합물이고, 아릴아미노기와 벤조시클로옥타테트라엔디인돌 모핵의 상호작용에 의해, 화합물의 전자 주기 능력을 현저하게 향상시켜, 분자가 비교적 앝은 호모(HOMO) 에너지 준위와 아주 강한 정공 주입 능력을 구비하도록 하며, 이러한 화합물은 정공 주입층의 재료로서 특히 적합하게 사용된다. 디아릴아미노기의 구체적인 예로서, 디페닐아미노기, 페닐나프틸아미노기 등을 들 수 있다. Ar1 내지 Ar4, R1 내지 R24 중의 하나 또는 다수는 트리아릴아미노기일 수 있고, 구체적인 예로서, 4-트리페닐아미노기, 3-트리페닐아미노기, 4-[N-페닐-N-(디벤조푸란-3-일)]페닐아미노기, 4-[N-페닐-N-(디벤조티오펜-3-일)페닐아미노기로부터 선택되는 것을 들 수 있다. 이러한 정공 주입층 재료 화합물로 사용하기에 적합한 구체적인 예로서, 바람직하게는 아래 C-1 내지 C-15의 화합물들이 있지만, 이들 화합물에 한정되지 않는다.As more preferable compounds of the present invention, Ar 1 to Ar 4 and R 1 to R 24 in the following general formulas II and III are each a hydrogen atom or an arylamino group, and the interaction between the arylamino group and the benzocyclooctatetraendiindole , The electron cycling ability of the compound is remarkably improved so that the molecule has a relatively high HOMO energy level and a very strong hole injection ability and this compound is particularly suitably used as the material of the hole injection layer . Specific examples of the diarylamino group include a diphenylamino group and a phenylnaphthylamino group. One or more of Ar 1 to Ar 4 and R 1 to R 24 may be a triarylamino group, and specific examples thereof include 4-triphenylamino group, 3-triphenylamino group, 4- [N-phenyl- Benzofuran-3-yl)] phenylamino group, and 4- [N-phenyl-N- (dibenzothiophen-3-yl) phenylamino group. As specific examples suitable for use as such hole injection layer material compounds, there are preferably the following compounds C-1 to C-15, but are not limited to these compounds.

Figure pct00028
Figure pct00028

Figure pct00029
Figure pct00029

Figure pct00030
Figure pct00030

Figure pct00031
Figure pct00031

본 발명의 화합물로서, 더욱 더 바람직한 하기 일반식II, III 중 Ar1 내지 Ar4, R1 내지 R24는 수소 또는 전자 끌기 성질의 기를 구비한 화합물이다. 비스인돌릴시클로옥타테트라엔 전구물질 상에 비교적 강한 전자 끌기 능력을 지닌 기가 연결될 경우, 분자가 동시에 바이폴라 수송 성능을 구비하도록, 원래의 정공 주입 및 수송 성능을 유지하는 외에, 전자의 주입과 수송 성능을 부가하였으며, 이러한 화합물은 전자와 정공의 수송 성능이 모두 우월하여, 호스트 재료, 특히 인광 발광 소자의 호스트 재료로서, 균일한 캐리어 수송 성능에 의해 높은 밝기 하에서의 효율 저하를 피함으로써, 소자의 밝기와 작업 전압을 저하시키고, 소자의 효율을 향상시키며, 소자의 수명을 연장한다. 전자 끄는 기로서, 피리딜기, 페닐피리딜기, 퀴놀릴기, 치환된 퀴놀릴기, 퀴나졸리닐기, 치환된 퀴나졸리닐기, 퀴녹살리닐기, 치환된 퀴녹살리닐기, 피리미디닐기, 치환된 피리미디닐기, o-페난트롤린기, 트리아지닐기, 치환된 트리아지닐기, 벤즈이미다졸릴기, 옥사졸릴기 등을 예로 들 수 있다. 이러한 바람직한 화합물의 구체적인 예로서, 아래 D-1 내지 D-39의 화합물을 들지만, 이들 화합물에 한정되지 않는다.As further preferred compounds of the present invention, Ar 1 to Ar 4 and R 1 to R 24 in the following general formulas (II) and (III) are compounds having hydrogen or an electron withdrawing group. In the case where a group having a relatively strong electron attracting ability is connected to the bisindolylcyclooctatetraene precursor, in addition to maintaining the original hole injecting and transporting performance so that the molecules simultaneously have the bipolar transporting performance, the electron injecting and transporting performance These compounds are excellent in the transporting performance of electrons and holes, and as a host material, particularly a host material of a phosphorescent light emitting device, by avoiding a decrease in efficiency under high brightness due to uniform carrier transporting performance, Lowering the working voltage, improving the efficiency of the device, and extending the lifetime of the device. Examples of the electron withdrawing group include a pyridyl group, a phenylpyridyl group, a quinolyl group, a substituted quinolyl group, a quinazolinyl group, a substituted quinazolinyl group, a quinoxalinyl group, a substituted quinoxalinyl group, a pyrimidinyl group, Naphthyl group, o-phenanthroline group, triazinyl group, substituted triazinyl group, benzimidazolyl group, oxazolyl group and the like. Specific examples of such preferred compounds include the following compounds D-1 to D-39, but are not limited to these compounds.

Figure pct00032
Figure pct00032

Figure pct00033
Figure pct00033

Figure pct00034
Figure pct00034

Figure pct00035
Figure pct00035

Figure pct00036
Figure pct00036

Figure pct00037
Figure pct00037

Figure pct00038
Figure pct00038

Figure pct00039
Figure pct00039

Figure pct00040
Figure pct00040

Figure pct00041
Figure pct00041

유기 abandonment 전계Field 발광 소자 Light emitting element

본 발명은 상기 본 발명의 신규한 화합물을 사용한 유기 전계 발광 소자를 더 제공한다. 본 발명의 유기 전계 발광 소자 구조는 일반적인 소자 구조와 다르지 않으며, 일반적으로 제1 전극, 제2 전극과 상기 제1 전극과 상기 제2 전극 사이에 삽입되는 한 층 또는 다층 유기층을 포함하고, 상기 유기층은 상기 유기 전계 발광 화합물을 포함하는 것을 특징으로 한다. 제1 전극과 제2 전극 사이의 유기층으로서, 통상적으로 전자 주입층, 전자 수송층, 발광층, 정공 수송층, 정공 주입층 등 유기층이 있다. 본 발명의 화합물은 정공 주입 재료/정공 수송 재료 및/또는 발광 호스트 재료로 사용 가능하지만 이에 한정되지 않는다.The present invention further provides an organic electroluminescent device using the novel compound of the present invention. The organic electroluminescent device structure of the present invention is not different from a general device structure and generally includes a first electrode, a second electrode and a single-layer or multi-layer organic layer interposed between the first electrode and the second electrode, Is characterized by including the organic electroluminescent compound. As the organic layer between the first electrode and the second electrode, an organic layer such as an electron injecting layer, an electron transporting layer, a light emitting layer, a hole transporting layer, and a hole injecting layer is usually used. The compound of the present invention can be used as a hole injecting material / hole transporting material and / or a light emitting host material, but is not limited thereto.

여기서, 본 발명의 유기 전계 발광 소자의 바람직한 예로서, 화합물A-1 내지 A-24, D-1 내지 D-39을 발광층 호스트 재료로 사용한 유기 전계 발광 소자, 화합물B-1 내지 B-30을 정공 수송층 재료로 사용한 유기 전계 발광 소자 및 상기 화합물 C-1 내지 C-15를 정공 주입층의 재료로 사용한 유기 전계 발광 소자를 들 수 있다. 본 발명의 유기 전계 발광 소자는 본 발명의 화합물의 우월한 성능에 기반하여, 소자의 밝기와 작업 전압을 저하시키고, 소자의 효율을 향상시키며, 소자 수명을 연장할 수 있다.As organic EL devices of the present invention, organic electroluminescent devices, compounds B-1 to B-30, which use compounds A-1 to A-24 and D-1 to D- An organic electroluminescent device used as a hole transporting layer material and an organic electroluminescent device using the above-mentioned compounds C-1 to C-15 as a material for a hole injecting layer. The organic electroluminescent device of the present invention can lower the brightness and the operation voltage of the device, improve the efficiency of the device, and extend the lifetime of the device based on the superior performance of the compound of the present invention.

실시예Example

아래 실시예를 참조하여 본 발명의 대표적인 화합물의 제조 방법을 설명한다. 본 발명의 화합물은 동일한 골격을 가지므로, 당업자들은 이러한 제조 방법에 기초하여, 공지된 관능기 전환 방법에 의해, 다른 본 발명의 화합물을 용이하게 합성할 수 있다. 이하, 상기 화합물을 포함하는 발광 소자의 제조 방법과 발광 성질 측정을 더 제공한다.The following examples illustrate the preparation of representative compounds of the present invention. Since the compounds of the present invention have the same skeleton, those skilled in the art can easily synthesize other compounds of the present invention based on such a production method by a known functional group conversion method. Hereinafter, a method for manufacturing a light emitting device including the compound and a measurement of light emitting properties are further provided.

합성 실시예Synthesis Example

이하 본 발명의 대표적인 화합물의 합성 방법을 간단히 설명한다.Hereinafter, a method of synthesizing the representative compounds of the present invention will be briefly described.

본 발명에서 사용한 여러 가지 화학약품, 예를 들어, 석유에테르, 아세트산에틸, n-헥산, 톨루엔, 테트라히드로푸란, 디클로로메탄, 사염화탄소, 아세톤, 1,2-비스(브로모메틸)벤젠, CuI, o-프탈로일디클로라이드, 페닐히드라진 히드로클로라이드, 트리플루오로아세트산, 아세트산, 트랜스-디아미노시클로헥산, 요오도벤젠, 탄산세슘, 인산칼륨, 에틸렌디아민, 벤조페논, 시클로펜타논, 9-플루오레논, 소듐 tert-부톡시드, 메탄술폰산, 1-브로모-2-메틸나프탈렌, o-디브로모벤젠, 부틸리튬, 디브로모에탄, o-디브로모벤젠, 벤조일퍼옥시드, 1-(2-브로모페닐)-2-메틸나프탈렌, N-브로모숙신이미드, 메톡시메틸트리메틸포스포늄 클로라이드, 트리스(디벤질리덴아세톤)디팔라듐, 테트라키스(트리페닐포스핀)팔라듐, 1,3-비스디페닐포스피노프로판니켈 클로라이드, 카르바졸, 3,6-디메틸카르바졸, 3-(2-나프틸)-6-페닐카르바졸, N-페닐카르바졸-3-보론산, 9-(2-나프틸)카르바졸-3-보론산 등의 기초 화학 원료는 모두 중국 국내 화학 공업 제품 시장에서 구매할 수 있다.Various chemicals used in the present invention such as petroleum ether, ethyl acetate, n-hexane, toluene, tetrahydrofuran, dichloromethane, carbon tetrachloride, acetone, 1,2- bis (bromomethyl) but are not limited to, o-phthaloyl chloride, phenylhydrazine hydrochloride, trifluoroacetic acid, acetic acid, trans-diaminocyclohexane, iodobenzene, cesium carbonate, potassium phosphate, ethylenediamine, benzophenone, cyclopentanone, Dibromoethane, o-dibromobenzene, benzoyl peroxide, 1- (2-methyl-2-naphthyl) benzene, (Dibenzylideneacetone) dipalladium, tetrakis (triphenylphosphine) palladium, 1,3-bis (triphenylphosphine) palladium, - bisdiphenylphosphinopropane nickel chloride, Carbazole, 9- (2-naphthyl) carbazole-3-boron, All basic chemical raw materials such as acids can be purchased in Chinese domestic chemical products market.

본 발명에서의 중간체와 화합물의 분석 검출은 ABSCIEX질량분석계(4000QTRAP)와 브루커 핵자기공명분광기(400M)를 사용하였다.Analysis of the intermediates and compounds in the present invention was performed using an ABSCIEX mass spectrometer (4000 QTRAP) and a Bruker nuclear magnetic resonance spectrometer (400M).

유기 발광 화합물의 제조:Preparation of organic luminescent compounds:

합성 실시예1. 중간체M1의 합성:Synthesis Example 1 Synthesis of intermediate M1:

Figure pct00042
Figure pct00042

1L의 삼구 플라스크에 1,2-비스(브로모메틸)벤젠(26.4g, 0.1mol)과 500mL의 무수 테트라히드로푸란(THF)을 넣고, 질소 기체 보호 하에서, 활성화시킨 아연 분말(13g, 0.2mol)을 넣어, 2시간 동안 반응시켜, 이중 아연 시약을 제조한다. CuI(2g, 10mmol)와 o-프탈로일디클로라이드(20g, 0.1mol)를 넣고, 우선 실온에서 1시간 동안 반응시키고, 다시 환류 조건 하에서 10시간 동안 반응시킨다. 반응 완료 후, 포화 염화암모늄 수용액을 천천히 넣어 반응을 종료시킨 후, 100mL의 아세트산에틸로 3회 추출하여 얻어진 유기상을 합치고, 무수 MgSO4로 건조시키고, 감압하여 유기 용매를 제거한 후, 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 중간체 화합물M(18.5g, 수율은 78.4%임)을 얻는다.To a 1 L three-necked flask was added 1,2-bis (bromomethyl) benzene (26.4 g, 0.1 mol) and 500 mL of anhydrous tetrahydrofuran (THF) and under nitrogen gas protection, activated zinc powder (13 g, 0.2 mol ), And the mixture is reacted for 2 hours to prepare a double zinc reagent. Phthaloyl chloride (20 g, 0.1 mol) was added to CuI (2 g, 10 mmol) and the reaction was first carried out at room temperature for 1 hour, followed by reaction under reflux condition for 10 hours. After completion of the reaction, the saturated ammonium chloride aqueous solution was slowly added thereto to terminate the reaction. The reaction was terminated by extraction with 100 mL of ethyl acetate three times. The combined organic phases were dried over anhydrous MgSO 4 and evaporated under reduced pressure to remove the organic solvent. Column chromatography separation was carried out to obtain intermediate compound M (18.5 g, yield 78.4%).

1L의 삼구 플라스크에 페닐히드라진 히드로클로라이드(63.6g, 0.44mol), 중간체 화합물M(47.2g, 0.2mol), 400mL의 에탄올을 넣고, 3분 내에 2.1g의 농황산을 드로핑 하며, 65℃에서 4시간 동안 반응시키고, 반응 완료 후, 실온까지 냉각시키며, 여과한 다음, 순차적으로 에탄올, 석유에테르로 필터 케이크를 세척하여, 백색 고체M1-1(83g, 수율은 82.9%임)을 얻는다.Phenylhydrazine hydrochloride (63.6 g, 0.44 mol), intermediate compound M (47.2 g, 0.2 mol) and 400 mL of ethanol were placed in a 1 L three-necked flask, 2.1 g of concentrated sulfuric acid was dropped in 3 minutes, After completion of the reaction, the reaction mixture is cooled to room temperature, filtered, and then the filter cake is sequentially washed with ethanol and petroleum ether to obtain 83.1 g of a white solid M1-1 (yield 82.9%).

1L의 삼구 플라스크에 상기 M1-1(49g, 0.1mol), 650g의 아세트산, 65g의 트리플루오로아세트산을 넣고, 72℃ 하에서 15시간 동안 환류 반응시키며, 실온까지 냉각시키고, 여과한 다음, 순차적으로 아세트산, 석유에테르로 필터 케이크를 세척하여, 백색 고체의 중간체 화합물M1(25g, 65%)을 얻는다.The above M1-1 (49 g, 0.1 mol), 650 g of acetic acid and 65 g of trifluoroacetic acid were placed in a 1 L three-necked flask, refluxed at 72 캜 for 15 hours, cooled to room temperature, filtered, The filter cake is washed with acetic acid and petroleum ether to give intermediate compound M1 (25 g, 65%) as a white solid.

M1의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of M1:

1H NMR(500 MHz, Chloroform) δ 8.76(s, 1H), 8.42(s, 2H), 8.14(d, J = 45.0 Hz, 3H), 7.40(s, 1H), 7.19(d, J = 10.0 Hz, 2H). 1 H NMR (500 MHz, Chloroform ) δ 8.76 (s, 1H), 8.42 (s, 2H), 8.14 (d, J = 45.0 Hz, 3H), 7.40 (s, 1H), 7.19 (d, J = 10.0 Hz, 2H).

합성 실시예2. 중간체M2의 합성Synthesis Example 2 Synthesis of intermediate M2

Figure pct00043
Figure pct00043

1L의 삼구 플라스크에 3-브로모페닐히드라진히드로클로라이드(92.8g, 0.415mol), 디케톤 중간체M(49g, 0.207mol, 에탄올(400mL), 교반 조건 하에서, 3분 내에 2g의 농황산을 드로핑 하며, 65℃에서 4시간 동안 반응시키고, 반응 완료 후, 실온까지 냉각시키며, 여과한 다음, 순차적으로 에탄올, 석유에테르로 필터 케이크를 세척하여, 중간체 화합물M2-1(122g, 91%)을 얻는다.In a 1 L three-necked flask, 3 g of 3-bromophenylhydrazine hydrochloride (92.8 g, 0.415 mol), dicetone intermediate M (49 g, 0.207 mol, ethanol (400 mL) , And reacted at 65 DEG C for 4 hours. After completion of the reaction, the reaction mixture was cooled to room temperature, filtered, and then washed with ethanol and petroleum ether sequentially to obtain an intermediate compound M2-1 (122 g, 91%).

1L의 삼구 플라스크에 화합물M2-1(48.4g, 74.8mmol), 아세트산(650g)과 트리플루오로아세트산(65g, 0.57mol)를 넣고, 72℃ 하에서 15시간 동안 환류 반응시키며, 실온까지 냉각시키고, 여과한 다음, 순차적으로 아세트산, 석유에테르로 필터 케이크를 세척하여, 중간체 화합물M2-2(35g, 85%)를 얻는다.The compound M2-1 (48.4 g, 74.8 mmol), acetic acid (650 g) and trifluoroacetic acid (65 g, 0.57 mol) were placed in a 1 L three-necked flask and refluxed at 72 ° C for 15 hours, cooled to room temperature, After filtration, the filter cake is sequentially washed with acetic acid and petroleum ether to obtain an intermediate compound M2-2 (35 g, 85%).

자일렌(100mL), M2-2(5.4g, 10mmol), 요오도벤젠(5.1g, 25mmol), CuI(0.9g, 5mmol), 트랜스-디아미노시클로헥산(2.1mL, 20mmol)과 탄산세슘(6.5g, 20mmol)을 혼합하고, 3시간 동안 환류 반응시키며, 반응 완료 후, 실온까지 냉각시키고, 여과한 다음, 디클로로메탄으로 필터 케이크를 세척하며, 여액을 합하고, 건조시킨 후, 감압하여 용매를 제거하여, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 체적비가 1:2인 디클로로메탄과 석유에테르의 혼합 용액), 중간체 화합물M2를 얻으며, 백색 고체(5.88g, 수율은 85%임)이다.(5.1 mL, 25 mmol), CuI (0.9 g, 5 mmol), trans-diaminocyclohexane (2.1 mL, 20 mmol) and cesium carbonate 6.5 g, 20 mmol) were mixed and refluxed for 3 hours. After completion of the reaction, the reaction mixture was cooled to room temperature, filtered and washed with dichloromethane. The filtrate was combined, dried, The obtained distillation residue was subjected to column chromatographic separation (eluent: mixed solution of dichloromethane and petroleum ether having a volume ratio of 1: 2) to obtain intermediate compound M2, and a white solid (5.88 g, yield 85 %).

M2의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of M2:

1H NMR(500 MHz, Chloroform) δ 8.72(s, 1H), 8.41(s, 2H), 8.09(s, 2H), 7.88(s, 1H), 7.59(d, J = 20.0 Hz, 3H), 7.49(s, 2H), 7.38(s, 1H). 1 H NMR (500 MHz, Chloroform ) δ 8.72 (s, 1H), 8.41 (s, 2H), 8.09 (s, 2H), 7.88 (s, 1H), 7.59 (d, J = 20.0 Hz, 3H), 7.49 (s, 2 H), 7.38 (s, 1 H).

합성 실시예3. 중간체M3의 합성Synthesis Example 3. Synthesis of intermediate M3

Figure pct00044
Figure pct00044

1L의 삼구 플라스크에 4-브로모페닐히드라진히드로클로라이드(92.8g, 0.415mol), 디케톤 중간체M(49g, 0.207mol, 에탄올(400mL)을 넣고, 교반 조건 하에서, 3분 내에 2g의 농황산을 드로핑 하며, 65℃에서 4시간 동안 반응시키고, 반응 완료 후, 실온까지 냉각시키며, 여과하고, 순차적으로 에탄올, 석유에테르로 필터 케이크를 세척하여, 중간체 화합물M3-1(113g, 수율은 84%임)을 얻는다.4-bromophenylhydrazine hydrochloride (92.8 g, 0.415 mol), dicetone intermediate M (49 g, 0.207 mol, ethanol (400 mL) were charged into a 1 L three-necked flask, and 2 g of concentrated sulfuric acid After completion of the reaction, the reaction mixture was cooled to room temperature, filtered, and the filter cake was washed successively with ethanol and petroleum ether to obtain Intermediate Compound M3-1 (113 g, yield: 84% ).

1L의 삼구 플라스크에 화합물M3-1(65g, 0.1mol), 아세트산(650g)과 트리플루오로아세트산(65g, 0.57mol)을 넣고, 72℃ 하에서 15시간 동안 환류 반응시키며, 실온까지 냉각시키고, 여과하고, 순차적으로 아세트산, 석유에테르로 필터 케이크를 세척하여, 중간체 화합물M3-2(42g, 수율은 77%임)를 얻는다.(65 g, 0.1 mol), acetic acid (650 g) and trifluoroacetic acid (65 g, 0.57 mol) were placed in a 1 L three-necked flask and refluxed at 72 ° C for 15 hours, cooled to room temperature, And the filter cake was washed sequentially with acetic acid and petroleum ether to obtain an intermediate compound M3-2 (42 g, yield: 77%).

자일렌(100mL), M3-2(5.4g, 10mmol), 요오도벤젠(5.1g, 25mmol), CuI(0.9g, 5mmol), 트랜스-디아미노시클로헥산(2.1mL, 20mmol)과 탄산세슘(6.5g, 20mmol)을 혼합하고, 3시간 동안 환류 반응시키며, 반응 완료 후, 실온까지 냉각시키고, 여과한 다음, 디클로로메탄으로 필터 케이크를 세척하며, 여액을 합하고, 건조시킨 후, 감압하여 용매를 제거하여, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 체적비가 1:2인 디클로로메탄과 석유에테르의 혼합 용액), 중간체 화합물M3을 얻으며, 백색 고체(4.92g, 수율은 71%임)이다.(5.1 mL, 25 mmol), CuI (0.9 g, 5 mmol), trans-diaminocyclohexane (2.1 mL, 20 mmol) and cesium carbonate 6.5 g, 20 mmol) were mixed and refluxed for 3 hours. After completion of the reaction, the reaction mixture was cooled to room temperature, filtered and washed with dichloromethane. The filtrate was combined, dried, (Eluent: a mixed solution of dichloromethane and petroleum ether having a volume ratio of 1: 2) to obtain an intermediate compound M3. A white solid (4.92 g, yield: 71%) was obtained, and the obtained distillation residue was subjected to column chromatography %).

M3의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of M3:

1H NMR(500 MHz, Chloroform) δ 8.42(s, 1H), 8.10(s, 1H), 7.89(s, 1H), 7.62(s, 1H), 7.58(s, 1H), 7.50(s, 1H), 7.43(d, J = 17.9 Hz, 1H). 1 H NMR (500 MHz, Chloroform ) δ 8.42 (s, 1H), 8.10 (s, 1H), 7.89 (s, 1H), 7.62 (s, 1H), 7.58 (s, 1H), 7.50 (s, 1H ), 7.43 (d, J = 17.9 Hz, 1 H).

합성 실시예4. 중간체M4의 합성Synthetic Example 4. Synthesis of intermediate M4

Figure pct00045
Figure pct00045

합성 실시예1과 동일한 합성 방법을 사용하는데, 구별점은, 페닐히드라진히드로클로라이드를 같은 당량의 2-나프틸히드라진히드로클로라이드로 교체하여, 세 단계의 합성 반응을 거쳐, 중간체M4를 얻고, 34.2g의 백색 고체이며, 마지막 한 단계의 합성 수율은 71%이다.The same synthetic method as in Synthesis Example 1 was used except that phenylhydrazine hydrochloride was replaced with the same equivalent amount of 2-naphthylhydrazine hydrochloride to obtain intermediate M4 through three stages of synthesis, and 34.2 g Of the title compound, the synthesis yield of the last step is 71%.

M4의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of M4:

1H NMR(500 MHz, Chloroform) δ 8.76(s, 1H), 8.42(s, 2H), 8.30(d, J = 16.0 Hz, 2H), 8.14(s, 1H), 8.10(s, 2H), 7.84(s, 1H), 7.75(s, 1H), 7.48(s, 1H). 1 H NMR (500 MHz, Chloroform ) δ 8.76 (s, 1H), 8.42 (s, 2H), 8.30 (d, J = 16.0 Hz, 2H), 8.14 (s, 1H), 8.10 (s, 2H), 7.84 (s, 1 H), 7.75 (s, 1 H), 7.48 (s, 1 H).

합성 실시예5. 중간체M5의 합성Synthesis Example 5. Synthesis of intermediate M5

Figure pct00046
Figure pct00046

합성 실시예1과 동일한 합성 방법을 사용하는데, 구별점은, 페닐히드라진히드로클로라이드를 같은 당량의 1-나프틸히드라진히드로클로라이드로 교체하여, 세 단계의 합성 반응을 거쳐, 중간체M5를 얻고, 31g의 백색 고체이며, 마지막 한 단계의 합성 수율은 67%이다.The same synthesis procedure as in Synthesis Example 1 was used except that phenylhydrazine hydrochloride was replaced by the same equivalent amount of 1-naphthylhydrazine hydrochloride and three stages of synthesis were conducted to obtain intermediate M5, and 31 g of It is a white solid and the synthesis yield in the last step is 67%.

M5의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of M5:

1H NMR(500 MHz, Chloroform) δ 9.60(s, 1H), 8.51(s, 1H), 8.42(s, 2H), 8.11(d, J = 5.0 Hz, 3H), 7.72(s, 1H), 7.67(s, 1H), 7.63(s, 1H), 7.08(s, 1H). 1 H NMR (500 MHz, Chloroform ) δ 9.60 (s, 1H), 8.51 (s, 1H), 8.42 (s, 2H), 8.11 (d, J = 5.0 Hz, 3H), 7.72 (s, 1H), 7.67 (s, 1 H), 7.63 (s, 1 H), 7.08 (s, 1 H).

합성 실시예6. 중간체M6의 합성: Synthesis Example 6. Synthesis of intermediate M6:

Figure pct00047
Figure pct00047

1L의 삼구 플라스크에 페닐히드라진 히드로클로라이드(60g, 0.415mol), 디벤조[a,e]-5,11-시클로옥타디엔(6H,12H)-디케톤(49g, 0.207mol)과 에탄올(400mL)을 넣고, 교반 조건 하에서, 3분 내에 2.1g의 농황산을 드로핑 하며, 65℃에서 4시간 동안 반응시키고, 반응 완료 후, 실온까지 냉각시키며, 여과한 다음, 순차적으로 아세트산, 석유에테르로 필터 케이크를 세척하여, 고체M6-1(56g)을 얻는다.(60 g, 0.415 mol), dibenzo [a, e] -5,11-cyclooctadiene (6H, 12H) -diketone (49 g, 0.207 mol) and ethanol (400 mL) were added to a 1 L three- 2.1 g of concentrated sulfuric acid was dropped in 3 minutes under agitation conditions and reacted at 65 DEG C for 4 hours. After completion of the reaction, the reaction mixture was cooled to room temperature and filtered. Then, acetic acid and petroleum ether were sequentially added to the filter cake To give solid M6-1 (56 g).

1L의 삼구 플라스크에 48g의 M6-1, 650g아세트산과 65g의 트리플루오로아세트산을 넣고, 72℃ 하에서 15시간 동안 환류 반응시키며, 실온까지 냉각시키고, 여과하고, 순차적으로 에탄올, 석유에테르로 필터 케이크를 세척하여, 화합물M6(29g, 65%)을 얻는다.48 g of M6-1, 650 g of acetic acid and 65 g of trifluoroacetic acid were placed in a 1 L three-necked flask, refluxed at 72 ° C for 15 hours, cooled to room temperature, filtered, washed successively with ethanol and petroleum ether To give compound M6 (29 g, 65%).

M6의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of M6:

1H NMR(500 MHz, Chloroform) δ 8.75(s, 1H), 8.42(s, 2H), 8.14(d, J = 45.0 Hz, 3H), 7.40(s, 1H), 7.19(d, J = 10.0 Hz, 2H). 1 H NMR (500 MHz, Chloroform ) δ 8.75 (s, 1H), 8.42 (s, 2H), 8.14 (d, J = 45.0 Hz, 3H), 7.40 (s, 1H), 7.19 (d, J = 10.0 Hz, 2H).

합성 실시예7. 중간체M7의 합성Synthetic Example 7. Synthesis of intermediate M7

Figure pct00048
Figure pct00048

중간체M7(38.6g, 0.1mol), 1-브로모-4-요오도벤젠(56.7g, 0.2mol), CuI(3.3g, 17.1mmol), K3PO4(21.8g, 102.9mmol), 에틸렌디아민(2.3mL, 34.3mmol)과 톨루엔(500mL)을 혼합하고, 환류 조건 하에서 하루 동안 교반하며, 반응 완료 후, 실온까지 냉각시키고, 유기층을 아세트산에틸로 추출하고 감압 증류하여, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 디클로로메탄/헥산), 화합물(48.3g, 70.1%)을 얻는다.Intermediate M7 (38.6g, 0.1mol), 1- bromo-4-iodobenzene (56.7g, 0.2mol), CuI ( 3.3g, 17.1mmol), K 3 PO 4 (21.8g, 102.9mmol), ethylene After completion of the reaction, the reaction mixture was cooled to room temperature. The organic layer was extracted with ethyl acetate, and the mixture was distilled under reduced pressure. The residue was purified by silica gel column chromatography (Eluent: dichloromethane / hexane) to obtain the compound (48.3 g, 70.1%).

M7의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of M7:

1H NMR(500 MHz, Chloroform) δ 8.47(d, J = 64.9 Hz, 46H), 8.38 - 8.37(m, 1H), 8.08(s, 26H), 7.77(s, 33H), 7.55(d, J = 49.9 Hz, 46H), 7.14(s, 9H), 7.09(s, 13H). 1 H NMR (500 MHz, Chloroform ) δ 8.47 (d, J = 64.9 Hz, 46H), 8.38 - 8.37 (m, 1H), 8.08 (s, 26H), 7.77 (s, 33H), 7.55 (d, J = 49.9 Hz, 46H), 7.14 (s, 9H), 7.09 (s, 13H).

합성 실시예8. 중간체M8의 합성Synthetic Example 8. Synthesis of intermediate M8

Figure pct00049
Figure pct00049

합성 실시예1과 동일한 합성 방법을 사용하는데, 구별점은, o-프탈로일디클로라이드를 같은 당량의 4-브로모-o-프탈로일디클로라이드로 교체하여, 세 단계의 합성 반응을 거쳐, 중간체M8을 얻고, 34.6g의 백색 고체이며, 세 단계 총 수율은 75%이다.The same synthetic method as in Synthesis Example 1 was used except that o-phthaloyl dichloride was replaced with the same equivalent amount of 4-bromo-o-phthaloyl dichloride to give the intermediate M8, 34.6 g of a white solid, with a total three-step yield of 75%.

M8의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of M8:

1H NMR(500 MHz, Chloroform) δ 8.76(d, J = 15.0 Hz, 2H), 8.42(s, 2H), 8.14(d, J = 45.0 Hz, 4H), 7.38(t, J = 27.5 Hz, 4H), 7.19(d, J = 10.0 Hz, 4H), 7.11(s, 1H). 1 H NMR (500 MHz, Chloroform ) δ 8.76 (d, J = 15.0 Hz, 2H), 8.42 (s, 2H), 8.14 (d, J = 45.0 Hz, 4H), 7.38 (t, J = 27.5 Hz, 4H), 7.19 (d, J = 10.0 Hz, 4H), 7.11 (s, 1H).

합성 실시예9. 중간체M9의 합성Synthesis Example 9. Synthesis of intermediate M9

Figure pct00050
Figure pct00050

합성 실시예6과 동일한 합성 방법을 사용하는데, 구별점은, 디벤조[a,e]-5,11-시클로옥타디엔(6H,12H)-디케톤을 같은 당량의 2-브로모디벤조[a,e]-5,11-시클로옥타디엔(6H,12H)-디케톤으로 교체하여, 두 단계의 합성 반응을 거쳐, 중간체M9를 얻고, 37g의 백색 고체이며, 세 단계 총 수율은 80%이다.Dibenzo [a, e] -5,11-cyclooctadiene (6H, 12H) -diketone was reacted with the same equivalent of 2-bromodibenzo [a , e] -5,11-cyclooctadiene (6H, 12H) -diketone to give intermediate M9, which is a white solid of 37 g, with a total three-step yield of 80% .

M9의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of M9:

1H NMR(500 MHz, Chloroform) δ 8.74(d, J = 8.5 Hz, 2H), 8.42(s, 2H), 8.14(d, J = 45.0 Hz, 4H), 7.38(t, J = 27.5 Hz, 4H), 7.19(d, J = 10.0 Hz, 4H), 7.11(s, 1H). 1 H NMR (500 MHz, Chloroform ) δ 8.74 (d, J = 8.5 Hz, 2H), 8.42 (s, 2H), 8.14 (d, J = 45.0 Hz, 4H), 7.38 (t, J = 27.5 Hz, 4H), 7.19 (d, J = 10.0 Hz, 4H), 7.11 (s, 1H).

합성 실시예10. 중간체M10의 합성Synthesis Example 10. Synthesis of intermediate M10

Figure pct00051
Figure pct00051

합성 실시예1과 동일한 합성 방법을 사용하는데, 구별점은, 1,2-비스(브로모메틸)벤젠을 같은 당량의 4-브로모-1,2-비스(브로모메틸)벤젠으로 교체하여, 세 단계의 합성 반응을 거쳐, 중간체M108을 얻고, 32g의 백색 고체이며, 세 단계 총 수율은 71%이다.The same synthetic method as in Synthesis Example 1 was used, the point of difference being that by replacing 1,2-bis (bromomethyl) benzene with the equivalent equivalent of 4-bromo-1,2-bis (bromomethyl) To give intermediate M108, which is 32 g of a white solid. The three-step total yield is 71%.

M10의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of M10:

1H NMR(500 MHz, Chloroform) δ 8.76(d, J = 8.5 Hz, 2H), 8.42(s, 2H), 8.14(d, J = 45.0 Hz, 4H), 7.38(t, J = 27.5 Hz, 4H), 7.19(d, J = 10.0 Hz, 4H), 7.11(s, 1H). 1 H NMR (500 MHz, Chloroform ) δ 8.76 (d, J = 8.5 Hz, 2H), 8.42 (s, 2H), 8.14 (d, J = 45.0 Hz, 4H), 7.38 (t, J = 27.5 Hz, 4H), 7.19 (d, J = 10.0 Hz, 4H), 7.11 (s, 1H).

합성 실시예11. 화합물A-1의 합성Synthesis Example 11. Synthesis of Compound A-1

Figure pct00052
Figure pct00052

중간체M6(38.2g, 0.1mol), 브로모벤젠(31.5g, 0.2mol), CuI(3.3g, 17.1mmol), K3PO4(21.8g, 102.9mmol), 에틸렌디아민(2.3mL, 34.3mmol)과 톨루엔(500mL)을 혼합하고, 환류 조건 하에서 하루 동안 교반반응시키며, 반응 완료 후, 실온까지 냉각시키고, 유기층을 아세트산에틸로 추출하고 감압 증류하여, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 디클로로메탄/헥산), 화합물A-1(37.3g, 70.1%)을 얻는다.Intermediate M6 (38.2g, 0.1mol), bromobenzene (31.5g, 0.2mol), CuI ( 3.3g, 17.1mmol), K 3 PO 4 (21.8g, 102.9mmol), ethylenediamine (2.3mL, 34.3mmol ) And toluene (500 mL) were mixed and stirred for one day under refluxing conditions. After completion of the reaction, the mixture was cooled to room temperature, and the organic layer was extracted with ethyl acetate and distilled under reduced pressure. The resulting residue was subjected to column chromatography (Eluent: dichloromethane / hexane) to obtain Compound A-1 (37.3 g, 70.1%).

A-1의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of A-1:

1H NMR(500 MHz, Chloroform) δ 8.54(s, 4H), 8.41(s, 6H), 8.09(s, 6H), 7.59(d, J = 20.0 Hz, 11H), 7.50(d, J = 10.0 Hz, 10H), 7.15(s, 2H), 7.10(s, 3H). 1 H NMR (500 MHz, Chloroform ) δ 8.54 (s, 4H), 8.41 (s, 6H), 8.09 (s, 6H), 7.59 (d, J = 20.0 Hz, 11H), 7.50 (d, J = 10.0 Hz, 10H), 7.15 (s, 2H), 7.10 (s, 3H).

합성 실시예12. 화합물A-2의 합성Synthesis Example 12. Synthesis of Compound A-2

Figure pct00053
Figure pct00053

실시예11에서 화합물A-1과 동일한 합성 방법을 사용하는데, 구별점은, 브로모벤젠을 같은 당량의 p-브로모톨루엔으로 교체하여, 반응 완료 후 처리하여 45.6g의 백색 고체를 얻으며, 수율은 81%이다.The same synthetic method as that for Compound A-1 was used in Example 11 except that bromobenzene was replaced with the same equivalent amount of p-bromotoluene and the reaction was completed after completion of the reaction to obtain 45.6 g of a white solid, Is 81%.

합성 실시예13. 화합물A-3의 합성Synthesis Example 13. Synthesis of Compound A-3

Figure pct00054
Figure pct00054

실시예11에서 화합물A-1과 동일한 합성 방법을 사용하는데, 구별점은, 브로모벤젠을 같은 당량의 2-브로모나프탈렌으로 교체하여, 반응 완료 후, 48.3g의 백색 고체를 얻으며, 수율은 76%이다.The same synthetic method as that of Compound A-1 was used in Example 11 except that bromobenzene was replaced with the same equivalent amount of 2-bromonaphthalene to give 48.3 g of a white solid after completion of the reaction, 76%.

합성 실시예14. 화합물A-4의 합성Synthesis Example 14. Synthesis of Compound A-4

Figure pct00055
Figure pct00055

실시예11에서 화합물A-1과 동일한 합성 방법을 사용하는데, 구별점은, 브로모벤젠을 같은 당량의 3-브로모페난트렌으로 교체하여, 반응 완료 후, 58.8g의 백색 고체를 얻으며, 수율은 80%이다.The same synthetic method as that of Compound A-1 was used in Example 11, except that bromobenzene was replaced with the same equivalent amount of 3-bromophenanthrene to give 58.8 g of a white solid after completion of the reaction, Is 80%.

A-4의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of A-4:

1H NMR(500 MHz, Chloroform) δ 9.40(s, 1H), 8.84(s, 1H), 8.55(s, 1H), 8.42(s, 2H), 8.25(s, 1H), 8.12(d, J = 18.2 Hz, 3H), 7.90(s, 1H), 7.75(s, 2H), 7.68(s, 1H), 7.63(s, 1H), 7.52(s, 1H), 7.16(s, 1H), 7.11(s, 1H). 1 H NMR (500 MHz, Chloroform ) δ 9.40 (s, 1H), 8.84 (s, 1H), 8.55 (s, 1H), 8.42 (s, 2H), 8.25 (s, 1H), 8.12 (d, J 1H), 7.16 (s, 1 H), 7.11 (s, IH), 7.62 (s, (s, 1 H).

합성 실시예15. 화합물A-5의 합성Synthesis Example 15. Synthesis of Compound A-5

Figure pct00056
Figure pct00056

실시예11에서 화합물A-1과 동일한 합성 방법을 사용하는데, 구별점은, 브로모벤젠을 같은 당량의 8-브로모플루오란텐으로 교체하여, 52.3g의 황색 고체를 얻으며, 수율은 67%이다.The same synthetic method as that for Compound A-1 was used in Example 11 except that bromobenzene was replaced with the same equivalent amount of 8-bromofluoranthene to give 52.3 g of a yellow solid in yield of 67% to be.

합성 실시예16. 화합물A-6의 합성Synthesis Example 16. Synthesis of Compound A-6

Figure pct00057
Figure pct00057

실시예11에서 화합물A-1과 동일한 합성 방법을 사용하는데, 구별점은, 브로모벤젠을 같은 당량의 3-브로모플루오란텐으로 교체하고, 후처리하여 49.5g의 담황색 고체를 얻으며, 수율은 60%이다.The same synthetic method as that for Compound A-1 was used in Example 11, with the exception that bromobenzene was replaced with the same equivalent amount of 3-bromofluoranthene and worked up to give 49.5 g of a light yellow solid, Is 60%.

A-6의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of A-6:

1H NMR(500 MHz, Chloroform) δ 8.55(s, 13H), 8.42(s, 46H), 8.32(s, 37H), 8.10(s, 25H), 8.02(d, J = 49.0 Hz, 7H), 7.94(s, 14H), 7.75(d, J = 55.0 Hz, 28H), 7.54(d, J = 15.0 Hz, 27H), 7.16(s, 8H), 7.11(s, 11H). 1 H NMR (500 MHz, Chloroform ) δ 8.55 (s, 13H), 8.42 (s, 46H), 8.32 (s, 37H), 8.10 (s, 25H), 8.02 (d, J = 49.0 Hz, 7H), 7.94 (s, 14H), 7.75 (d, J = 55.0 Hz, 28H), 7.54 (d, J = 15.0 Hz, 27H), 7.16 (s, 8H), 7.11 (s, 11H).

합성 실시예17. 화합물A-7의 합성Synthesis Example 17. Synthesis of Compound A-7

Figure pct00058
Figure pct00058

실시예11에서 화합물A-1과 동일한 합성 방법을 사용하는데, 구별점은, 브로모벤젠을 같은 당량의 3-브로모크리센으로 교체하고, 후처리하여 53.4g의 담황색 고체를 얻으며, 수율은 64%이다.The same synthetic method as that for Compound A-1 was used in Example 11 except that bromobenzene was replaced with an equivalent amount of 3-bromocyclene and worked up to give 53.4 g of a light yellow solid, 64%.

합성 실시예18. 화합물A-8의 합성Synthesis Example 18. Synthesis of Compound A-8

Figure pct00059
Figure pct00059

실시예11에서 화합물A-1과 동일한 합성 방법을 사용하는데, 구별점은, 브로모벤젠을 같은 당량의 2-브로모-9,9-디메틸플루오렌으로 교체하여, 60.6g의 담황색 고체를 얻으며, 수율은 79%이다.The same synthetic method as that for Compound A-1 was used in Example 11, with the exception that bromobenzene was replaced with the same equivalent amount of 2-bromo-9,9-dimethylfluorene to give 60.6 g of a light yellow solid , And the yield is 79%.

합성 실시예19. 화합물A-9의 합성Synthesis Example 19. Synthesis of Compound A-9

실시예11에서 화합물A-1과 동일한 합성 방법을 사용하는데, 구별점은, 브로모벤젠을 같은 당량의 3-브로모-9,9-비스메틸플루오렌으로 교체하여, 54g의 담황색 고체를 얻으며, 수율은 76%이다.The same synthetic method as that of Compound A-1 was used in Example 11 except that bromobenzene was replaced with the equivalent amount of 3-bromo-9,9-bismethylfluorene to obtain 54 g of a light yellow solid , And the yield is 76%.

A-9의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of A-9:

1H NMR(500 MHz, Chloroform) δ 8.55(s, 2H), 8.42(s, 4H), 8.19(s, 2H), 8.10(s, 4H), 7.98(d, J = 1.4 Hz, 1H), 7.94(d, J = 37.7 Hz, 3H), 7.78(s, 2H), 7.57(s, 2H), 7.52(s, 2H), 7.34(s, 2H), 7.24(s, 2H), 7.16(s, 2H), 7.11(s, 2H), 1.69(s, 12H). 1 H NMR (500 MHz, Chloroform ) δ 8.55 (s, 2H), 8.42 (s, 4H), 8.19 (s, 2H), 8.10 (s, 4H), 7.98 (d, J = 1.4 Hz, 1H), 7.94 (d, J = 37.7 Hz , 3H), 7.78 (s, 2H), 7.57 (s, 2H), 7.52 (s, 2H), 7.34 (s, 2H), 7.24 (s, 2H), 7.16 (s , 2H), 7.11 (s, 2H), 1.69 (s, 12H).

합성 실시예20. 화합물A-10의 합성Synthesis Example 20. Synthesis of Compound A-10

실시예11에서 화합물A-1과 동일한 합성 방법을 사용하는데, 구별점은, 브로모벤젠을 같은 당량의 3-브로모-11,11-디메틸벤조[b]플루오렌으로 교체하여, 47.7g의 황색 고체를 얻으며, 수율은 55%이다.The same synthetic method as that for Compound A-1 was used in Example 11 except that bromobenzene was replaced with the same equivalent amount of 3-bromo-11,11-dimethylbenzo [b] fluorene to obtain 47.7 g of A yellow solid is obtained, the yield being 55%.

합성 실시예21. 화합물A-11의 합성Synthesis Example 21. Synthesis of Compound A-11

Figure pct00060
Figure pct00060

중간체M1(38.2g, 0.1mol), 브로모벤젠(31.5g, 0.2mol), CuI(3.3g, 17.1mmol), K3PO4(21.8g, 102.9mmol)과 에틸렌디아민(2.3mL, 34.3mmol)을 톨루엔(500mL)과 혼합하고, 환류 조건 하에서 하루 동안 교반하며, 실온까지 냉각시키고, 탈이온수를 넣어 반응을 종료시킨다. 상기 반응계를 100mL의 아세트산에틸로 3회 추출하고, 합하여 유기상을 얻으며, 무수 MgSO4로 건조시키고, 여과 후 유기상을 감압하여 용매를 제거하며, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 디클로로메탄/n-헥산), 백색 화합물A-11(37.4g, 수율은 70%임)을 얻는다.Intermediate M1 (38.2g, 0.1mol), bromobenzene (31.5g, 0.2mol), CuI ( 3.3g, 17.1mmol), K 3 PO 4 (21.8g, 102.9mmol) and ethylene diamine (2.3mL, 34.3mmol ) Was mixed with toluene (500 mL), stirred under refluxing for one day, cooled to room temperature, and deionized water was added to terminate the reaction. The reaction system was extracted three times with 100 mL of ethyl acetate and combined to obtain an organic phase. The organic phase was dried over anhydrous MgSO 4. After filtration, the organic phase was decompressed to remove the solvent, and the obtained residue was subjected to column chromatography Eluent: dichloromethane / n-hexane) to obtain white compound A-11 (37.4 g, yield 70%).

합성 실시예22. 화합물A-12의 합성Synthesis Example 22. Synthesis of Compound A-12

Figure pct00061
Figure pct00061

중간체M1(38.2g, 0.1mol), 4-브로모바이페닐(46.6g, 0.2mol), CuI(3.3g, 17.1mmol), K3PO4(21.8g, 102.9mmol)과 에틸렌디아민(2.3mL, 34.3mmol)을 톨루엔(500mL)과 혼합하고, 환류 조건 하에서 하루 동안 교반하며, 실온까지 냉각시키고, 탈이온수를 넣어 반응을 종료시킨다. 상기 반응계를 100mL의 아세트산에틸로 3회 추출하고, 합하여 유기상을 얻으며, 무수 MgSO4로 건조시키고, 여과 후 유기상을 감압하여 용매를 제거하며, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 디클로로메탄/n-헥산), 백색 화합물A-12(52.2g, 수율은 76%임)를 얻는다.Intermediate M1 (38.2g, 0.1mol), 4- bromo-phenyl mobayi (46.6g, 0.2mol), CuI ( 3.3g, 17.1mmol), K 3 PO 4 (21.8g, 102.9mmol) and ethylene diamine (2.3mL, 34.3 mmol) were mixed with toluene (500 mL), stirred under refluxing for one day, cooled to room temperature, and deionized water was added to terminate the reaction. The reaction system was extracted three times with 100 mL of ethyl acetate and combined to obtain an organic phase. The organic phase was dried over anhydrous MgSO 4. After filtration, the organic phase was decompressed to remove the solvent, and the obtained residue was subjected to column chromatography Eluent: dichloromethane / n-hexane) to obtain white compound A-12 (52.2 g, yield 76%).

합성 실시예22. 화합물A-13의 합성Synthesis Example 22. Synthesis of Compound A-13

Figure pct00062
Figure pct00062

중간체M1(38.2g, 0.1mol), 2-브로모나프탈렌(41.4g, 0.2mol), CuI(3.3g, 17.1mmol), K3PO4(21.8g, 102.9mmol)과 에틸렌디아민(2.3mL, 34.3mmol)을 톨루엔(500mL)과 혼합하고, 환류 조건 하에서 하루 동안 교반하며, 실온까지 냉각시키고, 탈이온수를 넣어 반응을 종료시킨다. 상기 반응계를 100mL의 아세트산에틸로 3회 추출하고, 합하여 유기상을 얻으며, 무수 MgSO4로 건조시키고, 여과 후 유기상을 감압하여 용매를 제거하며, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 디클로로메탄/n-헥산), 백색 화합물A-13(43.2g, 수율은 68%임)을 얻는다.Intermediate M1 (38.2g, 0.1mol), 2- bromo-naphthalene (41.4g, 0.2mol), CuI ( 3.3g, 17.1mmol), K 3 PO 4 (21.8g, 102.9mmol) and ethylene diamine (2.3mL, 34.3 mmol) were mixed with toluene (500 mL), stirred under refluxing for one day, cooled to room temperature, and deionized water was added to terminate the reaction. The reaction system was extracted three times with 100 mL of ethyl acetate and combined to obtain an organic phase. The organic phase was dried over anhydrous MgSO 4. After filtration, the organic phase was decompressed to remove the solvent, and the obtained residue was subjected to column chromatography Eluent: dichloromethane / n-hexane) to obtain white compound A-13 (43.2 g, yield 68%).

합성 실시예23. 화합물A-14의 합성Synthesis Example 23. Synthesis of Compound A-14

Figure pct00063
Figure pct00063

중간체M2(6.92g, 10mmol), 벤젠보론산(3.05g, 25mmol), Pd(PPh3)4(0.58g, 0.5mmol), Na2CO3(5.3g, 50mmol), 톨루엔(60mL)과 에탄올(EtOH)(20mL)을 증류수(20mL)와 혼합한 후, 환류 하에서 2시간 동안 교반반응시킨다. 반응 완료 후, 증류수로 반응계를 세척한 후, 100mL의 아세트산에틸로 3회 추출하고, 합하여 유기층을 얻으며, MgSO4로 유기층을 건조시키고, 회전증발기로 용매를 제거하며, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 백색 고체의 화합물A-14(5.63g, 84%)를 얻는다.Intermediate M2 (6.92g, 10mmol), benzene boronic acid (3.05g, 25mmol), Pd ( PPh 3) 4 (0.58g, 0.5mmol), Na 2 CO 3 (5.3g, 50mmol), toluene (60mL) and ethanol (EtOH) (20 mL) were mixed with distilled water (20 mL), and the mixture was reacted with stirring for 2 hours under reflux. After completion of the reaction, the reaction system was washed with distilled water and extracted three times with 100 mL of ethyl acetate to obtain an organic layer. The organic layer was dried over MgSO 4 , the solvent was removed using a rotary evaporator, Column chromatography separation proceeded to obtain Compound A-14 as a white solid (5.63 g, 84%).

A-14의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of A-14:

1H NMR(500 MHz, Chloroform) δ 8.42(s, 21H), 8.38 - 7.82(m, 51H), 8.07 - 7.82(m, 2H), 7.79(s, 14H), 7.75(s, 23H), 7.62(s, 20H), 7.58(s, 15H), 7.49(d, J = 5.0 Hz, 46H), 7.41(s, 7H). 1 H NMR (500 MHz, Chloroform ) δ 8.42 (s, 21H), 8.38 - 7.82 (m, 51H), 8.07 - 7.82 (m, 2H), 7.79 (s, 14H), 7.75 (s, 23H), 7.62 (s, 20H), 7.58 (s, 15H), 7.49 (d, J = 5.0 Hz, 46H), 7.41 (s, 7H).

합성 실시예24. 화합물A-15의 합성Synthesis Example 24. Synthesis of Compound A-15

합성 실시예21과 동일한 합성 방법을 사용하는데, 구별점은, 브로모벤젠을 같은 당량의 2-브로모-9,9-디메틸플루오렌으로 교체하여, 반응 완료 후 백색 고체의 화합물A-15(59.8g, 수율은 78%임)를 얻는다.The same synthesis procedure as in Synthesis Example 21 was used, except that bromobenzene was replaced with the same equivalent amount of 2-bromo-9,9-dimethylfluorene to obtain Compound A-15 ( 59.8 g, yield: 78%).

합성 실시예25. 화합물A-16의 합성Synthesis Example 25. Synthesis of Compound A-16

Figure pct00064
Figure pct00064

N2 보호 하에서, 삼구 플라스크에 22g(0.11mol)의 요오도벤젠, 46.1g(0.1mol)의 중간체M8, 2g(20mmol)의 염화제일구리, 4g(20mmol)의 수화1,10-페난트롤린, 16.8g(0.3mol)의 수산화칼륨, 300mL의 자일렌을 넣는다. 반응계를 20시간 동안 환류 반응을 유지시키고, 반응이 완료되면, 증류수로 반응계를 세척한 후, 100mL의 아세트산에틸로 3회 추출하며, 합하여 유기층을 얻고, MgSO4로 유기층을 건조시키며, 회전증발기로 용매를 제거하고, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 중간체 화합물A-16-1을 얻으며, 백색 고체(52.3g, 86%)이다.Under N 2 protection, 1,10-phenanthroline hydrate in 22g (0.11mol) iodobenzene, 46.1g (0.1mol) Intermediate M8, 2g (20mmol) cuprous chloride, 4g (20mmol) of the of the three-necked flask Lin , 16.8 g (0.3 mol) of potassium hydroxide and 300 mL of xylene. After the reaction was completed, the reaction system was washed with distilled water and extracted three times with 100 mL of ethyl acetate. The organic layer was separated, dried over MgSO 4 , The solvent was removed, and the solvent-removed residue was subjected to column chromatography to obtain Intermediate Compound A-16-1, which was a white solid (52.3 g, 86%).

중간체A-16-1(6.14g, 10mmol), 바이페닐보론산(22g, 11mmol), Pd(PPh3)4(0.58g, 0.5mmol), Na2CO3(5.3g, 50mmol), 톨루엔(60mL)과 에탄올(EtOH)(20mL)을 증류수(20mL)와 혼합한 후, 환류 하에서 2시간 동안 교반반응시킨다. 반응 완료 후, 증류수로 반응계를 세척한 후, 100mL의 아세트산에틸로 3회 추출하고, 합하여 유기층을 얻으며, MgSO4로 유기층을 건조시키고, 회전증발기로 용매를 제거하며, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 화합물A-16을 얻으며, 백색 고체(5.97g, 87%)이다.Intermediate A-16-1 (6.14g, 10mmol) , biphenyl boronic acid (22g, 11mmol), Pd ( PPh 3) 4 (0.58g, 0.5mmol), Na 2 CO 3 (5.3g, 50mmol), toluene ( 60 mL) and ethanol (EtOH) (20 mL) were mixed with distilled water (20 mL), followed by stirring under reflux for 2 hours. After completion of the reaction, the reaction system was washed with distilled water and extracted three times with 100 mL of ethyl acetate to obtain an organic layer. The organic layer was dried over MgSO 4 , the solvent was removed using a rotary evaporator, Column chromatography separation was carried out to obtain Compound A-16, which was a white solid (5.97 g, 87%).

합성 실시예26. 화합물A-17의 합성Synthesis Example 26 Synthesis of Compound A-17

합성 실시예25와 동일한 합성 방법을 사용하는데, 구별점은, 중간체M8을 같은 당량의 중간체M9로 교체하고, 바이페닐보론산을 같은 당량의 2-트리페닐레닐보론산으로 치환하여, 반응 완료 후 백색 고체의 화합물A-17을 얻는다.The same synthetic method as that of Synthesis Example 25 was used except that intermediate M8 was replaced with the same equivalent of intermediate M9 and biphenylboronic acid was replaced with the same equivalent amount of 2-triphenylenyl boronic acid, Compound A-17 was obtained as a white solid.

합성 실시예27. 화합물A-18의 합성SYNTHESIS EXAMPLE 27 Synthesis of Compound A-18

Figure pct00065
Figure pct00065

1L의 삼구 플라스크에 3-페닐페닐히드라진 히드로클로라이드(91.6g, 0.415mol), 디벤조[a,e]-5,11-시클로옥타디엔(6H,12H)-디케톤(49g, 0.207mol), 에탄올(400mL)을 넣고, 교반 조건 하에서, 3분 내에 2g의 농황산을 드로핑 하며, 65℃에서 4시간 동안 반응시키고, 반응 완료 후, 실온까지 냉각시키며, 여과하고, 순차적으로 에탄올, 석유에테르로 필터 케이크를 세척하여, 화합물A-18-1(120g, 90%)을 얻는다.3-phenylphenylhydrazine hydrochloride (91.6 g, 0.415 mol), dibenzo [a, e] -5,11-cyclooctadiene (6H, 12H) -diketone (49 g, 0.207 mol) Ethanol (400 mL) was added thereto, and 2 g of concentrated sulfuric acid was dropped in 3 minutes under stirring conditions. The reaction was carried out at 65 DEG C for 4 hours. After the completion of the reaction, the reaction mixture was cooled to room temperature, filtered and washed successively with ethanol and petroleum ether The filter cake is washed to obtain compound A-18-1 (120 g, 90%).

1L의 삼구 플라스크에 화합물C-19-1(48g, 74.8mmol), 아세트산(650g)과 트리플루오로아세트산(65g, 0.57mol)을 넣고, 72℃ 하에서 15시간 동안 환류 반응시키며, 실온까지 냉각시키고, 여과하고, 순차적으로 아세트산, 석유에테르로 필터 케이크를 세척하여, 화합물A-18-2(33g, 82%)를 얻는다.Compound C-19-1 (48 g, 74.8 mmol), acetic acid (650 g) and trifluoroacetic acid (65 g, 0.57 mol) were placed in a 1 L three-necked flask and refluxed at 72 ° C for 15 hours. , Filtered, and the filter cake is sequentially washed with acetic acid and petroleum ether to obtain Compound A-18-2 (33 g, 82%).

자일렌(100mL), C-19-2(5.4g, 10mmol), 브로모벤젠(3.9g, 25mmol), CuI(0.9g, 5mmol), 트랜스-디아미노시클로헥산(2.1mL, 20mmol)과 탄산세슘(6.5g, 20mmol)을 혼합하고, 3시간 동안 환류 반응시키며, 반응 완료 후, 실온까지 냉각시키며, 여과한 후, 디클로로메탄(디클로로메탄)으로 필터 케이크를 세척하고, 여액을 감압 증류시키며, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: DCM/PE=1/2, v/v(체적비가 1:2인 디클로로메탄과 석유에테르의 혼합 용액)), 화합물A-18을 얻으며, 백색 고체(5.0g, 수율은 72%임)이다.(3.9 g, 25 mmol), CuI (0.9 g, 5 mmol), trans-diaminocyclohexane (2.1 mL, 20 mmol), and carbonic acid After the completion of the reaction, the reaction mixture was cooled to room temperature, filtered, washed with dichloromethane (dichloromethane), the filtrate was distilled under reduced pressure, and the filtrate was distilled under reduced pressure. The obtained residue was subjected to column chromatography (eluent: DCM / PE = 1/2, v / v (mixed solution of dichloromethane and petroleum ether having a volume ratio of 1: 2)), Compound A-18 , Which was a white solid (5.0 g, yield 72%).

합성 실시예28. 중간체M11의 합성Synthesis Example 28. Synthesis of intermediate M11

Figure pct00066
Figure pct00066

1L의 삼구 플라스크에 3-브로모페닐히드라진 히드로클로라이드(92.8g, 0.415mol), 디벤조[a,e]-5,11-시클로옥타디엔(6H,12H)-디케톤(49g, 0.207mol), 에탄올(400mL)을 넣고, 교반 조건 하에서, 3분 내에 2g의 농황산을 적가하며, 65℃에서 4시간 동안 반응시키고, 반응 완료 후, 실온까지 냉각시키며, 여과하고, 순차적으로 에탄올, 석유에테르로 필터 케이크를 세척하여, 중간체 화합물M11-1(122g, 91%)을 얻는다.3-bromophenylhydrazine hydrochloride (92.8 g, 0.415 mol), dibenzo [a, e] -5,11-cyclooctadiene (6H, 12H) -diketone (49 g, 0.207 mol) , And ethanol (400 mL) were added, and 2 g of concentrated sulfuric acid was added dropwise in 3 minutes under agitation conditions. The reaction was carried out at 65 DEG C for 4 hours. After completion of the reaction, the reaction mixture was cooled to room temperature, filtered and sequentially washed with ethanol and petroleum ether The filter cake is washed to obtain the intermediate compound M11-1 (122 g, 91%).

1L의 삼구 플라스크에 화합물M11-1(48.4g, 74.8mmol), 아세트산(650g)과 트리플루오로아세트산(65g, 0.57mol)을 넣고, 72℃ 하에서 15시간 동안 환류 반응시키며, 실온까지 냉각시키고, 여과하고, 순차적으로 아세트산, 석유에테르로 필터 케이크를 세척하여, 중간체 화합물M11-2(35g, 85%)를 얻는다.Compound 48-1 (48.4 g, 74.8 mmol), acetic acid (650 g) and trifluoroacetic acid (65 g, 0.57 mol) were placed in a 1 L three-necked flask and refluxed at 72 ° C for 15 hours, cooled to room temperature, Filtered, and the filter cake is washed sequentially with acetic acid and petroleum ether to obtain an intermediate compound M11-2 (35 g, 85%).

자일렌(100mL), M11-2(5.4g, 10mmol), 요오도벤젠(5.1g, 25mmol), CuI(0.9g, 5mmol), 트랜스-디아미노시클로헥산(2.1mL, 20mmol)과 탄산세슘(6.5g, 20mmol)을 혼합하고, 3시간 동안 환류 반응시키며, 반응 완료 후, 실온까지 냉각시키고, 여과한 후, 디클로로메탄(디클로로메탄)으로 필터 케이크를 세척하며, 여액을 합하고, 건조시킨 후, 감압하여 용매를 제거하여, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(DCM/PE=1/2, v/v(체적비가 1:2인 디클로로메탄과 석유에테르의 혼합 용액)), 중간체 화합물M11을 얻으며, 백색 고체(5.88g, 수율은 85%임)이다.(5.1 mL, 25 mmol), CuI (0.9 g, 5 mmol), trans-diaminocyclohexane (2.1 mL, 20 mmol) and cesium carbonate After the completion of the reaction, the reaction mixture was cooled to room temperature, filtered, and then the filter cake was washed with dichloromethane (dichloromethane). The filtrate was combined, dried, The solvent was removed by distillation under reduced pressure, and the resulting residue was subjected to column chromatography (DCM / PE = 1/2, v / v (mixed solution of dichloromethane and petroleum ether having a volume ratio of 1: 2) Intermediate compound M11 is obtained, which is a white solid (5.88 g, yield 85%).

합성 실시예29.화합물A-19의 합성Synthesis Example 29. Synthesis of Compound A-19

Figure pct00067
Figure pct00067

중간체M11(6.92g, 10mmol), 4-바이페닐보론산(4.95g, 25mmol), Pd(PPh3)4(0.58g, 0.5mmol), Na2CO3(5.3g, 50mmol), 톨루엔(60mL)과 에탄올(EtOH)(20mL)을 증류수(20mL)와 혼합한 후, 환류 하에서 2시간 동안 교반반응시킨다. 반응 완료 후, 증류수로 반응계를 세척한 후, 아세트산에틸로 추출하여 유기층을 얻고, MgSO4로 유기층을 건조시키며, 회전증발기로 용매를 제거하고, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 화합물A-19를 얻으며, 백색 고체(7.0g, 81%)이다.Intermediate M11 (6.92g, 10mmol), 4- biphenyl boronic acid (4.95g, 25mmol), Pd ( PPh 3) 4 (0.58g, 0.5mmol), Na 2 CO 3 (5.3g, 50mmol), toluene (60mL ) And ethanol (EtOH) (20 mL) were mixed with distilled water (20 mL), and stirred under reflux for 2 hours. After completion of the reaction, the reaction system was washed with distilled water and extracted with ethyl acetate to obtain an organic layer. The organic layer was dried over MgSO 4 , the solvent was removed using a rotary evaporator, and the solvent-removed residue was subjected to column chromatography To give Compound A-19, which is a white solid (7.0 g, 81%).

합성 실시예30. 화합물A-20의 합성Synthesis Example 30. Synthesis of Compound A-20

실시예29와 동일한 방법을 사용하여 화합물A-20을 제조하는데, 구별점은 4-바이페닐보론산을 같은 당량의 9,9-디메틸플루오렌-2-보론산으로 대체하여, 반응 완료 후, 분리하여 6.24g의 백색 고체를 얻으며, 수율은 68%이다.Compound A-20 was prepared using the same method as in Example 29 except that 4-biphenylboronic acid was replaced with the same equivalent amount of 9,9-dimethylfluorene-2-boronic acid, Separation afforded 6.24 g of a white solid, yield 68%.

합성 실시예31. 화합물A-21의 합성Synthesis Example 31. Synthesis of Compound A-21

Figure pct00068
Figure pct00068

합성 실시예21과 동일한 합성 방법을 사용하는데, 구별점은, 중간체M1을 같은 당량의 중간체M4로 대체하여, 반응 완료 후, 4.32g의 백색 고체를 얻으며, 수율은 68%이다.The same synthesis procedure as in Synthesis Example 21 was used, with the exception that intermediate M1 was replaced with the same equivalent of intermediate M4 to give 4.32 g of a white solid after completion of the reaction with a yield of 68%.

A-21의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of A-21:

1H NMR(500 MHz, Chloroform) δ 8.61(s, 1H), 8.43(d, J = 6.0 Hz, 3H), 8.28(s, 1H), 8.10(s, 2H), 7.84(s, 1H), 7.75(s, 1H), 7.62(s, 2H), 7.58(s, 1H), 7.49(d, J = 10.0 Hz, 3H). 1 H NMR (500 MHz, Chloroform ) δ 8.61 (s, 1H), 8.43 (d, J = 6.0 Hz, 3H), 8.28 (s, 1H), 8.10 (s, 2H), 7.84 (s, 1H), 7.75 (s, 1H), 7.62 (s, 2H), 7.58 (s, 1H), 7.49 (d, J = 10.0 Hz, 3H).

합성 실시예32. 화합물A-22의 합성Synthesis Example 32. Synthesis of Compound A-22

합성 실시예29와 동일한 합성 방법을 사용하는데, 구별점은, 4-바이페닐보론산을 같은 당량의 9,9-디메틸-2-플루오렌보론산으로 대체하여, 반응 완료 후, 7.08g의 담황색 고체를 얻으며, 수율은 77%이다.The same synthetic method as that of Synthesis Example 29 was used except that 4-biphenylboronic acid was replaced by the same equivalent amount of 9,9-dimethyl-2-fluoroboronic acid to give 7.08 g of a light yellow solid , And the yield is 77%.

합성 실시예33. 화합물A-23의 합성Synthesis Example 33. Synthesis of Compound A-23

실시예23과 동일한 방법을 사용하여 화합물A-23을 제조하는데, 구별점은 4-바이페닐보론산을 같은 당량의 6,6,12,12-테트라메틸-6,12-디히드로인데노[1,2-b]플루오렌-2-보론산으로 대체하여, 반응 완료 후, 분리하여 6.68g의 담황색 고체를 얻으며, 수율은 58%이다.Compound A-23 was prepared using the same method as Example 23, with the exception that 4-biphenylboronic acid was replaced with the same equivalent of 6,6,12,12-tetramethyl-6,12-dihydroindeno [ 1,2-b] fluorene-2-boronic acid, and after completion of the reaction, 6.68 g of a pale yellow solid was obtained, and the yield was 58%.

합성 실시예34. 화합물A-24의 합성Synthesis Example 34. Synthesis of Compound A-24

Figure pct00069
Figure pct00069

중간체M5(48.2g, 0.1mol), 2-브로모나프탈렌(41.4g, 0.2mol), CuI(3.3g, 17.1mmol), K3PO4(21.8g, 102.9mmol)과 에틸렌디아민(2.3mL, 34.3mmol)을 톨루엔(500mL)과 혼합하고, 환류 조건 하에서 하루 동안 교반하며, 실온까지 냉각시키고, 탈이온수를 넣어 반응을 종료시킨다. 상기 반응계를 100mL의 아세트산에틸로 3회 추출하고, 합하여 유기상을 얻으며, 무수 MgSO4로 건조시키고, 여과 후 유기상을 감압하여 용매를 제거하며, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 디클로로메탄/n-헥산), 백색 화합물A-24(49.9g, 수율은 68%임)를 얻는다.Intermediate M5 (48.2g, 0.1mol), 2- bromo-naphthalene (41.4g, 0.2mol), CuI ( 3.3g, 17.1mmol), K 3 PO 4 (21.8g, 102.9mmol) and ethylene diamine (2.3mL, 34.3 mmol) were mixed with toluene (500 mL), stirred under refluxing for one day, cooled to room temperature, and deionized water was added to terminate the reaction. The reaction system was extracted three times with 100 mL of ethyl acetate and combined to obtain an organic phase. The organic phase was dried over anhydrous MgSO 4. After filtration, the organic phase was decompressed to remove the solvent, and the obtained residue was subjected to column chromatography Eluent: dichloromethane / n-hexane) to obtain white compound A-24 (49.9 g, yield 68%).

합성 실시예35. 화합물B-1의 합성Synthesis Example 35. Synthesis of Compound B-1

Figure pct00070
Figure pct00070

중간체M2(69.6g, 0.1mol), 브로모벤젠(31.5g, 0.2mol), CuI(3.3g, 17.1mmol), K3PO4(21.8g, 102.9mmol)과 에틸렌디아민(2.3mL, 34.3mmol)을 톨루엔(500mL)과 혼합하고, 환류 조건 하에서 하루 동안 교반하며, 실온까지 냉각시키고, 탈이온수를 넣어 반응을 종료시킨다. 상기 반응계를 100mL의 아세트산에틸로 3회 추출하고, 합하여 유기상을 얻으며, 무수 MgSO4로 건조시키고, 여과 후 유기상을 감압하여 용매를 제거하며, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 디클로로메탄/n-헥산), 담황색 화합물B-1(55.4g, 수율은 64%임)을 얻는다.Intermediate M2 (69.6 g, 0.1 mol), bromobenzene (31.5 g, 0.2 mol), CuI (3.3 g, 17.1 mmol), K 3 PO 4 (21.8 g, 102.9 mmol) and ethylenediamine ) Was mixed with toluene (500 mL), stirred under refluxing for one day, cooled to room temperature, and deionized water was added to terminate the reaction. The reaction system was extracted three times with 100 mL of ethyl acetate and combined to obtain an organic phase. The organic phase was dried over anhydrous MgSO 4. After filtration, the organic phase was decompressed to remove the solvent, and the obtained residue was subjected to column chromatography Eluent: dichloromethane / n-hexane) to obtain pale yellow compound B-1 (55.4 g, yield 64%).

B-1의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of B-1:

1H NMR(500 MHz, Chloroform) δ 8.43 - 8.37(m, 1H), 8.36 - 8.29(m, 1H), 8.22 - 8.12(m, 1H), 8.09 - 7.97(m, 2H), 7.96 - 7.78(m, 2H), 7.64 - 7.54(m, 2H), 7.54 - 7.24(m, 4H). 1 H NMR (500 MHz, Chloroform ) δ 8.43 - 8.37 (m, 1H), 8.36 - 8.29 (m, 1H), 8.22 - 8.12 (m, 1H), 8.09 - 7.97 (m, 2H), 7.96 - 7.78 ( m, 2H), 7.64-7.54 (m, 2H), 7.54-7.24 (m, 4H).

합성 실시예36. 화합물B-2의 합성Synthesis Example 36. Synthesis of Compound B-2

Figure pct00071
Figure pct00071

9-페닐카르바졸-3-히드라진 히드로클로라이드(30.98g, 0.1mol), 중간체M(47.2g, 0.2mol)과 400mL의 에탄올을 혼합하고, 교반 조건 하에서, 3분 내에 2.1g의 농황산을 적가하며, 65℃에서 4시간 동안 반응시키고, 반응 완료 후, 실온까지 냉각시키며, 여과하고, 순차적으로 에탄올, 석유에테르로 필터 케이크를 세척하여, 고체 B-2-1(68g, 수율은 83%임)을 얻는다.(30.98 g, 0.1 mol), Intermediate M (47.2 g, 0.2 mol) and 400 mL of ethanol were mixed and under stirring conditions, 2.1 g of concentrated sulfuric acid was added dropwise within 3 minutes , And reacted at 65 DEG C for 4 hours. After completion of the reaction, the reaction mixture was cooled to room temperature, filtered, and washed sequentially with ethanol and petroleum ether to obtain 68 g of solid B-2-1 (yield 83% .

상기 고체 B-2-1(68g, 0.083mol), 600mL의 아세트산과 60mL의 트리플루오로아세트산을 혼합하고, 72℃ 하에서, 15시간 동안 환류 반응시키며, 실온까지 냉각시키고, 여과하고, 순차적으로 아세트산, 석유에테르로 필터 케이크를 세척하여, 화합물B-2-2(32g, 수율은 54%임)를 얻는다.The solid B-2-1 (68 g, 0.083 mol), 600 mL of acetic acid and 60 mL of trifluoroacetic acid were mixed, refluxed at 72 캜 for 15 hours, cooled to room temperature, filtered, , And the filter cake is washed with petroleum ether to obtain Compound B-2-2 (32 g, yield: 54%).

중간체B-2-2(35.84g, 50mmol), 브로모벤젠(39.2g, 250mol), CuI(1g, 5.3mmol), K3PO4(7g, 35mmol), 디아미노시클로헥산(6mL, 34.3mmol)과 자일렌(500mL)을 혼합하고, 환류 조건 하에서 하루 동안 교반반응시키며, 반응 완료 후, 실온까지 냉각시키며, 아세트산에틸로 유기층을 추출하고, 분리하여 얻은 유기층을 감압 증류시키며, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 디클로로메탄/헥산), 백색 화합물B-2(29.8g, 수율은 62%임)를 얻는다.Intermediate B-2-2 (35.84g, 50mmol) , bromobenzene (39.2g, 250mol), CuI ( 1g, 5.3mmol), K 3 PO 4 (7g, 35mmol), diaminocyclohexane (6mL, 34.3mmol ) And xylene (500 mL) were mixed and stirred for one day under refluxing conditions. After completion of the reaction, the reaction mixture was cooled to room temperature, and the organic layer was extracted with ethyl acetate. The organic layer was separated and distilled under reduced pressure. (Eluent: dichloromethane / hexane) to obtain a white compound B-2 (29.8 g, yield 62%).

합성 실시예37. 화합물B-3의 합성Synthesis Example 37. Synthesis of Compound B-3

Figure pct00072
Figure pct00072

중간체M7(6.9g, 10mmol), 9-페닐-[9H]-카르바졸-3-보론산(7.2g, 25mmol), Pd(PPh3)4(0.58g, 0.5mmol), K2CO3(5.3g, 50mmol), 톨루엔(60mL)과 에탄올(EtOH)(20mL)을 증류수(20mL)와 혼합한 후, 120℃ 하에서 2시간 동안 교반반응시킨다. 반응 완료 후, 증류수로 반응계를 세척한 후, 아세트산에틸로 추출하여 유기층을 얻고, MgSO4로 유기층을 건조시키며, 회전증발기로 용매를 제거하고, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 화합물B-3을 얻으며, 담황색 고체(8.8g, 87%)이다.Intermediate M7 (6.9g, 10mmol), 9- phenyl - [9H] - carbazole-3-boronic acid (7.2g, 25mmol), Pd ( PPh 3) 4 (0.58g, 0.5mmol), K 2 CO 3 ( Toluene (60 mL) and ethanol (EtOH) (20 mL) were mixed with distilled water (20 mL), and the mixture was reacted at 120 ° C for 2 hours with stirring. After completion of the reaction, the reaction system was washed with distilled water and extracted with ethyl acetate to obtain an organic layer. The organic layer was dried over MgSO 4 , the solvent was removed using a rotary evaporator, and the solvent-removed residue was subjected to column chromatography To give compound B-3, which is a light yellow solid (8.8 g, 87%).

B-3의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of B-3:

1H NMR(500 MHz, Chloroform) δ 9.81 - 9.75(m, 2H), 9.37(dd, J = 7.5, 1.4 Hz, 1H), 8.85(dd, J = 7.5, 2.0 Hz, 2H), 8.49 - 8.41(m, 4H), 8.17(dd, J = 7.4, 1.6 Hz, 1H), 8.05 - 7.84(m, 9H), 7.60(t, J = 7.5 Hz, 4H), 7.56 - 7.22(m, 14H), 7.07(dt, J = 7.5, 2.2 Hz, 2H), 6.76(td, J = 7.5, 2.0 Hz, 2H), 6.64(tdt, J = 7.3, 4.9, 2.2 Hz, 2H). 1 H NMR (500 MHz, Chloroform ) δ 9.81 - 9.75 (m, 2H), 9.37 (dd, J = 7.5, 1.4 Hz, 1H), 8.85 (dd, J = 7.5, 2.0 Hz, 2H), 8.49 - 8.41 (m, 4H), 8.17 (dd, J = 7.4,1.6 Hz, 1H), 8.05-7.84 (m, 9H), 7.60 (t, J = 7.5 Hz, 4H), 7.56-7.22 J = 7.5, 2.2 Hz, 2H), 6.76 (td, J = 7.5, 2.0 Hz, 2H), 6.64 (tdt, J = 7.3, 4.9, 2.2 Hz, 2H).

합성 실시예38. 화합물B-4의 합성Synthesis Example 38. Synthesis of Compound B-4

실시예11과 동일한 방법을 사용하여 화합물B-4를 제조하는데, 구별점은 브로모벤젠을 같은 당량의 9-(4-브로모페닐)-9H-카르바졸(9-(4-bromophenyl)-9H-carbazole)로 대체하여, 반응 완료 후, 분리하여 6.5g의 담황색 고체를 얻으며, 수율은 76%이다.Compound B-4 was prepared using the same method as Example 11 except that bromobenzene was replaced with the same equivalent of 9- (4-bromophenyl) -9H-carbazole (9- (4-bromophenyl) 9H-carbazole). Upon completion of the reaction, the reaction mixture was separated to obtain 6.5 g of a pale yellow solid, and the yield was 76%.

B-4의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of B-4:

1H NMR(500 MHz, Chloroform) δ 8.45 - 8.31(m, 1H), 8.22 - 8.07(m, 1H), 8.06 - 7.91(m, 2H), 7.91 - 7.78(m, 1H), 7.56 - 7.29(m, 3H). 1 H NMR (500 MHz, Chloroform ) δ 8.45 - 8.31 (m, 1H), 8.22 - 8.07 (m, 1H), 8.06 - 7.91 (m, 2H), 7.91 - 7.78 (m, 1H), 7.56 - 7.29 ( m, 3H).

합성 실시예39. 화합물B-5의 합성Synthesis Example 39. Synthesis of Compound B-5

실시예11과 동일한 방법을 사용하여 화합물B-5를 제조하는데, 구별점은 브로모벤젠을 같은 당량의 9-(3-브로모페닐)-9H-카르바졸(9-(3-bromophenyl)-9H-carbazole)로 대체하여, 반응 완료 후, 분리하여 6.7g의 담황색 고체를 얻으며, 수율은 78%이다.Compound B-5 was prepared using the same method as Example 11, with the exception that bromobenzene was replaced with the same equivalent of 9- (3-bromophenyl) -9H-carbazole (9- (3-bromophenyl) 9H-carbazole). Upon completion of the reaction, 6.7 g of a pale yellow solid was obtained by separation, and the yield was 78%.

합성 실시예40. 화합물B-6의 합성Synthesis Example 40. Synthesis of Compound B-6

실시예11과 동일한 방법을 사용하여 화합물B-6을 제조하는데, 구별점은 브로모벤젠을 같은 당량의 3-브로모-페닐카르바졸로 대체하여, 반응 완료 후, 분리하여 6.06g의 담황색 고체를 얻으며, 수율은 70%이다.Compound B-6 was prepared using the same procedure as in Example 11, with the exception that bromobenzene was replaced by the same equivalent amount of 3-bromo-phenylcarbazole, after completion of the reaction, 6.06 g of light yellow solid , And the yield is 70%.

B-6의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of B-6:

1H NMR(500 MHz, Chloroform) δ 8.62(dd, J = 16.8, 1.4 Hz, 1H), 8.51(ddd, J = 14.0, 7.6, 1.5 Hz, 1H), 8.42(dt, J = 7.4, 1.8 Hz, 1H), 8.21(ddd, J = 7.3, 5.9, 1.5 Hz, 1H), 8.14 - 8.02(m, 1H), 8.06 - 7.95(m, 1H), 7.95(dd, J = 7.8, 2.1 Hz, 1H), 7.89(ddd, J = 7.5, 4.1, 2.0 Hz, 1H), 7.79(dd, J = 24.9, 7.4 Hz, 1H), 7.70(ddd, J = 19.2, 7.5, 1.5 Hz, 1H), 7.60(t, J = 7.4 Hz, 2H), 7.54 - 7.24(m, 7H). 1 H NMR (500 MHz, Chloroform ) δ 8.62 (dd, J = 16.8, 1.4 Hz, 1H), 8.51 (ddd, J = 14.0, 7.6, 1.5 Hz, 1H), 8.42 (dt, J = 7.4, 1.8 Hz J = 7.8, 2.1 Hz, 1H), 8.21 (m, 1H), 8.21 (ddd, J = 7.3,5.9,1.5 Hz, 1H), 8.14-8.02 ), 7.89 (ddd, J = 7.5, 4.1,2.0 Hz, 1H), 7.79 (dd, J = 24.9, 7.4 Hz, 1H), 7.70 (ddd, J = 19.2, 7.5, 1.5 Hz, 1H) t, J = 7.4 Hz, 2H), 7.54-7.24 (m, 7H).

합성 실시예41. 화합물B-7의 합성Synthesis Example 41. Synthesis of Compound B-7

실시예21과 동일한 방법을 사용하여 화합물B-7을 제조하는데, 구별점은 브로모벤젠을 같은 당량의 9-(4-브로모페닐)-9H-카르바졸(9-(4-bromophenyl)-9H-carbazole)로 대체하여, 반응 완료 후, 분리하여 백색 고체B-7(4.7g, 수율은 54%임)를 얻는다.Compound B-7 was prepared using the same procedure as in Example 21, except that bromobenzene was replaced with the same equivalent of 9- (4-bromophenyl) -9H-carbazole (9- (4-bromophenyl) 9H-carbazole). After completion of the reaction, the reaction mixture was separated to obtain white solid B-7 (4.7 g, yield: 54%).

합성 실시예42. 화합물B-8의 합성Synthesis Example 42. Synthesis of Compound B-8

실시예21과 동일한 방법을 사용하여 화합물B-8을 제조하는데, 구별점은 브로모벤젠을 같은 당량의 9-(3-브로모페닐)-9H-카르바졸(9-(3-bromophenyl)-9H-carbazole)로 대체하여, 반응 완료 후, 분리하여 B-8을 얻고, 5.5g의 백색 고체이며, 수율은 61%이다.Compound B-8 was prepared using the same procedure as in Example 21 with the exception that bromobenzene was replaced with the same equivalent of 9- (3-bromophenyl) -9H-carbazole (9- (3-bromophenyl) 9H-carbazole). Upon completion of the reaction, separation yielded B-8, 5.5 g of a white solid, and a yield of 61%.

합성 실시예43. 화합물B-9의 합성Synthesis Example 43. Synthesis of Compound B-9

실시예23과 동일한 방법을 사용하여 화합물B-9를 제조하는데, 구별점은 벤젠보론산을 같은 당량의 (9-페닐-9H-카르바졸-3-일)보론산((9-phenyl-9H-carbazol-3-yl)boronic acid)으로 대체하여, 반응 완료 후, 분리하여 B-9를 얻고, 8.44g의 담황색 고체이며, 수율은 83%이다.Compound B-9 was prepared using the same procedure as in Example 23 except that benzeneboronic acid was replaced with the same equivalent amount of (9-phenyl-9H-carbazol-3-yl) -carbazol-3-yl) boronic acid, and after completion of the reaction, separation yielded B-9, 8.44 g of a light yellow solid, with a yield of 83%.

B-9의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of B-9:

1H NMR(500 MHz, Chloroform) δ 9.01(d, J = 1.4 Hz, 1H), 8.97 - 8.91(m, 2H), 8.42(dd, J = 7.3, 1.5 Hz, 1H), 8.32(d, J = 7.5 Hz, 1H), 8.26 - 8.08(m, 10H), 7.97(dd, J = 7.5, 2.0 Hz, 2H), 7.90(dd, J = 7.7, 2.0 Hz, 2H), 7.84(ddd, J = 7.5, 5.9, 1.6 Hz, 2H), 7.64 - 7.47(m, 10H), 7.43(td, J = 7.5, 1.6 Hz, 1H), 7.37 - 7.27(m, 4H), 7.31 - 7.24(m, 4H), 7.17(dd, J = 7.3, 2.3 Hz, 1H), 7.09(ddd, J = 13.6, 5.7, 3.9 Hz, 2H), 6.69(dtd, J = 19.6, 7.4, 2.2 Hz, 2H), 6.60(dd, J = 5.7, 3.8 Hz, 2H). 1 H NMR (500 MHz, Chloroform ) δ 9.01 (d, J = 1.4 Hz, 1H), 8.97 - 8.91 (m, 2H), 8.42 (dd, J = 7.3, 1.5 Hz, 1H), 8.32 (d, J = 7.5 Hz, 1H), 8.26 - 8.08 (m, 10H), 7.97 (dd, J = 7.5, 2.0 Hz, 2H), 7.90 (dd, J = 7.7, 2.0 Hz, 2H), 7.84 (ddd, J = 7.5, 5.9, 1.6 Hz, 2H), 7.64-7.47 (m, 10H), 7.43 (td, J = 7.5, 1.6 Hz, 1H), 7.37-7.27 (m, 4H), 7.31-7.24 , 7.17 (dd, J = 7.3 , 2.3 Hz, 1H), 7.09 (ddd, J = 13.6, 5.7, 3.9 Hz, 2H), 6.69 (dtd, J = 19.6, 7.4, 2.2 Hz, 2H), 6.60 (dd , J = 5.7,3.8 Hz, 2H).

합성 실시예44. 화합물B-10의 합성Synthesis Example 44. Synthesis of Compound B-10

실시예23과 동일한 방법을 사용하여 화합물B-10을 제조하는데, 구별점은 중간체M2를 같은 당량의 중간체M3으로 대체하는 동시에, 벤젠보론산을 같은 당량의 (4-(9H-카르바졸-9-일)페닐)보론산((4-(9H-carbazol-9-yl)phenyl)boronic acid)으로 대체하여, 반응 완료 후, 분리하여 B-10을 얻고, 백색류 고체(7.73g, 76%)이다.Compound B-10 was prepared using the same procedure as in Example 23 except that intermediate M2 was replaced with the same equivalent of intermediate M3 while benzeneboronic acid was replaced with the same equivalent amount of (4- (9H-carbazol-9 (7.73 g, 76%) was obtained as a white solid after the completion of the reaction, and the residue was separated to obtain B-10 by replacing the 4- (9H- )to be.

B-10의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of B-10:

1H NMR(500 MHz, Chloroform) δ 9.15 - 9.09(m, 1H), 8.55 - 8.39(m, 4H), 8.40 - 8.29(m, 2H), 8.20 - 8.13(m, 1H), 8.00 - 7.90(m, 2H), 7.90(dt, J = 7.7, 3.0 Hz, 2H), 7.72 - 7.55(m, 4H), 7.50 - 7.38(m, 2H), 7.35 - 7.24(m, 2H), 7.19(ddd, J = 12.7, 7.4, 2.1 Hz, 1H), 6.69(ddtd, J = 50.7, 23.4, 7.5, 2.2 Hz, 2H). 1 H NMR (500 MHz, Chloroform ) δ 9.15 - 9.09 (m, 1H), 8.55 - 8.39 (m, 4H), 8.40 - 8.29 (m, 2H), 8.20 - 8.13 (m, 1H), 8.00 - 7.90 ( (m, 2H), 7.90 (dt, J = 7.7, 3.0 Hz, 2H), 7.72-7.55 (m, 4H), 7.50-7.38 J = 12.7, 7.4, 2.1 Hz, 1H), 6.69 (ddt, J = 50.7, 23.4, 7.5, 2.2 Hz, 2H).

합성 실시예45. 화합물B-11의 합성Synthesis Example 45. Synthesis of Compound B-11

실시예21과 동일한 방법을 사용하여 화합물B-11을 제조하는데, 구별점은 브로모벤젠을 같은 당량의 3-브로모-9-에틸-9H-카르바졸(3-bromo-9-ethyl-9H-carbazole)로 대체하여, 반응 완료 후, 분리하여 5.5g의 B-11 백색류 고체를 얻으며, 수율은 72%이다.Compound B-11 was prepared using the same procedure as in Example 21 with the exception that bromobenzene was replaced with the same equivalent of 3-bromo-9-ethyl-9H-carbazole -carbazole), after completion of the reaction, separation yielded 5.5 g of B-11 white flow solid, the yield being 72%.

합성 실시예46. 화합물B-12의 합성Synthesis Example 46. Synthesis of Compound B-12

실시예21과 동일한 방법을 사용하여 화합물B-12를 제조하는데, 구별점은 브로모벤젠을 같은 당량의 3-브로모-9-페닐-9H-카르바졸(3-bromo-9-phenyl-9H-carbazole)로 대체하여, 반응 완료 후, 분리하여 B-12를 얻고, 5.8g의 담황색 고체이며, 수율은 67%이다.Compound B-12 was prepared using the same procedure as in Example 21 with the exception that bromobenzene was replaced with the same equivalent amount of 3-bromo-9-phenyl-9H -carbazole). After completion of the reaction, the reaction mixture was separated to obtain B-12, which was 5.8 g of light yellow solid, and the yield was 67%.

B-12의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of B-12:

1H NMR(500 MHz, Chloroform) δ 8.33(dddd, J = 13.1, 11.6, 7.0, 1.8 Hz, 2H), 8.24 - 8.09(m, 2H), 8.09 - 8.02(m, 1H), 8.02 - 7.85(m, 3H), 7.86 - 7.75(m, 1H), 7.73 - 7.61(m, 1H), 7.64 - 7.56(m, 2H), 7.53 - 7.42(m, 2H), 7.41 - 7.24(m, 4H). 1 H NMR (500 MHz, Chloroform ) δ 8.33 (dddd, J = 13.1, 11.6, 7.0, 1.8 Hz, 2H), 8.24 - 8.09 (m, 2H), 8.09 - 8.02 (m, 1H), 8.02 - 7.85 ( 2H), 7.41-7.24 (m, 4H), 7.86-7.75 (m, 1H), 7.73-7.61 (m, 1H).

합성 실시예47. 화합물B-13의 합성Synthesis Example 47. Synthesis of Compound B-13

실시예25와 동일한 방법을 사용하여 화합물B-13을 제조하는데, 구별점은 중간체M8을 같은 당량의 중간체M9로 대체하고, 4-바이페닐보론산을 같은 당량의 (9-페닐-9H-카르바졸-3-일)보론산((9-phenyl-9H-carbazol-3-yl)boronic acid)으로 대체하여, 반응 완료 후, 분리하여 B-13을 얻고, 6.1g의 백색 고체이며, 수율은 78%이다.Compound B-13 is prepared using the same procedure as in Example 25 except that intermediate M8 is replaced with the same equivalent of intermediate M9 and 4-biphenylboronic acid is replaced with the same equivalent amount of (9-phenyl-9H-carbaldehyde (9-phenyl-9H-carbazol-3-yl) boronic acid. After completion of the reaction, B-13 was isolated to obtain 6.1 g of a white solid, 78%.

B-13의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of B-13:

1H NMR(500 MHz, Chloroform) δ 8.50 - 8.43(m, 3H), 8.36(dd, J = 7.5, 1.4 Hz, 1H), 8.16(d, J = 1.0 Hz, 1H), 8.10(dt, J = 7.5, 1.9 Hz, 3H), 8.03(dd, J = 7.4, 2.1 Hz, 1H), 7.96 - 7.83(m, 8H), 7.77(dd, J = 7.4, 1.4 Hz, 1H), 7.67(d, J = 1.1 Hz, 2H), 7.60(t, J = 7.4 Hz, 6H), 7.54 - 7.47(m, 2H), 7.49 - 7.37(m, 3H), 7.37 - 7.24(m, 7H). 1 H NMR (500 MHz, Chloroform ) δ 8.50 - 8.43 (m, 3H), 8.36 (dd, J = 7.5, 1.4 Hz, 1H), 8.16 (d, J = 1.0 Hz, 1H), 8.10 (dt, J = 7.5, 1.9 Hz, 3H), 8.03 (dd, J = 7.4, 2.1 Hz, 1H), 7.96-7.83 (m, 8H), 7.77 (dd, J = 7.4, 1.4 Hz, 1H) J = 1.1 Hz, 2H), 7.60 (t, J = 7.4 Hz, 6H), 7.54-7.47 (m, 2H), 7.49-7.37 (m, 3H), 7.37-7.24 (m, 7H).

합성 실시예48. 화합물B-14의 합성Synthesis Example 48. Synthesis of Compound B-14

실시예25와 동일한 방법을 사용하여 화합물B-14를 제조하는데, 구별점은 중간체M8을 같은 당량의 중간체M10으로 대체하고, 4-바이페닐보론산을 같은 당량의 (9-페닐-9H-카르바졸-3-일)보론산((9-phenyl-9H-carbazol-3-yl)boronic acid)으로 대체하여, 반응 완료 후, 분리하여 B-14를 얻고, 6.5g의 백색 고체이며, 수율은 85%이다.Compound B-14 was prepared using the same procedure as in Example 25 except that intermediate M8 was replaced with the same equivalent of intermediate M10 and 4-biphenylboronic acid was replaced with the same equivalent of (9-phenyl-9H-carbaldehyde (9-phenyl-9H-carbazol-3-yl) boronic acid. After completion of the reaction, B-14 was isolated to obtain 6.5 g of a white solid, 85%.

합성 실시예49. 화합물B-15의 합성Synthesis Example 49. Synthesis of Compound B-15

Figure pct00073
Figure pct00073

9H-카르바졸-3-히드라진 히드로클로라이드(103g, 0.44mol), 디벤조[a,e]-5,11-시클로옥타디엔(6H,12H)-디케톤(49g, 0.207mol)과 400mL의 에탄올을 혼합하고, 교반 조건 하에서, 3분 내에 2.1g의 농황산을 적가하며, 65℃에서 4시간 동안 반응시키고, 반응 완료 후, 실온까지 냉각시키며, 여과하고, 순차적으로 에탄올, 석유에테르로 필터 케이크를 세척하여, 150g의 갈색 고체를 얻는다.A mixture of dibenzo [a, e] -5,11-cyclooctadiene (6H, 12H) -diketone (49 g, 0.207 mol) and 400 mL of ethanol And 2.1 g of concentrated sulfuric acid was added dropwise in 3 minutes under agitation conditions and reacted at 65 DEG C for 4 hours. After completion of the reaction, the reaction mixture was cooled to room temperature, filtered, sequentially filtered with ethanol and petroleum ether Wash to give 150 g of a brown solid.

150g의 상기 고체, 600mL의 아세트산과 60mL의 트리플루오로아세트산을 혼합하고, 72℃ 하에서, 15시간 동안 환류 반응시키며, 실온까지 냉각시키고, 여과하고, 순차적으로 아세트산, 석유에테르로 필터 케이크를 세척하여, 중간체 화합물M12를 얻으며, 백색 고체(84.6g, 75%)이다.150 g of the above solid, 600 mL of acetic acid and 60 mL of trifluoroacetic acid were mixed, refluxed at 72 캜 for 15 hours, cooled to room temperature, filtered, washed sequentially with acetic acid and petroleum ether To give the intermediate compound M12, which is a white solid (84.6 g, 75%).

중간체M12(28g, 50mmol), 요오도벤젠(51g, 250mol), CuI(1g, 5.3mmol), Cs2CO3(7g, 35mmol), 에틸렌디아민(10mL, 34.3mmol)과 자일렌(500mL)을 혼합하고, 환류 조건 하에서 하루 동안 교반반응시키며, 반응 완료 후, 실온까지 냉각시키고, 아세트산에틸로 유기층을 추출하며, 분리하여 얻은 유기층을 감압 증류시키고, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 디클로로메탄/헥산), 화합물B-15를 얻으며, 담황색 고체(26.8g, 62%)이다.(1 g, 5.3 mmol), Cs 2 CO 3 (7 g, 35 mmol), ethylenediamine (10 mL, 34.3 mmol) and xylene (500 mL) were added to a solution of intermediate M12 (28 g, 50 mmol), iodobenzene After completion of the reaction, the reaction mixture was cooled to room temperature, and the organic layer was extracted with ethyl acetate. The organic layer was separated and the filtrate was distilled under reduced pressure. The resulting residue was subjected to column chromatography (Eluent: dichloromethane / hexane) to give compound B-15, which is a light yellow solid (26.8 g, 62%).

합성 실시예50. 화합물B-16의 합성Synthesis Example 50. Synthesis of Compound B-16

실시예49와 동일한 방법을 사용하여 화합물B-16을 제조하는데, 구별점은 9H-카르바졸-3-히드라진 히드로클로라이드를 같은 당량의 9H-카르바졸-2-히드라진 히드로클로라이드로 대체하여, 세 단계 반응을 거쳐, 29g의 담황색 고체를 얻으며, 수율은 67.1%이다.Compound B-16 was prepared using the same method as Example 49, with the exception that 9H-carbazole-3-hydrazine hydrochloride was replaced with the equivalent equivalent of 9H-carbazole-2-hydrazine hydrochloride, After the reaction, 29 g of a light yellow solid were obtained, and the yield was 67.1%.

합성 실시예51. 화합물B-17의 합성Synthesis Example 51. Synthesis of Compound B-17

Figure pct00074
Figure pct00074

2-브로모니트로벤젠(46g, 230mmol), 디벤조티에닐-3-보론산(63, 276mmol), Pd(PPh3)4(5g, 4.6mmol), K2CO3(61g, 575mmol), 600mL의 톨루엔과 200mL의 에탄올(EtOH)을 혼합하고, 상기 혼합액에 200mL의 증류수를 넣은 후, 120℃ 하에서 2시간 동안 교반반응시킨다. 반응 완료 후, 증류수로 반응계를 세척하고, 아세트산에틸로 유기층을 추출하며, MgSO4로 유기층을 건조시키고, 회전증발시켜 용매를 제거한다. 마지막으로, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 화합물B-17-1(61g, 87%)을 얻는다.2-Bromo-nitrobenzene (46g, 230mmol), D-3-benzothienyl-boronic acid (63, 276mmol), Pd ( PPh 3) 4 (5g, 4.6mmol), K 2 CO 3 (61g, 575mmol), 600 ml of toluene and 200 ml of ethanol (EtOH) were mixed, and 200 ml of distilled water was added to the mixture, followed by stirring at 120 ° C for 2 hours. After completion of the reaction, the reaction system is washed with distilled water, the organic layer is extracted with ethyl acetate, the organic layer is dried with MgSO 4 , and the solvent is removed by rotary evaporation. Finally, the solvent-removed residue is subjected to column chromatography to obtain Compound B-17-1 (61 g, 87%).

화합물B-17-1(3.05g, 10mmol), 30mL의 P(OEt)3과 30mL의 1,2-디클로로벤젠을 혼합한 후, 150℃ 하에서 8시간 동안 교반반응시키며, 반응 완료 후, 용매를 제거하고, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 화합물B-17-2(1.2g, 48%)를 얻는다.Compound B-17-1 (3.05 g, 10 mmol), 30 mL of P (OEt) 3 and 30 mL of 1,2-dichlorobenzene were mixed and stirred at 150 ° C for 8 hours. After completion of the reaction, The solvent was removed, and the residue was subjected to column chromatography to obtain Compound B-17-2 (1.2 g, 48%).

100mL의 자일렌에, 화합물M7(6.9g, 10mmol), 화합물B-17-2(6.2g, 25mmol), CuI(0.9g, 5mmol), 트랜스-디아미노시클로헥산(2.1mL, 20mmol)과 탄산세슘(6.5g, 20mmol)을 혼합하고, 교반하여 3시간 동안 환류시킨다. 반응 완료 후, 실온까지 냉각시킨 후, 여과하고, 디클로로메탄(디클로로메탄)으로 필터 케이크를 세척하며, 여액을 합하고, 감압 증류시켜 용매를 제거하며, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 화합물B-17(5.6g, 수율은 52%임)을 얻으며, 담황색 고체이다.(6.2 g, 25 mmol), CuI (0.9 g, 5 mmol), trans-diaminocyclohexane (2.1 mL, 20 mmol) and carbonic acid Cesium (6.5 g, 20 mmol) is mixed, stirred and refluxed for 3 hours. After completion of the reaction, the reaction mixture was cooled to room temperature, filtered, and the filter cake was washed with dichloromethane (dichloromethane). The filtrates were combined and distilled under reduced pressure to remove the solvent. The resulting residue was subjected to column chromatography To give Compound B-17 (5.6 g, yield 52%), light yellow solid.

B-17의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of B-17:

1H NMR(500 MHz, Chloroform) δ 9.73(d, J = 7.5 Hz, 2H), 9.21(dd, J = 7.5, 1.5 Hz, 1H), 8.69 - 8.57(m, 5H), 8.47(dd, J = 7.3, 1.5 Hz, 1H), 8.38 - 8.28(m, 3H), 8.20(dt, J = 7.5, 1.7 Hz, 2H), 8.12 - 7.99(m, 5H), 7.98 - 7.93(m, 2H), 7.80(td, J = 7.5, 1.5 Hz, 1H), 7.74 - 7.60(m, 3H), 7.54 - 7.36(m, 4H), 7.37 - 7.29(m, 4H), 7.32 - 7.20(m, 4H), 7.07(td, J = 7.7, 1.8 Hz, 2H), 6.77(dddd, J = 14.8, 12.5, 7.4, 2.1 Hz, 3H), 6.63(td, J = 7.5, 2.1 Hz, 1H). 1 H NMR (500 MHz, Chloroform ) δ 9.73 (d, J = 7.5 Hz, 2H), 9.21 (dd, J = 7.5, 1.5 Hz, 1H), 8.69 - 8.57 (m, 5H), 8.47 (dd, J = 7.3, 1.5 Hz, 1H), 8.38-8.88 (m, 3H), 8.20 (dt, J = 7.5, 1.7 Hz, 2H), 8.12-7. 7.80 (td, J = 7.5, 1.5 Hz, 1H), 7.74 - 7.60 (m, 3H), 7.54 - 7.36 (m, 4H), 7.37 - 7.29 (m, 4H), 7.32 - 7.20 (m, 4H), 7.07 (td, J = 7.7, 1.8 Hz, 2H), 6.77 (dddd, J = 14.8, 12.5, 7.4, 2.1 Hz, 3H), 6.63 (td, J = 7.5, 2.1 Hz, 1H).

합성 실시예52. 화합물B-18의 합성Synthesis Example 52. Synthesis of Compound B-18

실시예51과 동일한 방법을 사용하여 화합물B-18을 제조하는데, 구별점은 디벤조티에닐-3-보론산을 같은 당량의 디벤조푸란-3-보론산으로 대체하여, 반응 완료 후, 칼럼크로마토그래피를 진행하여 조생성물을 분리하여, 7.1g의 백색 고체를 얻으며, 수율은 66%이다.Compound B-18 was prepared in the same manner as in Example 51, except that the dibenzothienyl-3-boronic acid was replaced with the same equivalent amount of dibenzofuran-3-boronic acid, Chromatography was carried out to separate the crude product, yielding 7.1 g of a white solid, with a yield of 66%.

B-18의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of B-18:

1H NMR(500 MHz, Chloroform) δ 8.33(dd, J = 7.5, 1.7 Hz, 2H), 7.98(dd, J = 7.5, 1.5 Hz, 2H), 7.88(dd, J = 5.6, 3.9 Hz, 2H), 7.64 - 7.56(m, 2H), 7.53(s, 4H), 7.44(td, J = 7.5, 1.6 Hz, 1H), 7.39 - 7.20(m, 7H), 7.16(td, J = 7.5, 1.6 Hz, 2H). 1 H NMR (500 MHz, Chloroform ) δ 8.33 (dd, J = 7.5, 1.7 Hz, 2H), 7.98 (dd, J = 7.5, 1.5 Hz, 2H), 7.88 (dd, J = 5.6, 3.9 Hz, 2H J = 7.5, 1.6 Hz, 1H), 7.39-7.20 (m, 7H), 7.16 (td, J = 7.5, 1.6 Hz, 2H).

합성 실시예53. 화합물B-19의 합성Synthesis Example 53. Synthesis of Synthesis of Compound B-19

Figure pct00075
Figure pct00075

Figure pct00076
Figure pct00076

Figure pct00077
Figure pct00077

Figure pct00078
Figure pct00078

화합물B-19-1의 제조Preparation of compound B-19-1

디벤조[b,d]푸란-3-보론산(106g, 0.5mol), 2-브로모-니트로벤젠(101g, 0.5mol), 테트라키스트리페닐포스핀팔라듐(1.15g, 1mmol), 탄산칼륨(138g, 1mol), 톨루엔(1L), 에탄올(0.5L)과 증류수(0.3L)를 혼합하고, 110℃ 하에서 2시간 동안 교반반응한다. 반응 완료 후, 증류수로 반응계를 세척한 후, 200mL의 아세트산에틸로 3회 추출하고, 합하여 유기층을 얻으며, 무수 MgSO4로 유기상을 건조시키고, 회전증발기로 용매를 제거하며, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 중간체 화합물B-19-1(130g, 수율은 89%임)을 얻는다.Dibenzo [b, d] furan-3-boronic acid (106 g, 0.5 mol), 2-bromo-nitrobenzene (101 g, 0.5 mol), tetrakistriphenylphosphine palladium (1.15 g, 1 mmol) (138 g, 1 mol), toluene (1 L), ethanol (0.5 L) and distilled water (0.3 L) were mixed and reacted at 110 ° C for 2 hours with stirring. After completion of the reaction, the reaction system was washed with distilled water and extracted three times with 200 mL of ethyl acetate to obtain an organic layer. The organic phase was dried over anhydrous MgSO 4 , the solvent was removed using a rotary evaporator, , The intermediate compound B-19-1 (130 g, yield: 89%) was obtained.

화합물B-19-2의 제조Preparation of compound B-19-2

2L의 반응 플라스크에, 중간체 화합물B-19-1(100g, 0.34mol)에 1000mL의 트리에틸포스파이트를 넣고, 150℃에서 6시간 교반한 후, 실온까지 냉각시키며, 300mL의 아세트산에틸로 3회 추출하고, 합하여 유기상을 얻으며, 500mL의 탈이온수로 유기상을 3회 세척하고, 유기상을 무수 MgSO4로 유기상 중의 수분을 제거한 후, 유기상을 감압 증류시키며, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 화합물B-19-2(56g, 수율은 64%임)를 얻는다.In a 2 L reaction flask, 1000 mL of triethyl phosphite was added to Intermediate Compound B-19-1 (100 g, 0.34 mol), and the mixture was stirred at 150 캜 for 6 hours, cooled to room temperature and washed three times with 300 mL of ethyl acetate Extracted and combined to obtain an organic phase. The organic phase was washed three times with 500 mL of deionized water. The organic phase was dried over anhydrous MgSO 4 to remove the water in the organic phase. The organic phase was distilled off under reduced pressure, and the obtained residue was subjected to column chromatography Proceeding, compound B-19-2 (56 g, yield 64%) is obtained.

화합물B-19-3의 제조Preparation of compound B-19-3

250mL의 삼구 플라스크에서, 중간체 화합물B-19-2(10.3g, 40mmol), p-브로모요오도벤젠(14.2g, 50mmol), CuI(1.8g, 10mmol), 트랜스-디아미노시클로헥산(4.2mL, 40mmol)과 탄산세슘(13g, 40mmol)으로 형성된 혼합액을 가열하여 3시간 동안 환류시킨다. 그 다음, 반응 혼합액을 실온까지 냉각시키고, 여과하며, 디클로로메탄으로 필터 케이크를 세척한 후, 얻은 여액을 감압 증류시키며, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 화합물B-19-3(12.4g, 수율은 75%임)을 얻는다.In a 250 mL three-necked flask, the intermediate compound B-19-2 (10.3 g, 40 mmol), p-bromoiodobenzene (14.2 g, 50 mmol), CuI (1.8 g, 10 mmol), trans-diaminocyclohexane mL, 40 mmol) and cesium carbonate (13 g, 40 mmol) was heated and refluxed for 3 hours. Thereafter, the reaction mixture was cooled to room temperature, filtered, and the filter cake was washed with dichloromethane. The obtained filtrate was distilled under reduced pressure, and the resulting residue was subjected to column chromatography to obtain Compound B-19- 3 (12.4 g, yield 75%).

화합물B-19-4의 제조Preparation of compound B-19-4

1L의 반응 플라스크에, 중간체M6(38.2g, 0.1mol), 브로모벤젠(16g, 0.1mol), CuI(3.3g, 17.1mmol), 탄산세슘(33.44g, 102.9mmol), 시클로헥실디아민(2.3mL, 34.3mmol)과 자일렌(500mL)을 혼합하고, 환류 조건 하에서 하루 동안 교반반응시키며, 반응 완료 후, 실온까지 냉각시키고, 250mL의 아세트산에틸로 추출하며, 유기층을 무수 황산 마그네슘으로 처리한 후 감압 증류시켜 용매를 제거하고, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 디클로로메탄/헥산), 화합물B-19-4(25.7g, 수율은 56%)를 얻는다.(38.2 g, 0.1 mol), bromobenzene (16 g, 0.1 mol), CuI (3.3 g, 17.1 mmol), cesium carbonate (33.44 g, 102.9 mmol) and cyclohexyldiamine (2.3 mol) were added to a 1 L reaction flask. mL, 34.3 mmol) and xylene (500 mL) were mixed and stirred for one day under reflux. After completion of the reaction, the mixture was cooled to room temperature and extracted with 250 mL of ethyl acetate. The organic layer was treated with anhydrous magnesium sulfate The solvent was removed by distillation under reduced pressure, and the resulting residue was subjected to column chromatography (eluent: dichloromethane / hexane) to obtain Compound B-19-4 (25.7 g, yield: 56%).

화합물A-19의 제조Preparation of Compound A-19

1L의 반응 플라스크에, 중간체 화합물B-19-4(45.9g, 0.1mol), 중간체 화합물B-19-3(42g, 0.1mol), CuI(3.3g, 17.1mmol), 탄산세슘(33.44g, 102.9mmol), 시클로헥실디아민(2.3mL, 34.3mmol)과 자일렌(500mL)을 혼합하고, 환류 조건 하에서 하루 동안 교반반응시키며, 반응 완료 후, 실온까지 냉각시키고, 250mL의 아세트산에틸로 추출하며, 유기층을 무수 황산 마그네슘으로 처리한 후 감압 증류시켜 용매를 제거하고, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 디클로로메탄/헥산), 담황색 화합물B-19(67.2g, 수율은 85%)를 얻는다.Intermediate compound B-19-4 (45.9g, 0.1mol), intermediate compound B-19-3 (42g, 0.1mol), CuI (3.3g, 17.1mmol), cesium carbonate (33.44g, (2.3 mL, 34.3 mmol) and xylene (500 mL) were mixed and reacted under reflux for one day. After completion of the reaction, the mixture was cooled to room temperature, extracted with 250 mL of ethyl acetate, The organic layer was treated with anhydrous magnesium sulfate and then distilled under reduced pressure to remove the solvent. The resulting residue was subjected to column chromatography (eluent: dichloromethane / hexane) to obtain pale yellow compound B-19 (67.2 g, 85%).

합성 실시예54. 화합물B-20의 합성Synthesis Example 54. Synthesis of Compound B-20

Figure pct00079
Figure pct00079

중간체 화합물B-20-1의 제조Preparation of intermediate compound B-20-1

500mL톨루엔, o-요오도니트로벤젠(30g, 120.4mmol), 4-브로모페닐보론산(26g, 132.5mmol), Pd(PPh3)4(6.9g, 6.02mmol)와 150mL의 Na2CO3(농도는 2M임)을 혼합하고, 100℃ 하에서 4시간 동안 반응시키며, 반응 완료 후, 실온까지 냉각시키고, 아세트산에틸로 추출하여, 유기상을 얻은 후, 증류수로 유기상을 세척하며, MgSO4로 유기상 중의 수분을 제거하고, 유기상을 감압 증류시키며, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 중간체 화합물B-20-1(28g, 83.3%)을 얻는다.500mL of toluene, o- iodo-nitrobenzene (30g, 120.4mmol), 4- bromo phenylboronic acid (26g, 132.5mmol), Pd ( PPh 3) 4 (6.9g, 6.02mmol) and 150mL of Na 2 CO 3 (concentration of 2M Im) were mixed, and sikimyeo react for 4 hours under 100 ℃, after the completion of the reaction, was cooled to room temperature, followed by extraction with ethyl acetate, and obtained the organic phase, the organic phase was washed with distilled water, with MgSO 4 the organic phase The organic phase was distilled off under reduced pressure, and the resulting residue was subjected to column chromatography to obtain intermediate compound B-20-1 (28 g, 83.3%).

중간체 화합물B-20-2의 제조Preparation of intermediate compound B-20-2

300mL의 트리에틸포스파이트에 28g의 화합물B-20-1(0.1mol)를 넣고, 150℃ 하에서 6시간 동안 교반시키며, 실온까지 냉각시키고, 아세트산에틸로 추출하여, 유기상을 얻은 후, 증류수로 유기상을 세척하며, 무수 MgSO4로 건조시켜 유기상 중의 수분을 제거하고, 유기상을 감압 증류시켜 유기 용매를 제거하며, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 중간체 화합물B-20-2(11g, 44.4%)를 얻는다.28 g of Compound B-20-1 (0.1 mol) was added to 300 mL of triethyl phosphite, stirred at 150 ° C for 6 hours, cooled to room temperature, extracted with ethyl acetate to obtain an organic phase, And dried over anhydrous MgSO 4 to remove water in the organic phase. The organic phase was distilled off under reduced pressure to remove the organic solvent. The resulting residue was subjected to column chromatography to obtain Intermediate Compound B-20-2 11 g, 44.4%).

중간체 화합물B-20-3의 제조Preparation of intermediate compound B-20-3

중간체 화합물B-20-2(24.6g, 0.1mol), 요오도벤젠(41.3g, 0.2mol), CuI(9.6g, 50mmol), Cs2CO3(82.5g, 0.25mol) 및 600mL의 톨루엔을 혼합하고, 50℃ 하에서 반응시킨 후, 혼합물에 에틸렌디아민(6.8mL, 0.1mol)을 넣어, 14시간 동안 환류 반응시키며, 반응 완료 후, 실온에서 냉각시키고, 여기에 증류수를 넣으며, 아세트산에틸로 추출하여, 유기상을 얻고, 무수 MgSO4로 건조시켜 유기상 중의 수분을 제거하고, 유기상을 감압 증류시키며, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 중간체 화합물B-20-3(24g, 수율은 75%임)을 얻는다.Intermediate compound B-20-2 (24.6 g, 0.1 mol), iodobenzene (41.3 g, 0.2 mol), CuI (9.6 g, 50 mmol), Cs 2 CO 3 (82.5 g, 0.25 mol) and 600 mL of toluene Ethylenediamine (6.8 mL, 0.1 mol) was added to the mixture and the mixture was refluxed for 14 hours. After completion of the reaction, the reaction mixture was cooled at room temperature, distilled water was added thereto, extracted with ethyl acetate An organic phase was obtained and dried over anhydrous MgSO 4 to remove moisture in the organic phase. The organic phase was distilled off under reduced pressure, and the resulting residue was subjected to column chromatography to obtain intermediate compound B-20-3 (24 g, yield Is 75%).

중간체 화합물B-20-4 의 제조Preparation of intermediate compound B-20-4

화합물B-20-3(21g, 86mmol)을 300mL의 THF에 용해시키고, -78℃에서 혼합물에 n-부틸리튬(38mL, 95mmol, 2.5M헥산 용액)을 천천히 넣는다. -78℃ 하에서 1시간 동안 유지한 후, 혼합물에 트리메틸보레이트(12.4mL, 112mmol)를 넣는다. 그 다음 실온까지 천천히 승온시키고, 실온 하에서 12시간 동안 교반반응시킨다. 교반한 혼합물에 포화 염화암모늄 수용액을 넣어 반응을 종료시키고, 아세트산에틸로 3회 추출하여, 유기상을 합하며, 유기상을 무수 MgSO4로 건조시켜 유기상 중의 수분을 제거한다. 유기상을 감압 증류시키며, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 중간체 화합물B-20-4(20g, 수율은 81%임)를 얻는다.Compound B-20-3 (21 g, 86 mmol) is dissolved in 300 mL of THF and n-butyllithium (38 mL, 95 mmol, 2.5 M hexane solution) is slowly added to the mixture at -78 ° C. After 1 h at -78 < 0 > C, trimethylborate (12.4 mL, 112 mmol) is added to the mixture. The mixture was then slowly warmed to room temperature, and stirred for 12 hours at room temperature. Saturated ammonium chloride aqueous solution was added to the stirred mixture to complete the reaction. The reaction mixture was extracted three times with ethyl acetate. The organic phases were combined, and the organic phase was dried over anhydrous MgSO 4 to remove moisture in the organic phase. The organic phase was distilled off under reduced pressure, and the obtained distillation residue was subjected to column chromatography to obtain Intermediate Compound B-20-4 (20 g, yield: 81%).

중간체 화합물B-20-5 의 제조Preparation of intermediate compound B-20-5

화합물B-20-4(20g, 70mmol), 1-브로모-2-니트로벤젠(14.3g, 71mmol), Pd(Ph3)4(4.3g, 2.4mmol), 75mL의 2M의 Na2CO3 용액, 300mL의 톨루엔 및 70mL의 에탄올을 혼합하고, 5시간 동안 환류하면서 교반시킨 후, 실온까지 냉각시키며, 혼합물에 200mL의 탈이온수를 넣은 후, 100mL의 아세트산에틸로 3회 추출하고, 유기상을 합하며, 무수 MgSO4로 건조시켜 유기상 중의 수분을 제거하고, 유기상을 감압 증류시키며, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 중간체 화합물B-20-5(20.6g, 수율은 81.%임)를 얻는다.Pd (Ph 3 ) 4 (4.3 g, 2.4 mmol), 75 mL of 2M Na 2 CO 3 (50 mL) The solution was mixed with 300 mL of toluene and 70 mL of ethanol and stirred under reflux for 5 hours. The mixture was cooled to room temperature and 200 mL of deionized water was added to the mixture. The mixture was extracted three times with 100 mL of ethyl acetate, And dried over anhydrous MgSO 4 to remove water in the organic phase. The organic phase was distilled off under reduced pressure, and the resulting residue was subjected to column chromatography to obtain intermediate compound B-20-5 (20.6 g, yield 81.0%). %).

중간체 화합물B-20-6 의 제조Preparation of intermediate compound B-20-6

화합물B-20-5(20g, 55mmol)에 200mL의 트리에틸포스파이트를 넣고, 150℃에서 6시간 교반한 후, 실온에서 냉각시키며, 아세트산에틸로 추출하여, 유기상을 얻고, 증류수로 유기상을 세척한 후, 무수 MgSO4로 건조시켜 유기상 중의 수분을 제거한 다음, 유기상을 감압 증류시키며, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 화합물B-20-6(7g, 수율은 38%임)을 얻는다.200 mL of triethyl phosphite was added to the compound B-20-5 (20 g, 55 mmol), and the mixture was stirred at 150 ° C for 6 hours, cooled at room temperature and extracted with ethyl acetate to obtain an organic phase, after, removal of the moisture in the organic phase was dried over anhydrous MgSO 4, and then the organic phase was evaporated under reduced pressure sikimyeo, the process proceeds to column chromatography separation from a distillation residue obtained, the compound B-20-6 (7g, 38% yield Im ).

화합물B-20의 제조Preparation of Compound B-20

100mL의 자일렌에 화합물M7(6.9g, 10mmol), 중간체 화합물C-31-6(8.3g, 25mmol), CuI(0.9g, 5mmol), 트랜스-디아미노시클로헥산(2.1mL, 20mmol)과 탄산세슘(6.5g, 20mmol)을 넣고, 상기 혼합물을 3시간 동안 환류시킨다. 다음, 반응 혼합액을 실온까지 냉각시키고, 여과하며, 디클로로메탄(디클로로메탄)으로 필터 케이크를 세척한 후, 얻은 여액을 감압 증류시키고, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 황색 고체의 화합물B-20(5.4g, 수율은 45%임)을 얻는다.(8.9 g, 25 mmol), CuI (0.9 g, 5 mmol), trans-diaminocyclohexane (2.1 mL, 20 mmol), and carbonic acid Cesium (6.5 g, 20 mmol) is added and the mixture is refluxed for 3 hours. Next, the reaction mixture was cooled to room temperature, filtered, and the filter cake was washed with dichloromethane (dichloromethane). The obtained filtrate was subjected to vacuum distillation, and the resulting residue was subjected to column chromatography to separate a yellow solid Of compound B-20 (5.4 g, yield 45%).

합성 실시예55. 화합물B-21의 합성Synthesis Example 55. Synthesis of Compound B-21

실시예11과 동일한 방법을 사용하여 화합물B-21을 제조하는데, 구별점은 브로모벤젠을 같은 당량의 2-브로모디벤조[b,d]푸란(2-bromodibenzo[b,d]furan)으로 대체하여, 반응 완료 후, 칼럼크로마토그래피를 진행하여 조생성물을 분리하여, 4.36g의 백색 고체를 얻으며, 수율은 61%이다.Compound B-21 was prepared using the same method as Example 11, with the exception that bromobenzene was replaced with the same equivalent amount of 2-bromodibenzo [b, d] furan as 2-bromodibenzo [ As an alternative, after completion of the reaction, column chromatography was carried out to separate the crude product to obtain 4.36 g of a white solid, the yield being 61%.

B-21의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of B-21:

1H NMR(500 MHz, Chloroform) δ 8.66 - 8.50(m, 3H), 8.24 - 8.13(m, 2H), 8.09 - 7.96(m, 3H), 7.89(ddd, J = 16.9, 7.4, 2.0 Hz, 1H), 7.67 - 7.44(m, 4H), 7.43 - 7.24(m, 3H). 1 H NMR (500 MHz, Chloroform ) δ 8.66 - 8.50 (m, 3H), 8.24 - 8.13 (m, 2H), 8.09 - 7.96 (m, 3H), 7.89 (ddd, J = 16.9, 7.4, 2.0 Hz, 1H), 7.67-7.44 (m, 4H), 7.43-7.24 (m, 3H).

합성 실시예56. 화합물B-22의 합성Synthesis Example 56. Synthesis of Compound B-22

실시예11과 동일한 방법을 사용하여 화합물B-22를 제조하는데, 구별점은 브로모벤젠을 같은 당량의 2-브로모디벤조[b,d]티오펜(2-bromodibenzo[b,d]thiophene)으로 대체하여, 반응 완료 후, 칼럼크로마토그래피를 진행하여 조생성물을 분리하여, 4.86g의 백색 고체를 얻으며, 수율은 65%이다.Compound B-22 was prepared using the same method as Example 11, with the exception that bromobenzene was replaced with the same equivalent of 2-bromodibenzo [b, d] thiophene After completion of the reaction, the reaction mixture was subjected to column chromatography to separate the crude product to obtain 4.86 g of a white solid. The yield was 65%.

합성 실시예57. 화합물B-23의 합성Synthesis Example 57. Synthesis of Compound B-23

실시예21과 동일한 방법을 사용하여 화합물B-23을 제조하는데, 구별점은 브로모벤젠을 같은 당량의 2-브로모디벤조[b,d]티오펜(2-bromodibenzo[b,d]thiophene)으로 대체하여, 반응 완료 후, 칼럼크로마토그래피를 진행하여 조생성물을 분리하여, 5.9g의 백색류 고체를 얻으며, 수율은 79%이다.Compound B-23 was prepared using the same method as in Example 21, except that bromobenzene was replaced with the same equivalent amount of 2-bromodibenzo [b, d] thiophene . After completion of the reaction, column chromatography was carried out to separate the crude product to obtain 5.9 g of a white-like solid, and the yield was 79%.

합성 실시예58. 화합물M13의 합성SYNTHESIS EXAMPLE 58 Synthesis of Compound M13

Figure pct00080
Figure pct00080

중간체M1(38.6g, 0.1mol), 1-브로모-4-요오도벤젠(56.7g, 0.2mol), CuI(3.3g, 17.1mmol), K3PO4(21.8g, 102.9mmol), 에틸렌디아민(2.3mL, 34.3mmol)과 톨루엔(500mL)을 혼합하고, 환류 조건 하에서 하루 동안 교반하며, 반응 완료 후, 실온까지 냉각시키고, 유기층을 아세트산에틸로 추출하며 감압 증류하여, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 디클로로메탄/헥산), 중간체 화합물M13(48.3g, 70.1%)을 얻는다.Intermediate M1 (38.6g, 0.1mol), 1- bromo-4-iodobenzene (56.7g, 0.2mol), CuI ( 3.3g, 17.1mmol), K 3 PO 4 (21.8g, 102.9mmol), ethylene After completion of the reaction, the reaction mixture was cooled to room temperature, and the organic layer was extracted with ethyl acetate and distilled under reduced pressure. The resulting residue was purified by silica gel column chromatography (silica gel, (Eluent: dichloromethane / hexane) to obtain intermediate compound M13 (48.3 g, 70.1%).

합성 실시예59. 화합물M14의 합성Synthesis Example 59. Synthesis of compound M14

실시예58과 동일한 방법을 사용하여 화합물M14를 제조하는데, 구별점은 p-브로모요오도벤젠을 같은 당량의 3-브로모요오도벤젠으로 대체하여, 반응 완료 후, 칼럼크로마토그래피를 진행하여 조생성물을 분리하여, 52.5g의 백색 고체의 중간체M14를 얻으며, 수율은 75%이다.Compound M14 was prepared using the same method as Example 58 except that p-bromoiodobenzene was replaced by the same equivalent amount of 3-bromoiodobenzene, and after completion of the reaction, column chromatography was performed The crude product is isolated to give 52.5 g of white solid intermediate M14, yield 75%.

합성 실시예60. 화합물B-24의 합성Synthesis Example 60. Synthesis of Compound B-24

Figure pct00081
Figure pct00081

중간체M13(6.9g, 10mmol), 디벤조티오펜-2-보론산(5.7g, 25mmol), Pd(PPh3)4(0.58g, 0.5mmol), Na2CO3(5.3g, 50mmol), 60mL의 톨루엔과 20mL의 에탄올(EtOH)을 혼합하고, 상기 혼합물에 20mL의 증류수를 넣은 후, 120℃ 하에서 2시간 동안 교반반응시킨다. 반응 완료 후, 증류수로 반응계를 세척한 후, 50mL의 아세트산에틸로 3회 추출하고, 합하여 유기층을 얻으며, MgSO4로 유기층을 건조시키고, 용매를 회전증발시켜 제거하고, 마지막으로, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 화합물B-24(7.3g, 81%)를 얻으며, 백색류 고체이다.Intermediate M13 (6.9g, 10mmol), di-benzothiophene-2-boronic acid (5.7g, 25mmol), Pd ( PPh 3) 4 (0.58g, 0.5mmol), Na 2 CO 3 (5.3g, 50mmol), 60 mL of toluene and 20 mL of ethanol (EtOH) were mixed, and 20 mL of distilled water was added to the mixture, followed by stirring at 120 ° C for 2 hours. After completion of the reaction, the reaction system was washed with distilled water and extracted three times with 50 mL of ethyl acetate to obtain an organic layer. The organic layer was dried over MgSO 4 and the solvent was removed by rotary evaporation. Finally, Water was subjected to column chromatographic separation to obtain Compound B-24 (7.3 g, 81%), which was a white flow solid.

합성 실시예61. 화합물B-25의 합성Synthesis Example 61. Synthesis of Compound B-25

실시예60과 동일한 방법을 사용하여 화합물B-25를 제조하는데, 구별점은 중간체M13을 같은 당량의 중간체M14로 대체하는 동시에, 디벤조티오펜-2-보론산을 같은 당량의 디벤조[b,d]푸란-2일보론산(dibenzo[b,d]furan-2-ylboronic acid)으로 치환하여, 반응 완료 후, 칼럼크로마토그래피를 진행하여 조생성물을 분리하여, 백색류 고체 화합물 B-25(6.4g, 74%)를 얻는다.Compound B-25 was prepared using the same procedure as in Example 60 except that intermediate M13 was replaced with the same equivalent of intermediate M14 while dibenzothiophene-2-boronic acid was replaced with the same equivalent amount of dibenzo [b (dibenzo [b, d] furan-2-ylboronic acid). After completion of the reaction, column chromatography was carried out to separate the crude product into white solid compound B-25 6.4 g, 74%).

합성 실시예62. 화합물B-26의 합성Synthesis Example 62. Synthesis of Compound B-26

합성 실시예23과 동일한 합성 방법을 사용하는데, 구별점은, 벤젠보론산을 같은 당량의 2-디벤조티오펜보론산으로 대체하여, 반응 완료 후, 8.1g의 담황색 고체를 얻으며, 수율은 80%이다.The same synthetic method as that of Synthesis Example 23 was used except that benzene boronic acid was replaced with the same equivalent amount of 2-dibenzothiophene boronic acid to obtain 8.1 g of a pale yellow solid after completion of the reaction and the yield was 80 %to be.

합성 실시예63. 화합물B-27의 합성Synthesis Example 63. Synthesis of Compound B-27

Figure pct00082
Figure pct00082

중간체M3-2(6.9g, 10mmol), 벤젠보론산(3.05g, 25mmol), Pd(PPh3)4(0.58g, 0.5mmol), Na2CO3(5.3g, 50mmol), 60mL의 톨루엔과 20mL의 에탄올(EtOH)을 혼합하고, 상기 혼합물에 20mL의 증류수를 넣은 후, 120℃ 하에서 2시간 동안 교반반응시킨다. 반응 완료 후, 증류수로 반응계를 세척한 후, 아세트산에틸로 추출하여 유기층을 얻고, MgSO4로 유기층을 건조시키며, 용매를 회전증발시켜 제거하고, 마지막으로, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 중간체 화합물B-27-1(4.5g, 84%)을 얻으며, 백색 고체이다.Intermediate M3-2 (6.9g, 10mmol), benzene boronic acid (3.05g, 25mmol), Pd ( PPh 3) 4 (0.58g, 0.5mmol), Na 2 CO 3 (5.3g, 50mmol), 60mL of toluene and 20 ml of ethanol (EtOH) were mixed, and 20 ml of distilled water was added to the mixture, followed by stirring at 120 ° C for 2 hours. After completion of the reaction, the reaction system was washed with distilled water and extracted with ethyl acetate to obtain an organic layer. The organic layer was dried over MgSO 4 , and the solvent was removed by rotary evaporation. Finally, the solvent was removed and the residue was subjected to column chromatography Separation was carried out to obtain Intermediate Compound B-27-1 (4.5 g, 84%), which was a white solid.

중간체 화합물B-27-1(5.35g, 10mmol), 2-브로모디벤조티오펜(5.4 g, 20mmol), CuI(1g, 5mmol), Cs2CO3(8.3g, 25mmol) 및 100mL의 톨루엔을 혼합하고, 50℃ 하에서 반응시킨 후, 혼합물에 에틸렌디아민(0.7mL, 10mmol)을 넣어, 14시간 동안 환류 반응시키며, 반응 완료 후, 실온에서 냉각시키고, 여기에 증류수를 넣으며, 아세트산에틸로 추출하여, 유기상을 얻고, 무수 MgSO4로 건조시켜 유기상 중의 수분을 제거하며, 유기상을 감압 증류시키고, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 담황색 고체의 목표 화합물B-27(5.84g, 수율은 65%임)을 얻는다.Intermediate compound B-27-1 (5.35g, 10mmol) , toluene of 2-bromo-modify-benzothiophene (5.4 g, 20mmol), CuI (1g, 5mmol), Cs 2 CO 3 (8.3g, 25mmol) and 100mL Ethylenediamine (0.7 mL, 10 mmol) was added to the mixture and the mixture was refluxed for 14 hours. After completion of the reaction, the mixture was cooled at room temperature, distilled water was added thereto, and the mixture was extracted with ethyl acetate , And an organic phase was obtained and dried over anhydrous MgSO 4 to remove water in the organic phase. The organic phase was distilled off under reduced pressure, and the resulting residue was subjected to column chromatography to obtain the target compound B-27 (5.84 g, Yield is 65%).

합성 실시예64. 화합물B-28의 합성Synthesis Example 64. Synthesis of Compound B-28

합성 실시예34과 동일한 합성 방법을 사용하는데, 구별점은 브로모벤젠을 같은 당량의 2-브로모디벤조[b,d]티오펜(2-bromodibenzo[b,d]thiophene)으로 치환하여, 반응 완료 후, 4.32g의 백색 고체를 얻으며, 수율은 68%이다.The same synthetic procedure as in Synthetic Example 34 was used except that bromobenzene was replaced with the same equivalent amount of 2-bromodibenzo [b, d] thiophene to give the reaction After completion, 4.32 g of a white solid are obtained, yielding 68%.

합성 실시예65. 화합물B-29의 합성Synthesis Example 65. Synthesis of Compound B-29

합성 실시예25와 동일한 합성 방법을 사용하는데, 구별점은 4-바이페닐보론산을 같은 당량의 디벤조[b,d]티오펜-2-일브론산(dibenzo[b,d]thiophen-2-ylboronic acid)으로 대체하여, 반응 완료 후, 4.15g의 백색 고체를 얻으며, 두 단계 총 수율은 58%이다.Dibenzo [b, d] thiophen-2 < RTI ID = 0.0 > -ylboronic acid) to give 4.15 g of a white solid after completion of the reaction, with a two-step total yield of 58%.

합성 실시예66. 화합물B-30의 합성Synthesis Example 66. Synthesis of Compound B-30

Figure pct00083
Figure pct00083

중간체M7(6.9g, 10mmol), 디벤조티오펜-2-보론산(5.7g, 25mmol), Pd(PPh3)4(0.58g, 0.5mmol), K2CO3(5.3g, 50mmol), 60mL의 톨루엔과 20mL의 에탄올(EtOH)을 혼합하고, 상기 혼합물에 20mL의 증류수를 넣은 후, 120℃ 하에서 2시간 동안 교반반응시킨다. 반응 완료 후, 증류수로 반응계를 세척한 후, 아세트산에틸로 추출하여 유기층을 얻고, MgSO4로 유기층을 건조시키며, 용매를 회전증발시켜 제거하고, 마지막으로, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 화합물B-30(6.8g, 76%)을 얻으며, 백색 고체이다.Intermediate M7 (6.9g, 10mmol), di-benzothiophene-2-boronic acid (5.7g, 25mmol), Pd ( PPh 3) 4 (0.58g, 0.5mmol), K 2 CO 3 (5.3g, 50mmol), 60 mL of toluene and 20 mL of ethanol (EtOH) were mixed, and 20 mL of distilled water was added to the mixture, followed by stirring at 120 ° C for 2 hours. After completion of the reaction, the reaction system was washed with distilled water and extracted with ethyl acetate to obtain an organic layer. The organic layer was dried over MgSO 4 , and the solvent was removed by rotary evaporation. Finally, the solvent was removed and the residue was subjected to column chromatography Separation was carried out to obtain Compound B-30 (6.8 g, 76%), which was a white solid.

B-30의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of B-30:

1H NMR(500 MHz, Chloroform) δ 8.39(dt, J = 7.5, 1.8 Hz, 1H), 8.23 - 8.16(m, 2H), 8.19 - 8.12(m, 1H), 8.15 - 8.04(m, 2H), 8.01(dt, J = 7.4, 2.2 Hz, 1H), 7.92 - 7.79(m, 2H), 7.83 - 7.72(m, 3H), 7.57 - 7.24(m, 7H). 1 H NMR (500 MHz, Chloroform ) δ 8.39 (dt, J = 7.5, 1.8 Hz, 1H), 8.23 - 8.16 (m, 2H), 8.19 - 8.12 (m, 1H), 8.15 - 8.04 (m, 2H) , 8.01 (dt, J = 7.4,2.2 Hz, 1H), 7.92-7.79 (m, 2H), 7.83-7.72 (m, 3H), 7.57-7.24 (m, 7H).

합성 실시예67. 화합물B-31의 합성Synthesis Example 67. Synthesis of Compound B-31

합성 실시예66과 동일한 합성 방법을 사용하는데, 구별점은 디벤조[b,d]티오펜-2-일브론산(dibenzo[b,d]thiophen-2-ylboronic acid)을 같은 당량의 디벤조[b,d]푸란-2-일보론산(dibenzo[b,d] furan-2-ylboronic acid)으로 대체하여, 반응 완료 후, 7.1g의 백색 고체를 얻으며, 수율은 66%이다.Dibenzo [b, d] thiophen-2-ylboronic acid) was treated with the same equivalent of dibenzo [b, d] [b, d] furan-2-ylboronic acid in place of dibenzo [b, d] furan-2-ylboronic acid to give 7.1 g of a white solid after completion of the reaction.

합성 실시예68. 화합물C-1의 합성SYNTHESIS EXAMPLE 68. Synthesis of Compound C-1

Figure pct00084
Figure pct00084

100mL의 자일렌에 화합물M6(3.86g, 10mmol), 4-브로모트리페닐아민(9.7g, 30mmol), CuI(0.9g, 5mmol), 트랜스-디아미노시클로헥산(2.1mL, 20mmol)과 탄산세슘(6.5g, 20mmol)을 넣고, 상기 혼합물을 3시간 동안 환류시킨다. 반응 혼합액을 실온까지 냉각시킨 후, 여과한 다음, 디클로로메탄으로 필터 케이크를 세척하고, 여액을 감압 증류시켜 용매를 제거하며, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 담황색 고체 화합물C-1(6.25g, 수율은 72%임)을 얻는다.(3.86 g, 10 mmol), 4-bromotriphenylamine (9.7 g, 30 mmol), CuI (0.9 g, 5 mmol) and trans-diaminocyclohexane (2.1 mL, 20 mmol) Cesium (6.5 g, 20 mmol) is added and the mixture is refluxed for 3 hours. The reaction mixture was cooled to room temperature and then filtered. The filter cake was washed with dichloromethane. The filtrate was distilled under reduced pressure to remove the solvent, and the obtained residue was subjected to column chromatography to separate the light yellow solid compound C -1 (6.25 g, yield 72%).

C-1의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of C-1:

1H NMR(500 MHz, Chloroform) δ 8.50(s, 12H), 8.37(s, 17H), 8.05(s, 17H), 7.64(s, 21H), 7.47(s, 10H), 7.32 - 7.03(m, 105H), 7.12(s, 6H), 7.15 - 7.03(m, 44H), 7.05(d, J = 14.9 Hz, 54H), 6.96(s, 14H). 1 H NMR (500 MHz, Chloroform)? 8.50 (s, 12H), 8.37 (s, 17H), 8.05 , 105H), 7.12 (s, 6H), 7.15-7.03 (m, 44H), 7.05 (d, J = 14.9 Hz, 54H), 6.96 (s, 14H).

합성 실시예69. 화합물C-2의 합성Synthesis Example 69. Synthesis of Compound C-2

화합물C-1과 동일한 합성 방법을 사용하는데, 구별점은, 4-브로모트리페닐아민을 같은 당량의 트리페닐아민-3-브로마이드로 대체하여, 반응 완료 후, 5.8g의 담황색 고체 C-2를 얻으며, 수율은 68%이다.The same synthetic method as that of Compound C-1 was used except that 4-bromotriphenylamine was replaced with the same equivalent amount of triphenylamine-3-bromide to obtain 5.8 g of light yellow solid C-2 And the yield is 68%.

합성 실시예70. 화합물C-3의 합성Synthesis Example 70. Synthesis of Compound C-3

화합물C-1과 동일한 합성 방법을 사용하는데, 구별점은, 트리페닐아민-4-브로마이드를 같은 당량의 N-페닐-N-(4-브로모페닐)일-2-나프틸아민으로 대체하여, 반응시켜 5.23g의 담황색 고체를 얻으며, 수율은 55%이다.The same synthetic method as Compound C-1 is used, with the exception that triphenylamine-4-bromide is replaced with the same equivalent amount of N-phenyl-N- (4-bromophenyl) , To give 5.23 g of a light yellow solid, the yield being 55%.

C-3의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of C-3:

1H NMR(500 MHz, Chloroform) δ 8.49(d, J = 65.0 Hz, 46H), 8.39(s, 2H), 8.10(s, 26H), 7.88 - 7.60(m, 61H), 7.53(d, J = 10.0 Hz, 30H), 7.43(d, J = 15.0 Hz, 33H), 7.38(s, 11H), 7.32(s, 27H), 7.24(s, 31H), 7.19 - 7.06(m, 72H), 7.00(s, 14H). 1 H NMR (500 MHz, Chloroform ) δ 8.49 (d, J = 65.0 Hz, 46H), 8.39 (s, 2H), 8.10 (s, 26H), 7.88 - 7.60 (m, 61H), 7.53 (d, J (M, 72H), 7.00 (s, 2H), 7.42 (d, J = (s, 14 H).

합성 실시예71. 화합물C-4의 합성Synthesis Example 71. Synthesis of Compound C-4

Figure pct00085
Figure pct00085

250mL의 삼구 플라스크에, N2를 통과시켜 보호한다. 4.22g(25mmol)의 디페닐아민, 6.92g(10mmol)의 중간체M11, 0.27 g(0.5mmol)의 Pd(dba)2, 6.2g(125mmol)의 소듐 tert-부톡시드, 1.04mL(0.5mmol)의 트리-tert-부틸포스핀, 150mL의 톨루엔을 삼구 플라스크 내에 넣어, 반응 혼합물을 환류 상태에서 2시간 동안 반응시키고, TLC 검출 결과 반응이 완료되면, 반응을 멈춘다. 혼합물을 실온까지 감온시킨 후, 탈이온수를 넣어 반응을 종료시키고, 톨루엔으로 3회 추출하며, 유기상을 합하고, 유기상을 무수 황산 마그네슘으로 건조시키며, 실리카 겔 단칼럼 크로마토그래피를 진행하여, 여액을 회전건조시키고, 잔류물에 대하여 칼럼 크로마토그래피 분리를 진행하여 7.04g의 황색 고체를 얻으며, 수율은 81%이다.A 250 mL three-necked flask is protected by passing through N 2 . A solution of 4.22 g (25 mmol) of diphenylamine, 6.92 g (10 mmol) of intermediate M11, 0.27 g (0.5 mmol) of Pd (dba) 2 , 6.2 g (125 mmol) Of tri-tert-butylphosphine and 150 mL of toluene were placed in a three-necked flask, and the reaction mixture was reacted for 2 hours under reflux. When the reaction was completed by TLC detection, the reaction was stopped. After the mixture was cooled to room temperature, deionized water was added to terminate the reaction, and the mixture was extracted three times with toluene. The organic phases were combined, the organic phase was dried over anhydrous magnesium sulfate, and the silica gel column chromatography was carried out. Drying and column chromatography on the residue gave 7.04 g of a yellow solid with a yield of 81%.

C-4의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of C-4:

1H NMR(500 MHz, Chloroform) δ 8.42(s, 2H), 8.10(s, 2H), 8.01(s, 1H), 7.60(d, J = 20.0 Hz, 3H), 7.49(d, J = 10.0 Hz, 3H), 7.24(s, 4H), 7.08(s, 4H), 7.00(s, 2H), 6.48(s, 1H). 1 H NMR (500 MHz, Chloroform ) δ 8.42 (s, 2H), 8.10 (s, 2H), 8.01 (s, 1H), 7.60 (d, J = 20.0 Hz, 3H), 7.49 (d, J = 10.0 Hz, 3H), 7.24 (s, 4H), 7.08 (s, 4H), 7.00 (s, 2H), 6.48 (s, 1H).

합성 실시예72. 화합물C-5의 합성Synthesis Example 72. Synthesis of Compound C-5

화합물C-4와 동일한 합성 방법을 사용하는데, 구별점은, 중간체M11을 같은 당량의 중간체M13으로 대체하여, 반응시켜 7.1g의 황색 고체를 얻으며, 수율은 82%이다.The same synthetic method as that of Compound C-4 is used, with the exception that intermediate M11 is replaced by the same equivalent of intermediate M13 to give 7.1 g of a yellow solid, yield 82%.

합성 실시예73. 화합물C-6의 합성Synthesis Example 73. Synthesis of Compound C-6

화합물C-5와 동일한 합성 방법을 사용하는데, 구별점은, 디페닐아민을 같은 당량의 페닐나프틸아민으로 대체하여, 반응시켜 7.5g의 황색 고체를 얻으며, 수율은 84%이다.The same synthetic method as that of Compound C-5 was used except that diphenylamine was replaced by the same equivalent amount of phenylnaphthylamine to give 7.5 g of yellow solid in yield of 84%.

합성 실시예74. 화합물C-7의 합성SYNTHESIS EXAMPLE 74. Synthesis of Compound C-7

Figure pct00086
Figure pct00086

중간체M1(38.6g, 0.1mol), 1-브로모-3-요오도벤젠(56.7g, 0.2mol), CuI(3.3g, 17.1mmol), K3PO4(21.8g, 102.9mmol), 에틸렌디아민(2.3mL, 34.3mmol)과 톨루엔(500mL)을 혼합하고, 환류 조건 하에서 하루 동안 교반하며, 반응 완료 후, 실온까지 냉각시키며, 유기층을 아세트산에틸로 추출하고 감압 증류하여, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 디클로로메탄/헥산), 중간체 화합물M14(48.3g, 70.1%)를 얻는다.Intermediate M1 (38.6g, 0.1mol), 1- bromo-3-iodobenzene (56.7g, 0.2mol), CuI ( 3.3g, 17.1mmol), K 3 PO 4 (21.8g, 102.9mmol), ethylene After completion of the reaction, the reaction mixture was cooled to room temperature. The organic layer was extracted with ethyl acetate, and the residue was distilled under reduced pressure. The residue was purified by silica gel column chromatography (silica gel, (Eluent: dichloromethane / hexane) to obtain intermediate compound M14 (48.3 g, 70.1%).

250mL의 삼구 플라스크에, N2를 통과시켜 보호한다. 4.22g(25mmol)의 디페닐아민, 6.92g(10mmol)의 중간체M14, 0.27g(0.5mmol)의 Pd(dba)2, 6.2g(125mmol)의 소듐 tert-부톡시드, 1.04mL(0.5mmol)의 트리-tert-부틸포스핀, 150mL의 톨루엔을 삼구 플라스크 내에 넣어, 반응 혼합물을 환류 상태에서 2시간 동안 반응시키고, TLC 검출 결과 반응이 완료되면, 반응을 멈춘다. 혼합물을 실온까지 감온시킨 후, 탈이온수를 넣어 반응을 종료시키고, 톨루엔으로 3회 추출하며, 유기상을 합하고, 유기상을 무수 황산 마그네슘으로 건조시키며, 실리카 겔 단칼럼 크로마토그래피를 진행하여, 여액을 회전건조시키고, 잔류물에 대하여 칼럼 크로마토그래피 분리를 진행하여 7.5g의 황색 고체 화합물C-7을 얻으며, 수율은 85%이다.A 250 mL three-necked flask is protected by passing through N 2 . (10 mmol) of intermediate M14, 0.27 g (0.5 mmol) of Pd (dba) 2 , 6.2 g (125 mmol) of sodium tert-butoxide, 1.04 mL (0.5 mmol) Of tri-tert-butylphosphine and 150 mL of toluene were placed in a three-necked flask, and the reaction mixture was reacted for 2 hours under reflux. When the reaction was completed by TLC detection, the reaction was stopped. After the mixture was cooled to room temperature, deionized water was added to terminate the reaction, and the mixture was extracted three times with toluene. The organic phases were combined, the organic phase was dried over anhydrous magnesium sulfate, and the silica gel column chromatography was carried out. Dried, and the residue was subjected to column chromatography separation to obtain 7.5 g of a yellow solid compound C-7, the yield being 85%.

합성 실시예75. 화합물C-8의 합성Synthesis Example 75. Synthesis of Compound C-8

Figure pct00087
Figure pct00087

실시예63에서 화합물B-27과 동일한 합성 방법을 사용하는데, 구별점은, 중간체2-브로모디벤조티오펜을 같은 당량의 4-브로모트리페닐아민으로 대체하여, 반응시켜 7.0g의 담황색 고체를 얻으며, 수율은 75%이다.The same synthetic method as that of Compound B-27 was used in Example 63 except that the intermediate 2-bromodibenzothiophene was replaced by the same equivalent amount of 4-bromotriphenylamine to give 7.0 g of a light yellow solid , And the yield is 75%.

합성 실시예76. 화합물C-9의 합성Synthesis Example 76. Synthesis of Compound C-9

화합물C-4와 동일한 합성 방법을 사용하는데, 구별점은, 중간체M11을 같은 당량의 중간체M3으로 대체하여, 반응시켜 7.04g의 황색 고체를 얻으며, 수율은 81%이다.The same synthetic method as that of the compound C-4 was used except that the intermediate M11 was replaced by the same equivalent amount of the intermediate M3 to obtain 7.04 g of a yellow solid in a yield of 81%.

합성 실시예77. 화합물C-10의 합성Synthesis Example 77. Synthesis of Synthesis of Compound C-10

화합물C-4와 동일한 합성 방법을 사용하는데, 구별점은, 중간체M11을 같은 당량의 중간체M2로 대체하여, 반응시켜 7.1g의 황색 고체를 얻으며, 수율은 82%이다.The same synthetic method as that of the compound C-4 was used except that the intermediate M11 was replaced by the same equivalent amount of the intermediate M2 to obtain 7.1 g of a yellow solid, and the yield was 82%.

합성 실시예78. 화합물C-11의 합성SYNTHESIS EXAMPLE 78. Synthesis of Compound C-11

화합물C-4와 동일한 합성 방법을 사용하는데, 구별점은, 중간체 디페닐아민을 같은 당량의 페닐-2-나프틸아민으로 대체하여, 반응시켜 7.2g의 담황색 고체를 얻으며, 수율은 74%이다.The same synthetic method as that of Compound C-4 was used except that the intermediate diphenylamine was replaced by the same equivalent amount of phenyl-2-naphthylamine to give 7.2 g of a pale yellow solid with a yield of 74% .

C-11의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of C-11:

1H NMR(500 MHz, Chloroform) δ 8.42(s, 19H), 8.23(s, 11H), 8.13(d, J = 6.6 Hz, 2H), 8.03(d, J = 70.0 Hz, 34H), 7.73(t, J = 3.3 Hz, 5H), 7.71(s, 10H), 7.66(d, J = 45.0 Hz, 35H), 7.72 - 7.52(m, 64H), 7.50(s, 12H), 7.43(d, J = 15.0 Hz, 33H), 7.38(s, 8H), 7.24(s, 22H), 7.10(d, J = 15.0 Hz, 31H), 7.00(s, 10H), 6.40(s, 11H). 1 H NMR (500 MHz, Chloroform ) δ 8.42 (s, 19H), 8.23 (s, 11H), 8.13 (d, J = 6.6 Hz, 2H), 8.03 (d, J = 70.0 Hz, 34H), 7.73 ( t, J = 3.3 Hz, 5H ), 7.71 (s, 10H), 7.66 (d, J = 45.0 Hz, 35H), 7.72 - 7.52 (m, 64H), 7.50 (s, 12H), 7.43 (d, J = 15.0 Hz, 33H), 7.38 (s, 8H), 7.24 (s, 22H), 7.10 (d, J = 15.0 Hz, 31H), 7.00 (s, 10H), 6.40 (s,

합성 실시예79. 화합물C-12의 합성Synthesis Example 79. Synthesis of Compound C-12

Figure pct00088
Figure pct00088

화합물C-12-1의 제조Preparation of Compound C-12-1

중간체M7(34.5g, 50mmol), N-페닐-디벤조[b,d]푸란-3-아민(7.8g, 30mmol), Pd2(dba)3(0.27g, 0.3mmol), 소듐 tert-부톡시드(5.8g, 60mmol)와 톨루엔(200mL)을 혼합한 후, 110℃ 하에서 2시간 동안 교반반응시킨다. 반응 완료 후, 증류수로 반응계를 세척한 후, 100mL의 아세트산에틸로 3회 추출하고, 합하여 유기층을 얻으며, 무수 MgSO4로 유기층을 건조시키고, 회전증발기로 용매를 제거하며, 마지막으로, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 화합물C-12-1(16g, 수율은 61.5%임)을 얻는다.(7.8 g, 30 mmol), Pd 2 (dba) 3 (0.27 g, 0.3 mmol), sodium tert-butoxide The seed (5.8 g, 60 mmol) and toluene (200 mL) were mixed and stirred at 110 ° C for 2 hours. After completion of the reaction, the reaction system was washed with distilled water and extracted three times with 100 mL of ethyl acetate to obtain an organic layer. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed using a rotary evaporator, The residue was subjected to column chromatography separation to obtain Compound C-12-1 (16 g, yield: 61.5%).

화합물C-12 의 제조Preparation of Compound C-12

화합물C-12-1(17g, 20mmol), N-페닐-디벤조[b,d]티오펜-3-아민(7.7g, 30mmol), Pd2(dba)3(0.27g, 0.3mmol), 소듐 tert-부톡시드(5.8g, 60mmol)와 톨루엔(200mL)을 혼합한 후, 110℃ 하에서 2시간 동안 교반반응시킨다. 반응 완료 후, 증류수로 반응계를 세척한 후, 100mL의 아세트산에틸로 3회 추출하고, 합하여 유기층을 얻으며, 무수 MgSO4로 유기층을 건조시키고, 회전증발기로 용매를 제거하며, 마지막으로, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 화합물C-12를 얻으며, 황색 화합물(18.9g, 89%)이다.(7.7 g, 30 mmol), Pd 2 (dba) 3 (0.27 g, 0.3 mmol), N-phenyl-dibenzo [b, Sodium tert-butoxide (5.8 g, 60 mmol) and toluene (200 mL) were mixed and stirred at 110 ° C for 2 hours. After completion of the reaction, the reaction system was washed with distilled water and extracted three times with 100 mL of ethyl acetate to obtain an organic layer. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed using a rotary evaporator, The residue was subjected to column chromatographic separation to obtain the compound C-12, which was a yellow compound (18.9 g, 89%).

C-12의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of C-12:

1H NMR(500 MHz, Chloroform) δ 8.56 - 8.38(m, 50H), 8.08(s, 25H), 8.05 - 8.03(m, 1H), 7.99(t, J = 12.5 Hz, 23H), 8.03 - 7.71(m, 38H), 7.57(dd, J = 39.9, 34.9 Hz, 54H), 7.51(s, 12H), 7.38(s, 8H), 7.33 - 7.26(m, 51H), 7.23(s, 28H), 7.15(s, 9H), 7.08(d, J = 15.0 Hz, 43H), 7.00(d, J = 15.0 Hz, 20H). 1 H NMR (500 MHz, Chloroform ) δ 8.56 - 8.38 (m, 50H), 8.08 (s, 25H), 8.05 - 8.03 (m, 1H), 7.99 (t, J = 12.5 Hz, 23H), 8.03 - 7.71 (m, 38H), 7.57 (dd, J = 39.9,34.9 Hz, 54H), 7.51 (s, 12H), 7.38 7.15 (s, 9H), 7.08 (d, J = 15.0 Hz, 43H), 7.00 (d, J = 15.0 Hz, 20H).

합성 실시예80. 화합물C-13의 합성Synthesis Example 80. Synthesis of Compound C-13

Figure pct00089
Figure pct00089

중간체 화합물C-13-1의 제조Preparation of intermediate compound C-13-1

중간체M7(34.5g, 50mmol), 디페닐아민(5.7g, 30mmol), Pd2(dba)3(0.27g, 0.3mmol), 소듐 tert-부톡시드(5.8g, 60mmol)와 톨루엔(200mL)을 혼합한 후, 110℃ 하에서 2시간 동안 교반반응시킨다. 반응 완료 후, 증류수로 반응계를 세척한 후, 100mL의 아세트산에틸로 3회 추출하고, 합하여 유기층을 얻으며, 무수 MgSO4로 유기층을 건조시키고, 회전증발기로 용매를 제거하며, 마지막으로, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 단일 치환 중간체 화합물C-13-1(21g, 90%)을 얻는다.Pd 2 (dba) 3 (0.27 g, 0.3 mmol), sodium tert-butoxide (5.8 g, 60 mmol) and toluene (200 mL) were added to a solution of intermediate M7 (34.5 g, 50 mmol), diphenylamine After mixing, the mixture is stirred for 2 hours at 110 ° C. After completion of the reaction, the reaction system was washed with distilled water and extracted three times with 100 mL of ethyl acetate to obtain an organic layer. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed using a rotary evaporator, The residue is subjected to column chromatography separation to obtain a mono-substituted intermediate compound C-13-1 (21 g, 90%).

화합물C-13의 제조Preparation of Compound C-13

화합물C-13-1(21g, 27mmol), N-페닐-디벤조[b,d]티오펜-3-아민(7.7g, 30mmol), Pd2(dba)3(0.27g, 0.3mmol), 소듐 tert-부톡시드(5.8g, 60mmol)과 톨루엔(200mL)을 혼합한 후, 120℃ 하에서 2시간 동안 교반반응시킨다. 반응 완료 후, 증류수로 반응계를 세척한 후, 100mL의 아세트산에틸로 3회 추출하고, 합하여 유기층을 얻으며, 무수 MgSO4로 유기층을 건조시키고, 회전증발기로 용매를 제거하며, 마지막으로, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 화합물C-13을 얻으며, 황색 고체(23.7g, 90%)이다.(7.7 g, 30 mmol), Pd 2 (dba) 3 (0.27 g, 0.3 mmol), N-phenyl-dibenzo [b, Sodium tert-butoxide (5.8 g, 60 mmol) and toluene (200 mL) were mixed and stirred at 120 ° C for 2 hours. After completion of the reaction, the reaction system was washed with distilled water and extracted three times with 100 mL of ethyl acetate to obtain an organic layer. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed using a rotary evaporator, The residue was subjected to column chromatography separation to obtain compound C-13, which was a yellow solid (23.7 g, 90%).

C-13의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of C-13:

1H NMR(500 MHz, Chloroform) δ 8.67 - 8.21(m, 259H), 8.37(s, 13H), 8.08(s, 122H), 8.05(s, 5H), 8.03(d, J = 21.7 Hz, 6H), 8.01 - 7.70(m, 112H), 7.61(d, J = 64.9 Hz, 190H), 7.51(s, 59H), 7.30(d, J = 5.0 Hz, 178H), 7.23(s, 226H), 7.15(s, 39H), 7.08(d, J = 15.0 Hz, 299H), 7.00(d, J = 15.0 Hz, 126H). 1 H NMR (500 MHz, Chloroform ) δ 8.67 - 8.21 (m, 259H), 8.37 (s, 13H), 8.08 (s, 122H), 8.05 (s, 5H), 8.03 (d, J = 21.7 Hz, 6H ), 8.01 - 7.70 (m, 112H), 7.61 (d, J = 64.9 Hz, 190H), 7.51 (s, 59H), 7.30 (d, J = 5.0 Hz, 178H), 7.23 (s, 226H), 7.15 (s, 39H), 7.08 (d, J = 15.0Hz, 299H), 7.00 (d, J = 15.0Hz, 126H).

합성 실시예81. 화합물C-14의 합성Synthesis Example 81. Synthesis of Compound C-14

실시예25로 화합물A-16을 제조하는 것과 동일한 방법을 사용하여 화합물C-14를 제조하는데, 구별점은 중간체M8을 같은 당량의 중간체M9로 대체하고, 4-바이페닐보론산을 같은 당량의 (4-(디페닐아미노)페닐)보론산((4-(diphenylamino)phenyl)boronic acid)으로 대체하여, 반응 완료 후, 분리하여 B-13을 얻고, 6.6g의 백색 고체이며, 수율은 85%이다.Compound C-14 was prepared using the same method as that for preparing Compound A-16 in Example 25 except that intermediate M8 was replaced with the same equivalent of intermediate M9 and 4-biphenylboronic acid was replaced with the same equivalent amount of (4- (diphenylamino) phenyl) boronic acid in place of 4- (4- (diphenylamino) phenyl) boronic acid. After completion of the reaction, B-13 was isolated to obtain 6.6 g of a white solid, %to be.

합성 실시예82. 화합물C-15의 합성Synthesis Example 82. Synthesis of Compound C-15

실시예25로 화합물A-16을 제조하는 것과 동일한 방법을 사용하여 화합물C-14를 제조하는데, 구별점은 중간체M8을 같은 당량의 중간체M9로 대체하고, 4-바이페닐보론산을 같은 당량의 (4-(디페닐아미노)페닐)보론산((4-(diphenylamino)phenyl)boronic acid)으로 대체하여, 반응 완료 후, 분리하여 B-13을 얻고, 6.6g의 백색 고체이며, 수율은 85%이다.Compound C-14 was prepared using the same method as that for preparing Compound A-16 in Example 25 except that intermediate M8 was replaced with the same equivalent of intermediate M9 and 4-biphenylboronic acid was replaced with the same equivalent amount of (4- (diphenylamino) phenyl) boronic acid in place of 4- (4- (diphenylamino) phenyl) boronic acid. After completion of the reaction, B-13 was isolated to obtain 6.6 g of a white solid, %to be.

C-15의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of C-15:

1H NMR(500 MHz, Chloroform) δ 8.51(s, 17H), 8.38(s, 13H), 8.06(s, 13H), 7.56(d, J = 19.9 Hz, 46H), 7.48(d, J = 10.0 Hz, 42H), 7.36(s, 7H), 7.21(s, 31H), 7.14(d, J = 10.0 Hz, 19H), 7.06(d, J = 14.9 Hz, 43H), 6.97(s, 9H), 6.90(s, 9H). 1 H NMR (500 MHz, Chloroform ) δ 8.51 (s, 17H), 8.38 (s, 13H), 8.06 (s, 13H), 7.56 (d, J = 19.9 Hz, 46H), 7.48 (d, J = 10.0 J = 10.0 Hz, 19H), 7.06 (d, J = 14.9 Hz, 43H), 6.97 (s, 9H) 6.90 (s, 9 H).

합성 실시예83. 화합물C-16의 합성SYNTHESIS EXAMPLE 83. Synthesis of Compound C-16

Figure pct00090
Figure pct00090

N2 보호 하에서, 삼구 플라스크에 22g(0.11mol)의 요오도벤젠, 46.1g(0.1mol)의 중간체M9, 2g(20mmol)의 염화제일구리, 4g(20mmol)의 수화1,10-페난트롤린, 16.8g(0.3mol)의 수산화칼륨, 300mL의 자일렌을 넣는다. 20시간 동안 반응계를 환류 반응을 유지시키고, 반응이 완료되면, 증류수로 반응계를 세척한 후, 100mL의 아세트산에틸로 3회 추출하며, 합하여 유기층을 얻고, MgSO4로 유기층을 건조시키며, 회전증발기로 용매를 제거하고, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 얻은 중간체 화합물은 백색 고체(46.1g, 75%)이다.Under N 2 protection, a solution of 22 g (0.11 mol) of iodobenzene, 46.1 g (0.1 mol) of intermediate M9, 2 g (20 mmol) of cuprous chloride chloride and 4 g (20 mmol) of hydrated 1,10-phenanthroline , 16.8 g (0.3 mol) of potassium hydroxide and 300 mL of xylene. After the reaction was completed, the reaction system was washed with distilled water and extracted three times with 100 mL of ethyl acetate. The organic layer was separated, dried over MgSO 4 and evaporated in a rotary evaporator The solvent was removed, and the solvent-removed residue was subjected to column chromatography, and the resulting intermediate compound was a white solid (46.1 g, 75%).

중간체C-16-1(6.14g, 10mmol), 디페닐아민(1.7g, 10mmol), Pd2(dba)3(0.03g, 0.03mmol), 소듐 tert-부톡시드(1.9g, 20mmol)와 톨루엔(100mL)을 혼합한 후, 120℃ 하에서 2시간 동안 교반반응시킨다. 반응 완료 후, 증류수로 반응계를 세척한 후, 100mL의 아세트산에틸로 3회 추출하고, 합하여 유기층을 얻으며, 무수 MgSO4로 유기층을 건조시키고, 회전증발기로 용매를 제거하며, 마지막으로, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 화합물C-16을 얻으며, 황색 고체(6.25g, 89%)이다.To a solution of intermediate C-16-1 (6.14 g, 10 mmol), diphenylamine (1.7 g, 10 mmol), Pd 2 (dba) 3 (0.03 g, 0.03 mmol), sodium tert-butoxide (1.9 g, 20 mmol) (100 mL) were mixed and stirred for 2 hours at 120 ° C. After completion of the reaction, the reaction system was washed with distilled water and extracted three times with 100 mL of ethyl acetate to obtain an organic layer. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed using a rotary evaporator, The residue was subjected to column chromatography to obtain Compound C-16, which was a yellow solid (6.25 g, 89%).

합성 실시예84. 화합물D-1의 합성Synthesis Example 84. Synthesis of Compound D-1

Figure pct00091
Figure pct00091

250mL의 삼구 플라스크에, 중간체 화합물M6(19.1g, 50mmol), 2-브로모피리딘(18.9g, 120mmol), CuI(1.8g, 10mmol), 트랜스-디아미노시클로헥산(5.4mL, 50mmol)과 탄산세슘(16g, 50mmol)으로 형성된 혼합액을 3시간 동안 가열하여 환류시킨다. 그 다음, 반응 혼합물을 실온까지 냉각시키고, 여과하며, 디클로로메탄으로 필터 케이크를 세척하여, 얻은 유기상을 탈이온수로 충분히 세척한 후, 무수 황산 나트륨으로 건조시킨다. 건조 후의 유기상을 감압하여 용매를 제거하고, 얻은 잔여물에 대하여 칼럼크로마토그래피 분리를 진행하여, 담황색 화합물D-1(23.1g, 수율은 86%임)을 얻는다.(18.1 g, 120 mmol), CuI (1.8 g, 10 mmol), trans-diaminocyclohexane (5.4 mL, 50 mmol), and carbonic acid Cesium (16 g, 50 mmol) was heated to reflux for 3 hours. Then, the reaction mixture is cooled to room temperature, filtered, washed with dichloromethane, and the obtained organic phase is sufficiently washed with deionized water and then dried with anhydrous sodium sulfate. The organic phase after drying is reduced in pressure to remove the solvent, and the resulting residue is subjected to column chromatography to obtain 23.1 g (86% yield) of light yellow compound D-1.

합성 실시예85. 화합물D-2의 합성Synthesis Example 85. Synthesis of Compound D-2

합성 실시예84와 동일한 합성 방법을 사용하는데, 구별점은, 2-브로모피리딘을 같은 당량의 5-브로모-2-페닐피리딘으로 대체하여, 반응시켜 27.1g의 담황색 고체를 얻으며, 수율은 79%이다.The same synthetic procedure as in Synthetic Example 84 was used, with the exception that 2-bromopyridine was replaced by the equivalent equivalent of 5-bromo-2-phenylpyridine to give 27.1 g of a light yellow solid, 79%.

합성 실시예86. 화합물D-3의 합성Synthesis Example 86. Synthesis of Compound D-3

합성 실시예84와 동일한 합성 방법을 사용하는데, 구별점은, 2-브로모피리딘을 같은 당량의 2-(4-브로모페닐)피리딘으로 대체하여, 반응시켜 29g의 담황색 고체를 얻으며, 수율은 84%이다.The same synthetic procedure as in Synthesis Example 84 was used, with the exception that 2-bromopyridine was replaced by the same equivalent of 2- (4-bromophenyl) pyridine to give 29 g of a light yellow solid, 84%.

합성 실시예87. 화합물D-4의 합성Synthesis Example 87. Synthesis of Compound D-4

합성 실시예84와 동일한 합성 방법을 사용하는데, 구별점은, 2-브로모피리딘을 같은 당량의 3-(4-브로모페닐)피리딘으로 대체하여, 반응시켜 24.5g의 담황색 고체를 얻으며, 수율은 71%이다.The same synthetic method as that of Synthesis Example 84 was used, with the exception that 2-bromopyridine was replaced by the same equivalent amount of 3- (4-bromophenyl) pyridine to give 24.5 g of a light yellow solid, Is 71%.

D-4의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of D-4:

1H NMR(500 MHz, Chloroform) δ 9.24(s, 21H), 8.70(s, 11H), 8.49(d, J = 65.0 Hz, 74H), 8.39(s, 3H), 8.33(s, 19H), 8.10(s, 35H), 7.91(d, J = 5.0 Hz, 84H), 7.49(d, J = 25.0 Hz, 39H), 7.44(s, 2H), 7.16(s, 12H), 7.11(s, 17H). 1 H NMR (500 MHz, Chloroform ) δ 9.24 (s, 21H), 8.70 (s, 11H), 8.49 (d, J = 65.0 Hz, 74H), 8.39 (s, 3H), 8.33 (s, 19H), 8.10 (s, 35H), 7.91 (d, J = 5.0 Hz, 84H), 7.49 (d, J = 25.0 Hz, 39H), 7.44 (s, 2H), 7.16 (s, 12H), 7.11 (s, 17H ).

합성 실시예88. 화합물D-5의 합성SYNTHESIS EXAMPLE 88. Synthesis of Compound D-5

Figure pct00092
Figure pct00092

실시예21에서 화합물A-11과 동일한 합성 방법을 사용하는데, 구별점은, 중간체 브로모벤젠을 같은 당량의 5-브로모-2-페닐피리딘(5-bromo-2-phenylpyridine)으로 대체하여, 반응시켜 5.65g의 황색 고체를 얻으며, 수율은 82%이다.The same synthetic method as that of Compound A-11 was used in Example 21 except that the intermediate bromobenzene was replaced with the same equivalent amount of 5-bromo-2-phenylpyridine, The reaction yielded 5.65 g of a yellow solid, yield 82%.

합성 실시예89. 화합물D-6의 합성Synthesis Example 89. Synthesis of Compound D-6

Figure pct00093
Figure pct00093

실시예63에서 화합물B-27과 동일한 합성 방법을 사용하는데, 구별점은, 중간체2-브로모디벤조티오펜을 같은 당량의 4-브로모트리페닐아민으로 대체하여, 반응시켜 7.0g의 담황색 고체를 얻으며, 수율은 75%이다.The same synthetic method as that of Compound B-27 was used in Example 63 except that the intermediate 2-bromodibenzothiophene was replaced by the same equivalent amount of 4-bromotriphenylamine to give 7.0 g of a light yellow solid , And the yield is 75%.

D-6의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of D-6:

1H NMR(500 MHz, Chloroform) δ 8.43(d, J = 5.0 Hz, 42H), 8.20(s, 15H), 8.11(d, J = 10.0 Hz, 41H), 7.92(t, J = 45.0 Hz, 45H), 7.79 - 7.57(m, 60H), 7.54(s, 12H), 7.49(s, 28H), 7.41(s, 8H). 1 H NMR (500 MHz, Chloroform ) δ 8.43 (d, J = 5.0 Hz, 42H), 8.20 (s, 15H), 8.11 (d, J = 10.0 Hz, 41H), 7.92 (t, J = 45.0 Hz, 45H), 7.79-7.57 (m, 60H), 7.54 (s, 12H), 7.49 (s, 28H), 7.41 (s, 8H).

합성 실시예90. 화합물D-7의 합성Synthesis Example 90. Synthesis of Compound D-7

실시예23과 동일한 방법을 사용하여 화합물D-7을 제조하는데, 구별점은 중간체M2을 같은 당량의 중간체M3으로 대체하는 동시에, 벤젠보론산을 같은 당량의 피리딘-2-보론산으로 대체하여, 반응 완료 후, 5.86g의 황색 고체를 얻으며, 수율은 85%이다.Compound D-7 was prepared using the same procedure as in Example 23 except that intermediate M2 was replaced with the same equivalent of intermediate M3 while benzeneboronic acid was replaced with the same equivalent amount of pyridine- After completion of the reaction, 5.86 g of a yellow solid was obtained, and the yield was 85%.

합성 실시예91. 화합물D-8의 합성Synthesis Example 91. Synthesis of Compound D-8

합성 실시예84와 동일한 합성 방법을 사용하여 화합물D-8을 제조하는데, 구별점은, 2-브로모피리딘을 같은 당량의 2-브로모퀴놀린으로 대체하여, 반응시켜 26.8g의 황색 화합물을 얻으며, 수율은 84%이다.Compound D-8 was prepared using the same synthetic procedure as in Synthesis Example 84 except that 2-bromopyridine was replaced by the same equivalent amount of 2-bromoquinoline to give 26.8 g of a yellow compound , And the yield is 84%.

합성 실시예92. 중간체 화합물M15의 합성Synthesis Example 92. Synthesis of intermediate compound M15

Figure pct00094
Figure pct00094

1L의 삼구 플라스크에 4-브로모페닐히드라진 히드로클로라이드(92.8g, 0.415mol), 디벤조[a,e]-5,11-시클로옥타디엔(6H,12H)-디케톤(49g, 0.207mol), 에탄올(400mL)을 넣고, 교반 조건 하에서, 3분 내에 2g의 농황산을 적가하며, 65℃에서 4시간 동안 반응시키고, 반응 완료 후, 실온까지 냉각시키며, 여과하여, 순차적으로 에탄올, 석유에테르로 필터 케이크를 세척하여, 중간체 화합물M15-1(110g, 85%)을 얻는다.4-bromophenylhydrazine hydrochloride (92.8 g, 0.415 mol), dibenzo [a, e] -5,11-cyclooctadiene (6H, 12H) -diketone (49 g, 0.207 mol) , And ethanol (400 mL) were added, and 2 g of concentrated sulfuric acid was added dropwise in 3 minutes under agitation conditions. The reaction was carried out at 65 DEG C for 4 hours. After the completion of the reaction, the reaction mixture was cooled to room temperature, filtered and washed successively with ethanol and petroleum ether The filter cake is washed to obtain the intermediate compound M15-1 (110 g, 85%).

1L의 삼구 플라스크에 화합물M15-1(48.4g, 74.8mmol), 아세트산(650g)과 트리플루오로아세트산(65g, 0.57mol)을 넣고, 72℃ 하에서 15시간 동안 환류 반응시키며, 실온까지 냉각시키며, 여과하고, 순차적으로 아세트산, 석유에테르로 필터 케이크를 세척하여, 중간체 화합물M15-2(32g, 80%)를 얻는다.Compound 48-1 (48.4 g, 74.8 mmol), acetic acid (650 g) and trifluoroacetic acid (65 g, 0.57 mol) were placed in a 1 L three-necked flask, refluxed at 72 ° C for 15 hours, cooled to room temperature, The filtrate is washed sequentially with acetic acid and petroleum ether to obtain an intermediate compound M15-2 (32 g, 80%).

자일렌(100mL), M15-2(5.4g, 10mmol), 요오도벤젠(5.1g, 25mmol), CuI(0.9g, 5mmol), 트랜스-디아미노시클로헥산(2.1mL, 20mmol)과 탄산세슘(6.5g, 20mmol)을 혼합하고, 3시간 동안 환류 반응시키며, 반응 완료 후, 실온까지 냉각시키고, 여과한 후, 디클로로메탄(디클로로메탄)으로 필터 케이크를 세척하며, 여액을 합하고, 건조시킨 후, 용매를 제거하여, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(DCM/PE=1/2, v/v(체적비가 1:2인 디클로로메탄과 석유에테르의 혼합 용액)), 중간체 화합물M15을 얻으며, 백색 고체(5.5g, 수율은 82%임)이다.(5.1 mL, 25 mmol), CuI (0.9 g, 5 mmol), trans-diaminocyclohexane (2.1 mL, 20 mmol) and cesium carbonate After the completion of the reaction, the reaction mixture was cooled to room temperature, filtered, and then the filter cake was washed with dichloromethane (dichloromethane). The filtrate was combined, dried, The solvent was removed, and the obtained distillation residue was subjected to column chromatography (DCM / PE = 1/2, v / v (mixed solution of dichloromethane and petroleum ether having a volume ratio of 1: 2)), M15, which is a white solid (5.5 g, yield 82%).

합성 실시예93. 화합물D-9의 합성Synthesis Example 93. Synthesis of Compound D-9

Figure pct00095
Figure pct00095

질소 기체 보호 하에서, 중간체M15(6.9g, 10mmol), 3-피리딘보론산(3.08g, 25mmol), Pd(PPh3)4(0.58g, 0.5mmol), Na2CO3(5.3g, 50mmol), 60mL의 톨루엔과 20mL의 에탄올(EtOH)을 혼합하고, 상기 혼합물에 20mL의 증류수를 넣은 후, 110℃ 하에서 2시간 동안 교반반응시킨다. 반응 완료 후, 증류수로 반응계를 세척한 후, 100mL의 아세트산에틸로 3회 추출하고, 합하여 유기층을 얻으며, MgSO4로 유기층을 건조시키고, 용매를 회전증발시켜 제거하며, 마지막으로, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 황색 고체 화합물D-9(5.2g, 75%)를 얻는다.Under nitrogen gas protection, the intermediate M15 (6.9g, 10mmol), 3- pyridineboronic acid (3.08g, 25mmol), Pd ( PPh 3) 4 (0.58g, 0.5mmol), Na 2 CO 3 (5.3g, 50mmol) , 60 ml of toluene and 20 ml of ethanol (EtOH) were mixed, and 20 ml of distilled water was added to the mixture, followed by stirring at 110 ° C for 2 hours. After completion of the reaction, the reaction system was washed with distilled water and extracted three times with 100 mL of ethyl acetate to obtain an organic layer. The organic layer was dried over MgSO 4 and the solvent was removed by rotary evaporation. Finally, Water was subjected to column chromatography to obtain a yellow solid compound D-9 (5.2 g, 75%).

합성 실시예94. 화합물D-10의 합성Synthesis Example 94. Synthesis of Compound D-10

합성 실시예84와 동일한 합성 방법을 사용하는데, 구별점은, 2-브로모피리딘을 같은 당량의5-브로모-1,10페난트롤린으로 대체하여, 반응시켜 29.9g의 담황색 고체를 얻으며, 수율은 81%이다.The same synthetic procedure as in Synthetic Example 84 was used, with the exception that 2-bromopyridine was replaced by the same equivalent of 5-bromo-1,10-phenanthroline to give 29.9 g of a light yellow solid, The yield is 81%.

D-10의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of D-10:

1H NMR(500 MHz, Chloroform) δ 8.80(s, 2H), 8.55(s, 1H), 8.43(d, J = 6.3 Hz, 3H), 8.12(d, J = 20.0 Hz, 4H), 7.52(s, 1H), 7.39(s, 2H), 7.16(s, 1H), 7.11(s, 1H). 1 H NMR (500 MHz, Chloroform ) δ 8.80 (s, 2H), 8.55 (s, 1H), 8.43 (d, J = 6.3 Hz, 3H), 8.12 (d, J = 20.0 Hz, 4H), 7.52 ( s, 1 H), 7.39 (s, 2 H), 7.16 (s, 1 H), 7.11 (s, 1 H).

합성 실시예95. 화합물D-11의 합성Synthesis Example 95. Synthesis of Compound D-11

Figure pct00096
Figure pct00096

건조한 1L의 삼구 플라스크에 중간체M6(22.9g, 50mmol)을 넣어 200mL의 무수 디메틸포름아미드(DMF)로 용해시키고, 실온, 질소 기체 보호, 자석 교반 하에서 60%의 NaH(4g, 0.1mol)를 회수를 나누어 넣으면, 대량의 기체가 생성되며, 전부 넣은 후 계속하여 실온에서 1시간 동안 교반한다. 그 다음, 실온 하에서, 항압 적하 깔때기로 2-클로로-4,6-디페닐피리미딘(32g, 120mmol)의 150mL의 무수 DMF 용액을 넣어, 약 1.5시간 동안 적가 완료한다. 적가 완료 후 계속하여 실온에서 3시간 동안 교반한 후, 천천히 물을 적가하여 반응을 종료시키고, 종료한 후 300mL의 아세트산에틸과 200mL의 물을 넣어 30분 동안 교반하며, 계는 현탁 상태가 된다. 여과하여, 고체를 디클로로메탄으로 용해시키고, 포화 식염수로 세척하며, 무수 황산 나트륨으로 건조시켜, 5cm의 실리카 겔 칼럼 크로마토그래피로 여과하고, 감압하여 회전건조시킨다. 칼럼 크로마토그래피 분리하여 화합물D-11을 얻고, 36.7g의 황색 분말상 고체이며, 수율은 87%이다.The intermediate M6 (22.9 g, 50 mmol) was added to a dry 1 L three-necked flask and dissolved with 200 mL of anhydrous dimethylformamide (DMF). 60% NaH (4 g, 0.1 mol) was recovered under nitrogen gas protection and magnetic stirrer , A large amount of gas is produced, and the mixture is continuously stirred at room temperature for 1 hour. Then, at room temperature, 150 mL of anhydrous DMF solution of 2-chloro-4,6-diphenylpyrimidine (32 g, 120 mmol) was added dropwise under a reduced pressure dropping funnel for about 1.5 hours. After completion of the dropwise addition, the mixture is stirred at room temperature for 3 hours, and then water is added dropwise to terminate the reaction. After completion, 300 mL of ethyl acetate and 200 mL of water are added and stirred for 30 minutes. After filtration, the solid was dissolved in dichloromethane, washed with saturated brine, dried over anhydrous sodium sulfate, filtered through a 5 cm silica gel column chromatography, and rotary evaporated under reduced pressure. Column chromatography separation afforded compound D-11, 36.7 g of a yellow powdery solid, with a yield of 87%.

합성 실시예96. 화합물D-12의 합성SYNTHESIS EXAMPLE 96. Synthesis of Compound D-12

합성 실시예95와 동일한 합성 방법을 사용하는데, 구별점은, 2-클로로-4,6-디페닐피리미딘을 같은 당량의 2-클로로-4-페닐퀴나졸린으로 대체하여, 반응시켜 32.4g의 황색 고체를 얻으며, 수율은 82%이다.The same synthetic procedure as in Synthesis example 95 was used, with the exception that 2-chloro-4,6-diphenylpyrimidine was replaced by the equivalent equivalent of 2-chloro-4-phenylquinazoline to give 32.4 g of A yellow solid is obtained and the yield is 82%.

합성 실시예97. 화합물D-13의 합성Synthesis Example 97. Synthesis of Compound D-13

합성 실시예95와 동일한 합성 방법을 사용하는데, 구별점은, 2-클로로-4,6-디페닐피리미딘을 같은 당량의 2-클로로-퀴녹살린으로 대체하여, 반응시켜 25g의 황색 고체를 얻으며, 수율은 75%이다.The same synthetic method as that of Synthesis Example 95 was used, with the exception that 2-chloro-4,6-diphenylpyrimidine was replaced by the same equivalent amount of 2-chloro-quinoxaline to give 25 g of a yellow solid , The yield is 75%.

합성 실시예98. 화합물D-14의 합성Synthesis Example 98. Synthesis of Compound D-14

합성 실시예95와 동일한 합성 방법을 사용하는데, 구별점은, 2-클로로-4,6-디페닐피리미딘을 같은 당량의 2-클로로퀴나졸린(2-chloroquinazoline)으로 대체하여, 반응시켜 22.7g의 황색 고체를 얻으며, 수율은 71%이다.The same synthetic procedure as in Synthesis Example 95 was used, with the exception that 2-chloro-4,6-diphenylpyrimidine was replaced with the equivalent equivalent of 2-chloroquinazoline to give 22.7 g Of yellow solid, the yield being 71%.

합성 실시예99. 화합물D-15의 합성Synthesis Example 99. Synthesis of Compound D-15

합성 실시예95와 동일한 합성 방법을 사용하는데, 구별점은, 2-클로로-4,6-디페닐피리미딘을 같은 당량의 2-클로로-4,6-디페닐-1,3,5-트리아진(2-chloro-4,6-diphenyl-1,3,5-triazine)으로 대체하여, 반응시켜 33.0g의 황색 고체를 얻으며, 수율은 78%이다.The same synthetic method as that of Synthesis Example 95 was used, the distinction being that 2-chloro-4,6-diphenylpyrimidine was replaced with the same equivalent amount of 2-chloro-4,6-diphenyl-1,3,5-tri Azine (2-chloro-4,6-diphenyl-1,3,5-triazine) to give 33.0 g of a yellow solid. The yield is 78%.

합성 실시예100. 화합물D-16의 합성Synthesis Example 100. Synthesis of Compound D-16

Figure pct00097
Figure pct00097

건조한 1L의 삼구 플라스크에 중간체B-19-4(22.9g, 50mmol, 합성 실시예53을 참조)를 넣어 200mL의 무수 DMF로 용해시키고, 실온, 질소 기체 보호, 자석 교반 하에서 60%의 NaH(4g, 0.1mol)를 회수를 나누어 넣으면, 대량의 기체가 생성되며, 전부 넣은 후 계속하여 실온에서 1시간 동안 교반한다. 그 다음, 실온 하에서, 항압 적하 깔때기로 2-클로로-4,6-디페닐피리미딘(16g, 60mmol)의 120mL의 무수 DMF 용액을 넣어, 약 1.5시간 동안 적가 완료한다. 적가 완료 후 계속하여 실온에서 3시간 동안 교반한 후, 천천히 물을 적가하여 반응을 종료시키고, 종료한 후 300mL의 아세트산에틸과 200mL의 물을 넣어 30분 동안 교반하며, 계는 현탁 상태가 된다. 여과하여, 고체를 디클로로메탄으로 용해시키고, 포화 식염수로 세척하며, 무수 황산 나트륨으로 건조시켜, 5cm의 실리카 겔 칼럼 크로마토그래피로 여과하고, 감압하여 회전건조시킨다. 칼럼 크로마토그래피 분리하여 화합물D-16을 얻고, 26.9g의 황색 분말상 고체이며, 수율은 78%이다.A dry 1 L three-necked flask was charged with Intermediate B-19-4 (22.9 g, 50 mmol, see Synthesis Example 53), dissolved in 200 mL of anhydrous DMF, and treated with 60 g of NaH , 0.1 mol) are added in divided portions, a large amount of gas is produced, and the mixture is continuously stirred at room temperature for 1 hour. Then, 120 mL of anhydrous DMF solution of 2-chloro-4,6-diphenylpyrimidine (16 g, 60 mmol) was added dropwise under a reduced pressure dropping funnel under room temperature for about 1.5 hours. After completion of the dropwise addition, the mixture is stirred at room temperature for 3 hours, and then water is added dropwise to terminate the reaction. After completion, 300 mL of ethyl acetate and 200 mL of water are added and stirred for 30 minutes. After filtration, the solid was dissolved in dichloromethane, washed with saturated brine, dried over anhydrous sodium sulfate, filtered through a 5 cm silica gel column chromatography, and rotary evaporated under reduced pressure. Column chromatography separation afforded compound D-16, 26.9 g of a yellow powdery solid, yield 78%.

합성 실시예101. 화합물D-17의 합성SYNTHESIS EXAMPLE 101 Synthesis of Compound D-17

Figure pct00098
Figure pct00098

건조한 1L의 삼구 플라스크에 중간체M1(22.9g, 50mmol)를 넣어 200mL의 무수 DMF로 용해시키고, 실온, 질소 기체 보호, 자석 교반 하에서 60%의 NaH(4g, 0.1mol)를 회수를 나누어 넣으면, 대량의 기체가 생성되며, 전부 넣은 후 계속하여 실온에서 1시간 동안 교반한다. 그 다음, 실온 하에서, 항압 적하 깔때기로 2-클로로-4-페닐피리미딘(23g, 120mmol)의 150mL의 무수 DMF 용액을 넣어, 약 1.5시간 동안 적가 완료한다. 적가 완료 후 계속하여 실온에서 3시간 동안 교반한 후, 천천히 물을 적가하여 반응을 종료시키고, 종료한 후 300mL의 아세트산에틸과 200mL의 물을 넣어 30분 동안 교반하며, 계는 현탁 상태가 된다. 여과하여, 고체를 디클로로메탄으로 용해시키고, 포화 식염수로 세척하며, 무수 황산 나트륨으로 건조시켜, 5cm의 실리카 겔 칼럼 크로마토그래피로 여과하고, 감압하여 회전건조시킨다. 칼럼 크로마토그래피 분리하여 화합물D-17을 얻고, 29.4g의 황색 분말상 고체이며, 수율은 85%이다.The intermediate M1 (22.9 g, 50 mmol) was added to a dry 1 L three-necked flask and dissolved with 200 mL of anhydrous DMF. When 60% NaH (4 g, 0.1 mol) was recovered under room temperature, nitrogen gas protection and magnetic stirring, And the mixture is stirred at room temperature for 1 hour. Then, at room temperature, 150 mL of anhydrous DMF solution of 2-chloro-4-phenylpyrimidine (23 g, 120 mmol) was added dropwise under a reduced pressure dropping funnel for about 1.5 hours. After completion of the dropwise addition, the mixture is stirred at room temperature for 3 hours, and then water is added dropwise to terminate the reaction. After completion, 300 mL of ethyl acetate and 200 mL of water are added and stirred for 30 minutes. After filtration, the solid was dissolved in dichloromethane, washed with saturated brine, dried over anhydrous sodium sulfate, filtered through a 5 cm silica gel column chromatography, and rotary evaporated under reduced pressure. Column chromatography separation afforded compound D-17, 29.4 g of a yellow powdery solid, with a yield of 85%.

합성 실시예102. 화합물D-18의 합성Synthesis Example 102. Synthesis of Compound D-18

합성 실시예101과 동일한 합성 방법을 사용하는데, 구별점은, 2-클로로-4-페닐피리미딘을 같은 당량의 2-클로로-4,6-디페닐피리미딘으로 대체하여, 반응 완료 후 33.3g의 황색 고체를 얻으며, 수율은 79%이다.The same synthesis procedure as in Synthesis Example 101 was used, with the exception that 2-chloro-4-phenylpyrimidine was replaced by the same equivalent amount of 2-chloro-4,6-diphenylpyrimidine to give 33.3 g Of a yellow solid, with a yield of 79%.

합성 실시예103. 화합물D-19의 합성SYNTHESIS EXAMPLE 103 Synthesis of Compound D-19

합성 실시예101과 동일한 합성 방법을 사용하는데, 구별점은, 2-클로로-4-페닐피리미딘을 같은 당량의 2-클로로-4-페닐퀴나졸린으로 대체하여, 반응 완료 후 34.4g의 황색 고체를 얻으며, 수율은 87%이다.The same synthetic procedure as in Synthesis example 101 was used, with the exception that 2-chloro-4-phenylpyrimidine was replaced by the same equivalent amount of 2-chloro-4-phenylquinazoline to give 34.4 g of a yellow solid And the yield is 87%.

합성 실시예104. 화합물D-20의 합성Synthesis Example 104. Synthesis of Compound D-20

합성 실시예101과 동일한 합성 방법을 사용하는데, 구별점은, 2-클로로-4-페닐피리미딘을 같은 당량의 2-클로로-퀴녹살린으로 대체하여, 반응 완료 후 22.7g의 황색 고체를 얻으며, 수율은 71%이다.The same synthetic procedure as in Synthesis example 101 was used, with the exception that 2-chloro-4-phenylpyrimidine was replaced by the same equivalent amount of 2-chloro-quinoxaline to give 22.7 g of a yellow solid after completion of the reaction, The yield is 71%.

합성 실시예105. 화합물D-21의 합성SYNTHESIS EXAMPLE 105. Synthesis of Compound D-21

합성 실시예101과 동일한 합성 방법을 사용하는데, 구별점은, 2-클로로-4-페닐피리미딘을 2-클로로-4-바이페닐퀴나졸린으로 대체하여, 반응 완료 후 35g의 황색 고체를 얻으며, 수율은 74%이다.The same synthetic procedure as in Synthesis example 101 was used, with the exception that 2-chloro-4-phenylpyrimidine was replaced with 2-chloro-4-biphenylquinazoline to give 35 g of a yellow solid after the reaction was complete, The yield is 74%.

합성 실시예106. 화합물D-22의 합성Synthesis Example 106. Synthesis of Compound D-22

합성 실시예101과 동일한 합성 방법을 사용하는데, 구별점은, 2-클로로-4-페닐피리미딘을 같은 당량의 2-클로로-4-바이페닐피리미딘으로 대체하여, 반응 완료 후 34.1g의 황색 고체를 얻으며, 수율은 81%이다.The same synthetic procedure as in Synthesis Example 101 was used, with the exception that 2-chloro-4-phenylpyrimidine was replaced by the same equivalent amount of 2-chloro-4-biphenylpyrimidine to give 34.1 g of yellow A solid is obtained, the yield being 81%.

합성 실시예107. 화합물D-23의 합성Synthesis Example 107. Synthesis of Compound D-23

합성 실시예101과 동일한 합성 방법을 사용하는데, 구별점은, 2-클로로-4-페닐피리미딘을 같은 당량의 2-클로로-4,6-디페닐트리아진으로 대체하여, 반응 완료 후 33.8g의 황색 고체를 얻으며, 수율은 80%이다.The same synthetic procedure as in Synthesis Example 101 was used, with the exception that 2-chloro-4-phenylpyrimidine was replaced by the same equivalent amount of 2-chloro-4,6-diphenyltriazine to give 33.8 g Of yellow solid, the yield being 80%.

합성 실시예108. 화합물D-24의 합성Synthesis Example 108: Synthesis of Compound D-24

합성 실시예88에서 화합물D-5를 제조하는 것과 동일한 합성 방법을 사용하는데, 구별점은, 5-브로모-2-페닐피리딘(5-bromo-2-phenylpyridine)을 같은 당량의 5-브로모-1,10-페난트롤린으로 대체하여, 반응 완료 후 4.95g의 황색 고체를 얻으며, 수율은 67%이다.5-bromo-2-phenylpyridine was reacted with the same equivalent amount of 5-bromo-2-phenylpyridine as in Synthesis Example 88, using the same synthetic method as that for preparing Compound D- -1,10-phenanthroline to give 4.95 g of a yellow solid after completion of the reaction, yielding 67%.

합성 실시예109. 화합물D-25의 합성Synthesis Example 109. Synthesis of Synthesis of Compound D-25

Figure pct00099
Figure pct00099

1L의 반응 플라스크에, 중간체M1(38.2g, 0.1mol), 4-브로모바이페닐(23.3g, 0.1mol), CuI(3.3g, 17.1mmol), K3PO4(21.8g, 102.9mmol), 시클로헥실디아민(2.3mL, 34.3mmol)과 톨루엔(500mL)을 혼합하고, 환류 조건 하에서 하루 동안 교반반응시키며, 반응 완료 후, 실온까지 냉각시키고, 250mL의 아세트산에틸로 추출하며, 유기층을 무수 황산 마그네슘으로 처리한 후 감압 증류시켜 용매를 제거하고, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 디클로로메탄/헥산), 화합물D-25-1(26.8g, 수율은 50%)을 얻는다.To the reaction flask, 1L, Intermediate M1 (38.2g, 0.1mol), 4- bromo-phenyl mobayi (23.3g, 0.1mol), CuI ( 3.3g, 17.1mmol), K 3 PO 4 (21.8g, 102.9mmol), After completion of the reaction, the reaction mixture was cooled to room temperature, extracted with 250 mL of ethyl acetate, and the organic layer was washed with anhydrous magnesium sulfate (50 mL) and dried over anhydrous magnesium sulfate , The solvent was removed by distillation under reduced pressure, and the obtained residue was subjected to column chromatography (eluent: dichloromethane / hexane) to obtain Compound D-25-1 (26.8 g, yield 50%) .

건조한 1L의 삼구 플라스크에 중간체D-25-1(26.8g, 50mmol)을 넣어 200mL의 무수 DMF로 용해시키고, 실온, 질소 기체 보호, 자석 교반 하에서 60%의 NaH(2g, 50mmol)를 회수를 나누어 넣으면, 대량의 기체가 생성되며, 전부 넣은 후 계속하여 실온에서 1시간 동안 교반한다. 그 다음, 실온 하에서, 항압 적하 깔때기로 2-클로로-4,6-디페닐트리아진(16.1g, 60mmol)의 150mL의 무수 DMF 용액을 넣어, 약 1.5시간 동안 적가 완료한다. 적가 완료 후 계속하여 실온에서 3시간 동안 교반한 후, 천천히 물을 적가하여 반응을 종료시키고, 종료한 후 300mL의 아세트산에틸과 200mL의 물을 넣어 30분 동안 교반하며, 계는 현탁 상태가 된다. 여과하여, 고체를 디클로로메탄으로 용해시키고, 포화 식염수로 세척하며, 무수 황산 나트륨으로 건조시켜, 5cm의 실리카 겔 칼럼 크로마토그래피로 여과하고, 감압하여 회전건조시킨다. 칼럼 크로마토그래피 분리하여 화합물D-25를 얻고, 34.5g의 황색 분말 상태 고체이며, 수율은 90%이다.A dry 1 L three-necked flask was charged with intermediate D-25-1 (26.8 g, 50 mmol), dissolved in 200 mL of anhydrous DMF, and 60% NaH (2 g, 50 mmol) was recovered at room temperature under nitrogen gas protection and magnetic stirring When it is put, a large amount of gas is produced, and the mixture is continuously stirred at room temperature for 1 hour. Then, at room temperature, 150 mL of anhydrous DMF solution of 2-chloro-4,6-diphenyltriazine (16.1 g, 60 mmol) was added dropwise under a reduced pressure dropping funnel for about 1.5 hours. After completion of the dropwise addition, the mixture is stirred at room temperature for 3 hours, and then water is added dropwise to terminate the reaction. After completion, 300 mL of ethyl acetate and 200 mL of water are added and stirred for 30 minutes. After filtration, the solid was dissolved in dichloromethane, washed with saturated brine, dried over anhydrous sodium sulfate, filtered through a 5 cm silica gel column chromatography, and rotary evaporated under reduced pressure. Column chromatographic separation afforded compound D-25, 34.5 g of a yellow powdery solid, with a yield of 90%.

D-25의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of D-25:

1H NMR(500 MHz, Chloroform) δ 8.49(d, J = 65.0 Hz, 47H), 8.37(ddd, J = 5.3, 3.9, 2.7 Hz, 12H), 8.36(s, 20H), 8.10(s, 20H), 7.91(d, J = 5.0 Hz, 24H), 7.77(dd, J = 3.1, 1.4 Hz, 4H), 7.75(s, 10H), 7.76 - 7.39(m, 75H), 7.16(s, 7H), 7.11(s, 10H). 1 H NMR (500 MHz, Chloroform ) δ 8.49 (d, J = 65.0 Hz, 47H), 8.37 (ddd, J = 5.3, 3.9, 2.7 Hz, 12H), 8.36 (s, 20H), 8.10 (s, 20H ), 7.91 (d, J = 5.0 Hz, 24H), 7.77 (dd, J = 3.1, 1.4 Hz, 4H), 7.75 , ≪ / RTI > 7.11 (s, 10H).

합성 실시예110. 화합물D-26의 합성Synthesis Example 110. Synthesis of Compound D-26

합성 실시예109와 동일한 합성 방법을 사용하는데, 구별점은, 첫번째 단계 반응에서 4-브로모바이페닐을 같은 당량의 브로모벤젠으로 대체하고, 두번째 단계 반응에서 2-클로로-4, 6-디페닐트리아진을 같은 당량의 2-클로로-4,6-디바이페닐트리아진으로 대체하여, 반응 완료 후 35.8g의 황색 고체를 얻으며, 수율은 85%이다.The same synthetic method as that of Synthesis Example 109 was used, the point of difference being that 4-bromobiphenyl was replaced with the same equivalent amount of bromobenzene in the first step reaction and 2-chloro-4,6-diphenyl After replacing the triazine with an equivalent amount of 2-chloro-4,6-divinylphenyl triazine, 35.8 g of a yellow solid were obtained after the completion of the reaction, and the yield was 85%.

합성 실시예111. 화합물D-27의 합성Synthesis Example 111 embedded image Synthesis of Compound D-27

합성 실시예109와 동일한 합성 방법을 사용하는데, 구별점은, 첫번째 단계 반응에서 4-브로모바이페닐을 같은 당량의 브로모벤젠으로 대체하고, 중간체M1을 같은 당량의 중간체B-27-1로 대체하여, 반응 완료 후 얻은 화합물D-27은 황색 고체이다.The same synthetic method as that in Synthesis Example 109 was used except that in the first step reaction 4-bromobiphenyl was replaced by the same equivalent amount of bromobenzene and intermediate M1 was replaced with the same equivalent of intermediate B-27-1 Compound D-27 obtained after completion of the reaction was a yellow solid.

D-27의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of D-27:

1H NMR(500 MHz, Chloroform) δ 8.42(s, 16H), 8.36(s, 15H), 8.24(s, 5H), 8.10(d, J = 2.5 Hz, 21H), 7.89(d, J = 2.9 Hz, 4H), 7.81(d, J = 60.0 Hz, 23H), 7.72(s, 2H), 7.67(d, J = 45.0 Hz, 16H), 7.58(s, 11H), 7.47(t, J = 22.5 Hz, 59H), 7.39(s, 1H). 1 H NMR (500 MHz, Chloroform ) δ 8.42 (s, 16H), 8.36 (s, 15H), 8.24 (s, 5H), 8.10 (d, J = 2.5 Hz, 21H), 7.89 (d, J = 2.9 Hz, 4H), 7.81 (d , J = 60.0 Hz, 23H), 7.72 (s, 2H), 7.67 (d, J = 45.0 Hz, 16H), 7.58 (s, 11H), 7.47 (t, J = 22.5 Hz, < / RTI > 59H), 7.39 (s, 1H).

합성 실시예112. 화합물B-28의 합성SYNTHESIS EXAMPLE 112 Synthesis of Compound B-28

합성 실시예109와 동일한 합성 방법을 사용하는데, 구별점은, 첫번째 단계 반응에서 중간체M1을 같은 당량의 중간체M4로 대체하여, 반응 완료 후 얻은 화합물D-28은 황색 고체이다.The same synthesis procedure as in Synthesis Example 109 was used, with the exception that intermediate M1 was replaced with the same equivalent of intermediate M4 in the first step reaction, and compound D-28 obtained after completion of the reaction was a yellow solid.

합성 실시예113. 화합물D-29의 합성Synthesis Example 113 Synthesis of Synthesis of Compound D-29

합성 실시예109와 동일한 합성 방법을 사용하는데, 구별점은, 첫번째 단계 반응에서 4-브로모바이페닐을 같은 당량의 브로모벤젠으로 대체하고, 중간체M1을 같은 당량의 중간체M5로 대체하며; 두번째 단계 반응에서 2-클로로-4, 6-디페닐트리아진을 같은 당량의 2-클로로-4,6-디바이페닐트리아진으로 대체하여, 반응 완료 후 얻은 화합물D-29는 황색 고체이다.The same synthetic method as that of Synthetic example 109 was used, with the exception that in the first step reaction, 4-bromobiphenyl was replaced with the same equivalent amount of bromobenzene and intermediate M1 was replaced with the same equivalent amount of intermediate M5; Compound D-29 obtained after completion of the reaction by replacing 2-chloro-4,6-diphenyltriazine with the equivalent amount of 2-chloro-4,6-divinylphenyltriazine in the second step reaction is a yellow solid.

합성 실시예114. 화합물D-30의 합성SYNTHESIS EXAMPLE 114. Synthesis of Compound D-30

Figure pct00100
Figure pct00100

1L의 반응 플라스크에 중간체M1(38.2g, 0.1mol), 브로모벤젠(15.7g, 0.1mol), CuI(3.3g, 17.1mmol), Cs2CO3(21.8g, 102.9mmol), 시클로헥실디아민(2.3mL, 34.3mmol)과 톨루엔(500mL)을 혼합하고, 환류 조건 하에서 하루 동안 교반반응시키며, 반응 완료 후, 실온까지 냉각시키고, 250mL의 아세트산에틸로 추출하며, 유기층을 무수 황산 마그네슘으로 처리한 후 감압 증류시켜 용매를 제거하고, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 디클로로메탄/헥산), 화합물D-30-1(20.2g, 수율은 44%임)을 얻는다.To a 1 L reaction flask was added intermediate Ml (38.2 g, 0.1 mol), bromobenzene (15.7 g, 0.1 mol), CuI (3.3 g, 17.1 mmol), Cs 2 CO 3 (21.8 g, 102.9 mmol), cyclohexyldiamine (2.3 mL, 34.3 mmol) and toluene (500 mL) were mixed and stirred for one day under reflux. After completion of the reaction, the mixture was cooled to room temperature, extracted with 250 mL of ethyl acetate, and the organic layer was treated with anhydrous magnesium sulfate The solvent was removed by distillation under reduced pressure, and the resulting residue was subjected to column chromatography (eluant: dichloromethane / hexane) to obtain compound D-30-1 (20.2 g, yield 44%).

1L의 반응 플라스크에, 중간체D-30-1(23g, 50mmol), 1-(4-브로모페닐)-2-페닐-1H-벤조이미다졸(20.9g, 60mmol), CuI(1.7g, 8.5mmol), Cs2CO3(21.8g, 102.9mmol), 시클로헥실디아민(1.2mL, 17mmol)과 톨루엔(300mL)을 혼합하고, 환류 조건 하에서 하루 동안 교반반응시키며, 반응 완료 후, 실온까지 냉각시키고, 150mL의 아세트산에틸로 추출하며, 유기층을 무수 황산 마그네슘으로 처리한 후 감압 증류시켜 용매를 제거하고, 얻은 증류 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여(용리액: 디클로로메탄/헥산), 화합물D-30(30.9g, 수율은 85%)을 얻는다.To a 1 L reaction flask was added Intermediate D-30-1 (23 g, 50 mmol), 1- (4-bromophenyl) -2- phenyl-1H- benzoimidazole (20.9 g, 60 mmol) mmol), Cs 2 CO 3 (21.8 g, 102.9 mmol), cyclohexyldiamine (1.2 mL, 17 mmol) and toluene (300 mL) were mixed and stirred under refluxing for 1 day. After completion of the reaction, , And extracted with 150 mL of ethyl acetate. The organic layer was treated with anhydrous magnesium sulfate and then distilled under reduced pressure to remove the solvent. The resulting residue was subjected to column chromatography (eluent: dichloromethane / hexane) -30 (30.9 g, yield: 85%).

합성 실시예115. 화합물D-31의 합성Synthesis Example 115. Synthesis of Compound D-31

합성 실시예109와 동일한 합성 방법을 사용하는데, 구별점은, 첫번째 단계 반응에서 4-브로모바이페닐을 같은 당량의 브로모벤젠으로 대체하고, 두번째 단계 반응에서 2-클로로-4, 6-디페닐트리아진을 같은 당량의 2-브로모-디벤조[f,h]퀴녹살린으로 대체하여, 반응 완료 후 얻은 화합물D-31은 황색 고체이다.The same synthetic method as that of Synthesis Example 109 was used, the point of difference being that 4-bromobiphenyl was replaced with the same equivalent amount of bromobenzene in the first step reaction and 2-chloro-4,6-diphenyl Compound D-31 obtained after completion of the reaction by replacing triazine with the equivalent amount of 2-bromo-dibenzo [f, h] quinoxaline was a yellow solid.

합성 실시예116. 화합물D-32의 합성Synthesis Example 116. Synthesis of Compound D-32

Figure pct00101
Figure pct00101

중간체D-32-1의 합성: 250mL의 삼구 플라스크에, 중간체 화합물M1(19.1g, 50mmol), 3-브로모바이페닐(11.7.9g, 50mmol), CuI(1.8g, 10mmol), 트랜스-디아미노시클로헥산(5.4mL, 50mmol)과 탄산세슘(16g, 50mmol)으로 형성된 혼합물을 3시간 동안 가열하여 환류시킨다. 그 다음, 반응 혼합물을 실온까지 냉각시키고, 여과하며, 디클로로메탄으로 필터 케이크를 세척하여, 얻은 유기상을 탈이온수로 충분히 세척한 후, 무수 황산 나트륨으로 건조시킨다. 건조 후의 유기상을 감압하여 용매를 제거하고, 얻은 잔여물에 대하여 칼럼크로마토그래피 분리를 진행하여, 백색 화합물D-32-1(16.3g, 수율은 61%임)을 얻는다.Synthesis of Intermediate D-32-1 Intermediate compound M1 (19.1 g, 50 mmol), 3-bromobiphenyl (11.7.9 g, 50 mmol), CuI (1.8 g, 10 mmol), trans- A mixture of cyclohexane (5.4 mL, 50 mmol) and cesium carbonate (16 g, 50 mmol) was heated to reflux for 3 h. Then, the reaction mixture is cooled to room temperature, filtered, washed with dichloromethane, and the obtained organic phase is sufficiently washed with deionized water and then dried with anhydrous sodium sulfate. The organic phase after drying was reduced to remove the solvent, and the resulting residue was subjected to column chromatography to obtain 16.3 g (yield: 61%) of a white compound D-32-1.

화합물D-32의 합성: 250mL의 삼구 플라스크에, 중간체 화합물D-32-1(26.7g, 50mmol), 2-(4-브로모페닐)-4,6-디페닐-1,3,5-트리아진(21.3g, 55mmol), CuI(1.8g, 10mmol), 트랜스-디아미노시클로헥산(5.4mL, 50mmol)과 탄산세슘(16g, 50mmol)으로 형성된 혼합물을 3시간 동안 가열하여 환류시킨다. 그 다음, 반응 혼합물을 실온까지 냉각시키고, 여과하며, 디클로로메탄으로 필터 케이크를 세척하여, 얻은 유기상을 탈이온수로 충분히 세척한 후, 무수 황산 나트륨으로 건조시킨다. 건조 후의 유기상을 감압하여 용매를 제거하고, 얻은 잔여물에 대하여 칼럼크로마토그래피 분리를 진행하여, 담황색 화합물D-32(35.8g, 수율은 85%임)를 얻는다.Synthesis of Compound D-32: To a 250 mL three-necked flask was added the intermediate compound D-32-1 (26.7 g, 50 mmol), 2- (4-bromophenyl) A mixture of triazine (21.3 g, 55 mmol), CuI (1.8 g, 10 mmol), trans-diaminocyclohexane (5.4 mL, 50 mmol) and cesium carbonate (16 g, 50 mmol) was heated to reflux for 3 h. Then, the reaction mixture is cooled to room temperature, filtered, washed with dichloromethane, and the obtained organic phase is sufficiently washed with deionized water and then dried with anhydrous sodium sulfate. The organic phase after drying is reduced in pressure to remove the solvent, and the resulting residue is subjected to column chromatography to obtain a pale yellow compound D-32 (35.8 g, yield 85%).

D-32의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of D-32:

1H NMR(500 MHz, Chloroform) δ 8.53(s, 3H), 8.40(s, 4H), 8.34(s, 4H), 8.19(s, 1H), 8.08(s, 4H), 7.89(d, J = 5.0 Hz, 5H), 7.68(d, J = 49.9 Hz, 4H), 7.60(dd, J = 5.8, 2.8 Hz, 1H), 7.58(s, 1H), 7.52 - 7.43(m, 13H), 7.39(s, 1H), 7.14(s, 1H), 7.09(s, 2H). 1 H NMR (500 MHz, Chloroform ) δ 8.53 (s, 3H), 8.40 (s, 4H), 8.34 (s, 4H), 8.19 (s, 1H), 8.08 (s, 4H), 7.89 (d, J = 5.0 Hz, 5H), 7.68 (d, J = 49.9 Hz, 4H), 7.60 (dd, J = 5.8, 2.8 Hz, 1H), 7.58 (s, 1 H), 7.14 (s, 1 H), 7.09 (s, 2 H).

합성 실시예117. 화합물D-33의 합성Synthesis Example 117. Synthesis of Compound D-33

Figure pct00102
Figure pct00102

합성 실시예116과 동일한 합성 방법을 사용하는데, 구별점은, 첫번째 단계의 3-브로모바이페닐을 같은 당량의 2-브로모-디벤조푸란으로 대체하고, 두번째 반응 단계에서 2-(4-브로모페닐)-4,6-디페닐-1,3,5-트리아진를 같은 당량의 2-(3-브로모페닐)-4-페닐퀴나졸린으로 대체하여 반응시킨 후 32.3g의 황색 고체를 얻으며, 두 단계 총 수율은 47%이다.Using the same synthetic method as in Synthesis Example 116, the point of difference is that the 3-bromobiphenyl of the first step is replaced by the same equivalent amount of 2-bromo-dibenzofuran, and the 2- Phenylene) -4,6-diphenyl-1,3,5-triazine with the equivalent amount of 2- (3-bromophenyl) -4-phenylquinazoline to give 32.3 g of a yellow solid , The two-step total yield is 47%.

D-33의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of D-33:

1H NMR(500 MHz, Chloroform) δ 8.55(s, 20H), 8.45(d, J = 7.2 Hz, 3H), 8.42(s, 39H), 8.47 - 8.14(m, 73H), 8.12(d, J = 15.0 Hz, 41H), 8.08 - 7.86(m, 35H), 7.82(t, J = 2.7 Hz, 7H), 7.80(d, J = 3.6 Hz, 24H), 7.81 - 7.58(m, 71H), 7.52(dd, J = 18.2, 8.2 Hz, 44H), 7.39(s, 10H), 7.31(s, 5H), 7.16(s, 11H), 7.11(s, 16H). 1 H NMR (500 MHz, Chloroform ) δ 8.55 (s, 20H), 8.45 (d, J = 7.2 Hz, 3H), 8.42 (s, 39H), 8.47 - 8.14 (m, 73H), 8.12 (d, J = 15.0 Hz, 41H), 8.08 - 7.86 (m, 35H), 7.82 (t, J = 2.7 Hz, 7H), 7.80 (d, J = 3.6 Hz, 24H), 7.81 - 7.58 (m, 71H), 7.52 (d, J = 18.2,2.2 Hz, 44H), 7.39 (s, 10H), 7.31 (s, 5H), 7.16 (s, 11H), 7.11 (s, 16H).

합성 실시예118. 화합물D-34의 합성SYNTHESIS EXAMPLE 118. Synthesis of Compound D-34

Figure pct00103
Figure pct00103

합성 실시예116과 동일한 합성 방법을 사용하는데, 구별점은, 첫번째 단계의 3-브로모바이페닐을 같은 당량의 2-브로모나프토푸란으로 대체하고, 두번째 반응 단계에서 2-(4-브로모페닐)-4,6-디페닐-1,3,5-트리아진을 같은 당량의 2-(4-브로모페닐)-4,6-디페닐피리미딘으로 대체하여 반응시킨 후 34.3g의 황색 고체를 얻으며, 두 단계 총 수율은 53%이다.The same synthetic procedure as in Synthesis Example 116 was used, the point of difference being that 3-bromobiphenyl in the first step was replaced with the same equivalent amount of 2-bromonaphthofuran, and 2- (4-bromophenyl ) -4,6-diphenyl-1,3,5-triazine with the equivalent amount of 2- (4-bromophenyl) -4,6-diphenylpyrimidine to give 34.3 g of a yellow solid And the total yield of the two steps is 53%.

합성 실시예119. 화합물D-35의 합성Synthesis Example 119. Synthesis of Compound D-35

Figure pct00104
Figure pct00104

합성 실시예116과 동일한 합성 방법을 사용하는데, 구별점은, 첫번째 단계의 3-브로모바이페닐을 같은 당량의 3-브로모-N-페닐카르바졸로 대체하고, 두번째 반응 단계에서 2-(4-브로모페닐)-4,6-디페닐-1,3,5-트리아진를 같은 당량의 2-(4-브로모페닐)-4-페닐퀴나졸린로 대체하여 반응시킨 후 35g의 황색 고체를 얻으며, 두 단계 총 수율은 49%이다.Using the same synthetic method as in Synthesis Example 116, the point of difference was that 3-bromobiphenyl in the first step was replaced by the same equivalent amount of 3-bromo-N-phenylcarbazole and 2- (4 -Bromophenyl) -4,6-diphenyl-1,3,5-triazine with the equivalent amount of 2- (4-bromophenyl) -4-phenylquinazoline, 35 g of a yellow solid , And the two-step total yield is 49%.

합성 실시예119. 화합물D-36의 합성Synthesis Example 119. Synthesis of Compound D-36

Figure pct00105
Figure pct00105

합성 실시예84에서 화합물D-1을 합성하는 것과 동일한 합성 방법을 사용하는데, 구별점은, 2-클로로피리딘을 같은 당량의 2-(3-브로모페닐)-4-페닐퀴나졸린으로 대체하여, 반응시킨 후 34.9g의 황색 고체를 얻으며, 수율은 74%이다.Using the same synthetic method as that for the synthesis of compound D-1 in synthesis example 84, the differentiation point was obtained by replacing 2-chloropyridine with the same equivalent of 2- (3-bromophenyl) -4-phenylquinazoline To give 34.9 g of a yellow solid. The yield is 74%.

합성 실시예120. 화합물D-37의 합성SYNTHESIS EXAMPLE 120. Synthesis of Compound D-37

Figure pct00106
Figure pct00106

N2 보호 하에서, 삼구 플라스크에 22g(0.11mol)의 요오도벤젠, 중간체M10(46.1g, 0.1mol), 2g(20mmol)의 염화제일구리, 4g(20mmol)의 수화1,10-페난트롤린, 16.8g(0.3mol)의 수산화칼륨, 300mL의 자일렌을 넣는다. 반응계를 20시간 동안 환류 반응을 유지시키고, 반응이 완료되면, 증류수로 반응계를 세척한 후, 100mL의 아세트산에틸로 3회 추출하고, 합하여 유기층을 얻으며, MgSO4로 유기층을 건조시키고, 회전증발기로 용매를 제거하며, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 얻은 중간체 화합물은 백색 고체(52.3g, 86%)이다Under N 2 protection, iodo of 22g (0.11mol) to the three-necked flask FIG benzene, intermediate M10 (46.1g, 0.1mol), 2g 1,10-phenanthroline hydrate of cuprous chloride, 4g (20mmol) of (20mmol) , 16.8 g (0.3 mol) of potassium hydroxide and 300 mL of xylene. After the reaction was completed, the reaction system was washed with distilled water and extracted three times with 100 mL of ethyl acetate. The organic layer was separated, dried over MgSO 4, and concentrated under reduced pressure using a rotary evaporator The solvent was removed, and the solvent-removed residue was subjected to column chromatography to obtain the intermediate compound as a white solid (52.3 g, 86%)

질소 기체 보호 하에서, 기계적 교반, 저온 온도계, 항압 깔때기가 있는 1L의 삼구 플라스크에 31g(50mmol)의 상기 중간체 화합물, 500mL의 THF을 넣고, 액체 질소로 온도를 -80℃ 이하까지 감온하며, 여기에 2.4M의 23mL(55mmol)의 n-부틸리튬을 적가하여, -80℃를 초과하지 않도록 제어하고, 적가 완료 후 온도를 -80℃ 이하로 15분 동안 보온하며, 여기에 14.2g(75mmol)의 트리이소프로필보레이트를 적가하기 시작하고, 적가 완료 후 온도를 -80℃ 이하로 제어하여 1시간 동안 반응시키며, 실온까지 승온시켜, 실온에서 계속하여 5시간 동안 반응시키고, 반응액을 100mL의 농염산과 1L의 물로 배합한 희석산에 넣어, 교반하며, 상층 유기상을 분리하여, 수상을 600mL의 디클로로메탄으로 1회 추출하고, 유기상을 합하며, 감압 농축하여 담황색 오일상 물질을 얻는다. 칼럼 크로마토그래피로 분리하여 26g의 백색 고체를 얻으며, 수율은 90%이다.31 g (50 mmol) of the above intermediate compound and 500 mL of THF were placed in a 1 L three-necked flask equipped with a mechanical stirrer, a thermometer and a pressure-reducing funnel under nitrogen gas protection, the temperature was lowered to -80 ° C or lower with liquid nitrogen, 23 mmol (55 mmol) of 2.4M of n-butyllithium was added dropwise and controlled so as not to exceed -80 캜. After completion of dropwise addition, the temperature was kept at -80 캜 or lower for 15 minutes. 14.2 g Triisopropylborate was added dropwise. After completion of the dropwise addition, the temperature was controlled to -80 占 폚 or lower and the reaction was carried out for 1 hour. The temperature was raised to room temperature, and the reaction was continued at room temperature for 5 hours. The reaction mixture was poured into 100 ml of concentrated hydrochloric acid The organic phase is separated and the aqueous phase is extracted once with 600 ml of dichloromethane. The organic phases are combined and concentrated under reduced pressure to obtain a pale yellow oily substance. Separated by column chromatography to obtain 26 g of a white solid, the yield being 90%.

질소 기체 보호 하에서, 중간체 보론산(5.78g, 10mmol), 2-클로로-4-페닐퀴나졸린(2-chloro-4-phenyl quinazoline)(2.4g, 10mmol), Pd(PPh3)4(0.58g, 0.5mmol), Na2CO3(5.3g, 50mmol), 60mL의 톨루엔과 20mL의 에탄올(EtOH)을 혼합하고, 상기 혼합물에 20mL의 증류수를 넣은 후, 110℃ 하에서 2시간 동안 교반반응시킨다. 반응 완료 후, 증류수로 반응계를 세척한 후, 100mL의 아세트산에틸로 3회 추출하고, 합하여 유기층을 얻으며, MgSO4로 유기층을 건조시키고, 용매를 회전증발시켜 제거하며, 마지막으로, 용매를 제거한 잔류물에 대하여 칼럼크로마토그래피 분리를 진행하여, 황색 고체 화합물D-37(6.2g, 84%)을 얻는다.Under nitrogen gas protection, the intermediate boronic acid (5.78g, 10mmol), 2- chloro-4-phenyl-quinazoline (2-chloro-4-phenyl quinazoline) (2.4g, 10mmol), Pd (PPh 3) 4 (0.58g , Na 2 CO 3 (5.3 g, 50 mmol), 60 mL of toluene and 20 mL of ethanol (EtOH) were mixed, and 20 mL of distilled water was added to the mixture, followed by stirring at 110 ° C. for 2 hours. After completion of the reaction, the reaction system was washed with distilled water and extracted three times with 100 mL of ethyl acetate to obtain an organic layer. The organic layer was dried over MgSO 4 and the solvent was removed by rotary evaporation. Finally, Water was subjected to column chromatographic separation to obtain a yellow solid compound D-37 (6.2 g, 84%).

D-37의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of D-37:

1H NMR(500 MHz, Chloroform) δ 8.49(d, J = 65.0 Hz, 6H), 8.40(s, 1H), 8.19 - 7.89(m, 7H), 7.89 - 7.73(m, 7H), 7.63(d, J = 15.0 Hz, 11H), 7.60 - 7.45(m, 19H), 7.33(s, 2H), 7.16(s, 2H), 7.11(s, 3H). 1 H NMR (500 MHz, Chloroform ) δ 8.49 (d, J = 65.0 Hz, 6H), 8.40 (s, 1H), 8.19 - 7.89 (m, 7H), 7.89 - 7.73 (m, 7H), 7.63 (d , J = 15.0 Hz, 11H), 7.60-7.45 (m, 19H), 7.33 (s, 2H), 7.16 (s, 2H), 7.11 (s, 3H).

합성 실시예121. 화합물D-38의 합성SYNTHESIS EXAMPLE 121. Synthesis of Compound D-38

합성 실시예120에서 화합물D-37을 합성한 것과 동일한 합성 방법을 사용하는데, 구별점은, 2-클로로-4-페닐퀴나졸린(2-chloro-4-phenyl quinazoline)을 같은 당량의 2-(4-브로모페닐)-5-페닐-1,3,4-옥사다이아졸(2-(4-bromophenyl)-5-phenyl-1,3,4 -oxadiazole)로 대체하여, 반응시킨 후, 얻은 화합물D-38은 6.11g의 황색 고체이며, 수율은 81%이다.The same synthetic method as that for the synthesis of compound D-37 in Synthesis Example 120 was used, except that 2-chloro-4-phenyl quinazoline was replaced with the same equivalent amount of 2- ( (4-bromophenyl) -5-phenyl-1,3,4-oxadiazole in place of 4-bromophenyl) -5-phenyl-1,3,4-oxadiazole Compound D-38 is 6.11 g of a yellow solid with a yield of 81%.

합성 실시예122. 화합물D-39의 합성Synthesis Example 122. Synthesis of Compound D-39

합성 실시예120에서 화합물D-37을 합성한 것과 동일한 합성 방법을 사용하는데, 구별점은 첫번째 반응 단계에서 중간체M10을 같은 당량의 중간체M9로 대체하고; 세번째 반응 단계에서 2-클로로-4-페닐퀴나졸린(2-chloro-4-phenyl quinazoline)을 같은 당량의 2-(3-브로모페닐)-4,6-디페닐-1,3,5-트리아진(2-(3-bromophenyl)-4,6-diphenyl-1, 3,5-triazine)으로 대체하여, 반응시킨 후 얻은 화합물D-39은 7.58g의 황색 고체이며, 수율은 90%이다.Use the same synthetic method as that for the synthesis of compound D-37 in example 120, substituting intermediate M10 in the first reaction step with the same equivalent of intermediate M9; In the third reaction step, 2-chloro-4-phenyl quinazoline is reacted with the same equivalent amount of 2- (3-bromophenyl) -4,6-diphenyl-1,3,5- Compound D-39 obtained after the reaction was replaced with 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine, was 7.58 g of yellow solid, and the yield was 90% .

D-39의 핵자기스펙트럼 데이터:Nuclear magnetic spectrum data of D-39:

1H NMR(500 MHz, Chloroform) δ 8.54(s, 6H), 8.52 - 8.33(m, 24H), 8.09(s, 5H), 7.69(s, 3H), 7.63 - 7.55(m, 23H), 7.50(d, J = 10.0 Hz, 34H), 7.32(s, 4H), 7.24(d, J = 85.0 Hz, 10H), 7.36 - 6.89(m, 19H). 1 H NMR (500 MHz, Chloroform ) δ 8.54 (s, 6H), 8.52 - 8.33 (m, 24H), 8.09 (s, 5H), 7.69 (s, 3H), 7.63 - 7.55 (m, 23H), 7.50 (d, J = 10.0 Hz, 34H), 7.32 (s, 4H), 7.24 (d, J = 85.0 Hz, 10H), 7.36- 6.89 (m, 19H).

본 발명에서 구체적인 합성 실시예 중 화합물의 분석 검출 데이터는 하기 표1에 열거하였다.The analytical detection data of the compounds in the specific synthetic examples in the present invention are listed in Table 1 below.

표1Table 1

Figure pct00107
Figure pct00107

Figure pct00108
Figure pct00108

Figure pct00109
Figure pct00109

Figure pct00110
Figure pct00110

Figure pct00111
Figure pct00111

Figure pct00112
Figure pct00112

소자 실시예Device Example

아래 소자 구조를 응용하여 유기 발광 다이오드(OLED) 소자를 평가하였다: ITO/HIL/HTL/EML/ETL/LiF/Al(상기 약자는 각각 ITO 양극/정공 주입층/정공 수송층/발광층/전자 수송층/전자 주입층/LiF와 Al의 음극에 대응되고, 아래 상기 약자의 의미는 동일하다), 하기 도면은 소자 중 각 기능층에 사용된 재료의 구조식(모든 재료는 J&K Scientific에서 구매하고, 순도>99.9%)을 나타낸다.EML / ETL / LiF / Al (abbreviated as ITO anode / hole injection layer / hole transport layer / light emitting layer / electron transport layer / ITO / HIL / HTL / EML) The following abbreviations have the same meanings), and the following drawings show the structural formula of the material used for each functional layer in the device (all materials are purchased from J & K Scientific, purity is> 99.9 %).

Figure pct00113
Figure pct00113

Figure pct00114
Figure pct00114

소자 실시예1. 본 발명의 화합물을 정공 주입 재료로 한다.Device Example 1. The compound of the present invention is used as a hole injecting material.

ITO(150nm)을 도포한 투명한 전도층의 유리 기판을 상업용 세제에서 초음파 처리하고, 탈이온수에서 세척하며, 아세톤:에탄올 혼합 용매(체적비는 1:1임)에서 초음파로 탈지하고, 깨끗한 환경 하에서 수분을 완전히 제거할 때까지 말리며(baking), 자와선과 오존으로 세척하고, 사텔라(Satella(ULVAC))의 저에너기 양이온 빔으로 표면에 충격을 가하며; The glass substrate of the transparent conductive layer coated with ITO (150 nm) was ultrasonicated in a commercial detergent, washed with deionized water, degreased with an ultrasonic wave in an acetone: ethanol mixed solvent (volume ratio is 1: 1) Baking until complete removal, scrubbing with lines, lines and ozone, and impacting the surface with a low energy cation beam from Satella (ULVAC);

상기 양극을 띤 유리 기판을 진공 챔버에 넣고, 1×10-5 내지 9×10-3Pa까지 진공을 걸며, 상기 양극층 막 상에 화합물C-1을 진공 층착하여, 두께가 60nm인 정공 주입층을 형성하고; 정공 주입층 상에 화합물NPB를 진공 증착하여, 두께가 20nm인 정공 수송층을 형성하며, 증착 속도는 0.1nm/s이고;The glass substrate with the anode was placed in a vacuum chamber, vacuum was applied to 1 × 10 -5 to 9 × 10 -3 Pa, the compound C-1 was vacuum-deposited on the anode layer film, and a hole injection Forming a layer; Compound NPB was vacuum deposited on the hole injection layer to form a hole transport layer having a thickness of 20 nm, and the deposition rate was 0.1 nm / s;

상기 정공 수송층 상에 전계발광층을 형성하되, 구체적인 조작은, 발광층 호스트인 CBP[4,4'-N,N'-디카르바졸-바이페닐]을 진공 증착기기의 챔버에 넣고, 도판트인 (piq)2Ir(acac)[디-(1-페닐이소퀴놀릴)아세틸아세톤이리듐(III)]을 진공 증착기기의 다른 챔버에 넣고, 상이한 속도로 동시에 두 가지 재료를 증발시키며, (piq)2Ir(acac)의 농도는 4%이고, 증착막의 총 두께는 30nm이며;Specifically, CBP [4,4'-N, N'-dicarbazole-biphenyl], which is a host of a light emitting layer, was placed in a chamber of a vacuum evaporation apparatus, and an electroluminescent layer ) 2 Ir (acac) [di- (1-phenylisoquinolyl) acetylacetone iridium (III)] was placed in another chamber of a vacuum vapor deposition apparatus and the two materials were evaporated at different rates at the same time, and (piq) 2 Ir (acac) is 4%, the total thickness of the vapor deposition film is 30 nm;

발광층 상에 Bphen을 진공 증착하여 막두께 20nm인 전자 수송층을 형성하고, 이의 증착 속도는 0.1nm/s이며;Bphen was vacuum-deposited on the light-emitting layer to form an electron transport layer having a thickness of 20 nm, and the deposition rate thereof was 0.1 nm / s;

전자 수송층 상에 0.5nm의 LiF를 진공 증착하여 전자 주입층으로하고 150nm의 Al층을 소자의 음극으로 한다.0.5 nm of LiF was vacuum deposited on the electron transporting layer to form an electron injecting layer and an Al layer of 150 nm as the cathode of the device.

소자 실시예2. 본 발명 화합물을 정공 주입 재료로 한다.Device Example 2. The compound of the present invention is used as a hole injecting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 화합물C-3로 대체한다.An organic electroluminescent device is produced in the same manner as in Example 1, except that Compound C-1 is replaced with Compound C-3.

소자 실시예3. 본 발명 화합물을 정공 주입 재료로 한다.Device Example 3. The compound of the present invention is used as a hole injecting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 화합물C-4로 대체한다.An organic electroluminescent device is produced in the same manner as in Example 1 except that the compound C-1 is replaced with the compound C-4.

소자 실시예4. 본 발명 화합물을 정공 주입 재료로 한다.Device Example 4. The compound of the present invention is used as a hole injecting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 화합물C-11로 대체한다.An organic electroluminescent device is produced in the same manner as in Example 1, except that Compound C-1 is replaced with Compound C-11.

소자 실시예5. 본 발명 화합물을 정공 주입 재료로 한다.Device Example 5. The compound of the present invention is used as a hole injecting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 화합물C-12로 대체한다.An organic electroluminescent device is produced in the same manner as in Example 1, except that Compound C-1 is replaced with Compound C-12.

소자 실시예6. 본 발명 화합물을 정공 주입 재료로 한다.Device Example 6. The compound of the present invention is used as a hole injecting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 화합물C-13로 대체한다.An organic electroluminescent device is produced in the same manner as in Example 1, except that Compound C-1 is replaced with Compound C-13.

소자 실시예7. 본 발명 화합물을 정공 주입 재료로 한다.Device Example 7. The compound of the present invention is used as a hole injecting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 화합물C-15로 대체한다.An organic electroluminescent device is produced in the same manner as in Example 1, except that Compound C-1 is replaced with Compound C-15.

소자 실시예8. 본 발명 화합물을 정공 수송 재료로 한다.Device Example 8. The compound of the present invention is used as a hole transporting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, NPB를 화합물B-1로 대체한다.An organic electroluminescent device is manufactured in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the NPB is replaced with compound B-1.

소자 실시예9. 본 발명 화합물을 정공 수송 재료로 한다.Device Example 9. The compound of the present invention is used as a hole transporting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로대체하고, NPB를 화합물B-3로 대체한다.An organic electroluminescent device is prepared in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the NPB is replaced with compound B-3.

소자 실시예10. 본 발명 화합물을 정공 수송 재료로 한다.Device Example 10. The compound of the present invention is used as a hole transporting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, NPB를 화합물B-4로 대체한다.An organic electroluminescent device is prepared in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the NPB is replaced with compound B-4.

소자 실시예11. 본 발명 화합물을 정공 수송 재료로 한다.Device Example 11. The compound of the present invention is used as a hole transporting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, NPB를 화합물B-6로 대체한다.An organic electroluminescent device is prepared in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the NPB is replaced with compound B-6.

소자 실시예12. 본 발명 화합물을 정공 수송 재료로 한다.Device Example 12. The compound of the present invention is used as a hole transporting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, NPB를 화합물B-9로 대체한다.An organic electroluminescent device is produced in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the NPB is replaced with compound B-9.

소자 실시예13. 본 발명 화합물을 정공 수송 재료로 한다.Device Example 13. The compound of the present invention is used as a hole transporting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, NPB를 화합물B-10로 대체한다.An organic electroluminescent device is produced in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the NPB is replaced with compound B-10.

소자 실시예14. 본 발명 화합물을 정공 수송 재료로 한다.Device Example 14. The compound of the present invention is used as a hole transporting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, NPB를 화합물B-12로 대체한다.An organic electroluminescent device is prepared in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the NPB is replaced with compound B-12.

소자 실시예15. 본 발명 화합물을 정공 수송 재료로 한다.Device Example 15. The compound of the present invention is used as a hole transporting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, NPB를 화합물B-13로 대체한다.An organic electroluminescent device is produced in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the NPB is replaced with compound B-13.

소자 실시예16. 본 발명 화합물을 정공 수송 재료로 한다.Device Example 16. The compound of the present invention is used as a hole transporting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, NPB를 화합물B-17 로 대체한다.An organic electroluminescent device was prepared in the same manner as in Example 1 except that the compound C-1 was replaced with 2-TNATA and the NPB was replaced with compound B-17.

소자 실시예17. 본 발명 화합물을 정공 수송 재료로 한다.Device Example 17. The compound of the present invention is used as a hole transporting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, NPB를 화합물B-18로 대체한다.An organic electroluminescent device was prepared in the same manner as in Example 1 except that the compound C-1 was replaced with 2-TNATA and the NPB was replaced with compound B-18.

소자 실시예18. 본 발명 화합물을 정공 수송 재료로 한다.Device Example 18. The compound of the present invention is used as a hole transporting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, NPB를 화합물B-21로 대체한다.An organic electroluminescent device was prepared in the same manner as in Example 1 except that the compound C-1 was replaced with 2-TNATA and the NPB was replaced with compound B-21.

소자 실시예19. 본 발명 화합물을 정공 수송 재료로 한다.Device Example 19. The compound of the present invention is used as a hole transporting material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, NPB를 화합물B-30로 대체한다.An organic electroluminescent device is manufactured in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the NPB is replaced with compound B-30.

소자 실시예20. 본 발명 화합물을 적색 인광 호스트 재료로 한다.Device Example 20. The compound of the present invention is referred to as a red phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, CBP를 화합물A-1로 대체한다.An organic electroluminescent device is manufactured in the same manner as in Example 1 except that the compound C-1 is replaced with 2-TNATA and the CBP is replaced with the compound A-1.

소자 실시예21. 본 발명 화합물을 적색 인광 호스트 재료로 한다.Device Example 21. The compound of the present invention is referred to as a red phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, CBP를 화합물A-4로 대체한다.An organic electroluminescent device was prepared in the same manner as in Example 1 except that the compound C-1 was replaced with 2-TNATA and the CBP was replaced with Compound A-4.

소자 실시예22. 본 발명 화합물을 적색 인광 호스트 재료로 한다.Device Example 22. The compound of the present invention is referred to as a red phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, CBP를 화합물A-6로 대체한다.An organic electroluminescent device is manufactured in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the CBP is replaced with the compound A-6.

소자 실시예23. 본 발명 화합물을 적색 인광 호스트 재료로 한다.Device Example 23. The compound of the present invention is referred to as a red phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, CBP를 화합물A-9로 대체한다.An organic electroluminescent device is manufactured in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the CBP is replaced with the compound A-9.

소자 실시예24. 본 발명 화합물을 적색 인광 호스트 재료로 한다.Device Embodiment 24. The compound of the present invention is referred to as a red phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, CBP를 화합물A-14로 대체한다.An organic electroluminescent device was prepared in the same manner as in Example 1, except that the compound C-1 was replaced with 2-TNATA and the CBP was replaced with Compound A-14.

소자 실시예25. 본 발명 화합물을 적색 인광 호스트 재료로 한다.Device Example 25. The compound of the present invention is referred to as a red phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, CBP를 화합물A-21로 대체한다.An organic electroluminescent device is prepared in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the CBP is replaced with the compound A-21.

소자 실시예26. 본 발명 화합물을 적색 인광 호스트 재료로 한다.Device Example 26. The compound of the present invention is referred to as a red phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, CBP를 화합물D-4로 대체한다.An organic electroluminescent device is manufactured in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the CBP is replaced with the compound D-4.

소자 실시예27. 본 발명 화합물을 적색 인광 호스트 재료로 한다.Device Example 27. The compound of the present invention is referred to as a red phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, CBP를 화합물D-6로 대체한다.An organic electroluminescent device is manufactured in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the CBP is replaced with the compound D-6.

소자 실시예28. 본 발명 화합물을 적색 인광 호스트 재료로 한다.Device Example 28. The compound of the present invention is referred to as a red phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, CBP를 화합물D-10로 대체한다.An organic electroluminescent device is prepared in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the CBP is replaced with the compound D-10.

소자 실시예29. 본 발명 화합물을 적색 인광 호스트 재료로 한다.Device Example 29. The compound of the present invention is referred to as a red phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, CBP를 화합물D-25로 대체한다.An organic electroluminescent device is produced in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the CBP is replaced with the compound D-25.

소자 실시예30. 본 발명 화합물을 적색 인광 호스트 재료로 한다.Device Example 30. The compound of the present invention is referred to as a red phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, CBP를 화합물D-27로 대체한다.An organic electroluminescent device is manufactured in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the CBP is replaced with the compound D-27.

소자 실시예31. 본 발명 화합물을 적색 인광 호스트 재료로 한다.Device Example 31. The compound of the present invention is referred to as a red phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, CBP를 화합물D-33로 대체한다.An organic electroluminescent device is manufactured in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the CBP is replaced with the compound D-33.

소자 실시예32. 본 발명 화합물을 적색 인광 호스트 재료로 한다.Device Example 32. The compound of the present invention is referred to as a red phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, CBP를 화합물D-37로 대체한다.An organic electroluminescent device is manufactured in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA and the CBP is replaced with the compound D-37.

소자 실시예33. 본 발명 화합물을 각각 정공 주입 재료, 정공 수송 재료와 적색 인광 호스트 재료로 한다.Device Example 33. Each of the compounds of the present invention is used as a hole injecting material, a hole transporting material and a red phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 C-10로 대체하고, NPB를 화합물B-8로 대체하며, CBP를 화합물D-25로 대체한다.An organic electroluminescent device was prepared in the same manner as in Example 1 except that Compound C-1 was replaced with C-10, NPB was replaced with Compound B-8, and CBP was replaced with Compound D-25 .

소자 실시예34. 본 발명 화합물을 각각 정공 주입 재료, 정공 수송 재료와 적색 인광 호스트 재료로 한다.Device Example 34. Each of the compounds of the present invention is used as a hole injecting material, a hole transporting material and a red phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 C-13로 대체하고, NPB를 화합물B-6으로 대체하며, CBP를 화합물D-37로 대체한다.An organic electroluminescent device was prepared in the same manner as in Example 1 except that the compound C-1 was replaced with C-13, the NPB was replaced with the compound B-6, and the CBP was replaced with the compound D-37 .

소자 실시예35. 본 발명 화합물을 각각 정공 주입 재료, 정공 수송 재료와 적색 인광 호스트 재료로 한다.Device Example 35. Each of the compounds of the present invention is used as a hole injecting material, a hole transporting material and a red phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 C-3으로 대체하고, NPB를 화합물B-30으로 대체하며, CBP를 화합물D-4로 대체한다.An organic electroluminescent device was prepared in the same manner as in Example 1 except that Compound C-1 was replaced with C-3, NPB was replaced with Compound B-30, and CBP was replaced with Compound D-4 .

소자 실시예36. 본 발명 화합물을 녹색 인광 호스트 재료로 한다.Example Embodiment 36. The compound of the present invention is referred to as a green phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, CBP를 화합물D-32로 대체하며, (piq)2Ir(acac)을 Ir(ppy)3으로 대체하며, 도핑 농도를 10% 바꾼다.The organic EL device was prepared in the same manner as in Example 1 except that the compound C-1 was replaced with 2-TNATA, the CBP was replaced with the compound D-32, and (piq) 2 Ir (acac) Ir (ppy) 3 , and the doping concentration is changed by 10%.

소자 실시예37. 본 발명 화합물을 녹색 인광 호스트 재료로 한다.Device Example 37. The compound of the present invention is referred to as a green phosphorescent host material.

실시예26과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물D-32를 D-39로 대체한다.An organic electroluminescent device was produced in the same manner as in Example 26 except that Compound D-32 was replaced with D-39.

소자 실시예38. 본 발명 화합물을 각각 정공 주입 재료, 정공 수송 재료와 녹색 인광 호스트 재료로 한다.Device Example 38. Each of the compounds of the present invention is used as a hole injecting material, a hole transporting material and a green phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 C-3으로 대체하고, NPB를 화합물B-8로 대체하며, CBP를 화합물D-32로 대체하고, (piq)2Ir(acac)를 Ir(ppy)3으로 대체하며, 도핑 농도를 10%로 바꾼다.An organic electroluminescent device was prepared in the same manner as in Example 1 except that Compound C-1 was replaced with C-3, NPB was replaced with Compound B-8, CBP was replaced with Compound D-32 , (piq) 2Ir (acac) is replaced with Ir (ppy) 3 , and the doping concentration is changed to 10%.

소자 실시예39. 본 발명 화합물을 각각 정공 주입 재료, 정공 수송 재료와 녹색 인광 호스트 재료로 한다.Device Example 39. Each of the compounds of the present invention is used as a hole injecting material, a hole transporting material and a green phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 C-11로 대체하고, NPB를 화합물B-30으로 대체하며, CBP를 화합물D-39로 대체하고, (piq)2Ir(acac)를 Ir(ppy)3으로 대체하며, 도핑 농도를 10%로 바꾼다.An organic electroluminescent device was prepared in the same manner as in Example 1 except that the compound C-1 was replaced with C-11, the NPB was replaced with the compound B-30, the CBP was replaced with the compound D-39 , (piq) 2 Ir (acac) is replaced with Ir (ppy) 3 , and the doping concentration is changed to 10%.

비교 실시예1. 2-TNATA를 정공 주입 재료로 하고, NPB를 정공 수송 재료로 하며, CBP를 적색 인광 호스트 재료로 한다.Comparative Example 1 2-TNATA is used as a hole injecting material, NPB is used as a hole transporting material, and CBP is used as a red phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체한다.An organic electroluminescent device is prepared in the same manner as in Example 1, except that the compound C-1 is replaced with 2-TNATA.

비교 실시예2. 2-TNATA를 정공 주입 재료로 하고, NPB를 정공 수송 재료로 하며, CBP를 녹색 인광 호스트 재료로 한다.Comparative Example 2 2-TNATA is used as a hole injecting material, NPB is used as a hole transporting material, and CBP is used as a green phosphorescent host material.

실시예1과 동일한 방법으로 유기 전계 발광 소자를 제조하는데, 구별점은, 화합물C-1을 2-TNATA로 대체하고, (piq)2Ir(acac)를 Ir(ppy)3으로 대체하며, 도핑 농도를 10%로 바꾼다.Carried out to prepare an organic EL device in the same manner as in Example 1, distinguished points, and replacing the compound C-1 to 2-TNATA, and replacing (piq) 2 Ir (acac) with Ir (ppy) 3, doped Change the concentration to 10%.

테스트 실시예1Test Example 1

적색광 소자를 휘도 1000cd/m2 하에서, Keithley 2602 SourceMeter 광도계(Beijing Normal University Photoelectric Instrument Factory / 베이징 사범대학 광전자계기공장)를 사용하여 소자 실시예1 내지 25 및 비교예1에서 제조하여 얻은 유기 전계 발광 소자의 구동 전압과 전류 효율을 측정한 결과는 표1과 같다.A red light device was fabricated using the Keithley 2602 SourceMeter photometer (Beijing Normal University Photoelectric Instrument Factory, Beijing Normal University) under the luminance of 1000 cd / m 2 , and the organic electroluminescent device obtained in Device Examples 1 to 25 and Comparative Example 1 Table 1 shows the results of measuring the driving voltage and the current efficiency.

테스트 실시예2Test Example 2

녹색광 소자를 휘도 2000cd/m2 하에서, Keithley 2602 SourceMeter 광도계(베이징 사범대학 광전자계기공장 / Beijing Normal University Photoelectric Instrument Factory)를 사용하여 소자 실시예26 내지 27 및 비교예2에서 제조하여 얻은 유기 전계 발광 소자의 구동 전압과 전류 효율을 측정한 결과는 표1과 같다.The green light elements were measured at a luminance of 2000 cd / m 2 using a Keithley 2602 SourceMeter photometer (Beijing Normal University Photoelectric Instrument Factory / Beijing Normal University Photoelectric Instrument Factory) Table 1 shows the results of measuring the driving voltage and the current efficiency.

표2Table 2

Figure pct00115
Figure pct00115

Figure pct00116
Figure pct00116

Figure pct00117
Figure pct00117

표1에서 소자 실시예1 내지 7과 비교 실시예1로부터, 유기 전계 발광 소자 구조에서 기타 재료가 동일한 경우, 본 발명 C계열 화합물로 소자 비교 실시예1에서 2-TNATA를 대체하여 정공 주입 재료로 한다. C계열 화합물은 바람직하게 방향족 아민계 치환기로 모핵의 호모(HOMO) 에너지 준위를 향상시켜, 단일 캐리어 성능을 향상시킴으로써; 소자 성능은 더욱 낮은 구동 전압 및 비교적 높은 전류 효율을 얻었고, 발광소자의 발광 효율도 향상시킴으로써, 본 발명 재료가 더욱 높은 효율의 정공 주입성을 구비하였음을 나타낸다.From the device examples 1 to 7 and the comparative example 1 in Table 1, it can be seen that when the other materials are the same in the organic electroluminescent device structure, 2-TNATA is substituted for the present invention C series compound in the device comparison example 1, do. The C-based compounds preferably improve the homokine (HOMO) energy level of the parent moiety with an aromatic amine-based substituent and improve single carrier performance; The device performance shows that a lower driving voltage and a relatively higher current efficiency are obtained, and the luminous efficiency of the light emitting device is also improved, so that the material of the present invention has a higher efficiency of hole injecting property.

소자 실시예8 내지 19와 비교 실시예1로부터, 유기 전계 발광 소자 구조에서 기타 재료가 동일한 경우, 본 발명 B계열 화합물로 소자 비교 실시예1에서 NPB를 대체하여 정공 수송 재료로 한다. B계열 화합물은 바람직하게 카르바졸릴기, 디벤조푸라닐기, 디벤조티에닐기 등 치환기이고, 모핵 호모(HOMO) 에너지 준위를 조금 향상시켜, 호스트 에너지 준위와 더욱 잘 매치되도록 하며, 상대적으로 더욱 높은 삼중항 에너지 준위는 동시에 엑시톤 차단층 역할을 할 수 있도록 하여, 단일 캐리어의 주입 수송 성능을 향상시키고, 동시에 비교적 강한 정공 수송 능력을 구비하여, 동일한 소자 구조에서 더욱 높은 전류 효율과 비교적 낮은 구동 전압을 얻음으로써, 발광소자의 발광 효율을 향상시켰다.From the device examples 8 to 19 and the comparative example 1, when the other materials in the organic electroluminescent device structure are the same, the hole transport material is replaced with NPB in the device comparison example 1 with the present invention B series compound. The B series compound is preferably a substituent such as a carbazolyl group, a dibenzofuranyl group, a dibenzothienyl group, or the like, and slightly improves the HOMO energy level, more closely matches the host energy level, The triplet energy level can simultaneously serve as an exciton blocking layer to improve the injection carrier transport performance of a single carrier and at the same time to have a relatively strong hole transporting ability so that a higher current efficiency and a relatively lower driving voltage Thereby improving the luminous efficiency of the light emitting element.

소자 실시예20 내지 32과 소자 비교 실시예1로부터, 유기 전계 발광 소자 구조에서 기타 재료가 동일한 경우, 본 발명 A, D계열의 화합물로 소자 비교 실시예1에서 CBP를 대체하여 적색광 호스트 재료로 한다. A계열 화합물의 중성 아릴기는 모핵에 미치는 영향이 적고, 이의 단일 캐리어 성능이 우수하며; 해당 소자는 더욱 낮은 전압과 더욱 높은 전류 효율을 구비한다. D계열 화합물은 바람직하게 피리딜기, 페닐피리딜기, 퀴놀릴기 등 전자 끌기 성능 치환기로서, 이중 캐리어 성능이 우수하고, 복합 영역이 넓어, 소자의 작업 전압을 진일보 저하시켰으며 더욱 높은 효율은 본 발명에서 재료의 우수한 캐리어 수송 균질성 및 에너지 준위 매칭성을 나타냈다.From the device examples 20 to 32 and the device comparison example 1, when the other materials are the same in the organic electroluminescent device structure, the red light host material is substituted for CBP in the device comparison example 1 with the compounds of the present invention A and D series . The neutral aryl group of the A-based compound has little influence on the mother nucleus, and its single carrier performance is excellent; The device has lower voltage and higher current efficiency. The D-series compound is preferably an electron attracting substituent such as a pyridyl group, a phenylpyridyl group, or a quinolyl group, and has excellent dual carrier performance and broader composite domains, further lowering the working voltage of the device. Showed excellent carrier transport homogeneity and energy level matching properties of the material.

소자 실시예36/37과 소자 비교 실시예2로부터, 유기 전계 발광 소자 구조에서 기타 재료가 동일한 경우, 본 발명 D-32, D-39 화합물로 소자 비교 실시예2에서 CBP를 대체하여 녹색광 호스트 재료로 하고, 전류 효율을 30cd/A로부터 40cd/A까지 향상시키므로써, 현저한 향상 효과를 나타내는 동시에, 작업 전압도 대폭 저하되었다. 소자 실시예33 내지 35과 소자 비교 실시예1로부터, 유기 전계 발광 소자 구조에서 기타 재료가 동일한 경우, 각각 동시에 본 발명의 상이한 유형의 재료 C-10, C-13, C-3로 2-TNATA를 대체하고; B-8, B-6, B-30로 NPB를 대체하며, D-25, D-37, D-4로 CBP를 대체함으로써, 적색광 소자에서 유기 전계 발광 소자의 작업 전압을 현저하게 저하시키고 전류 효율을 향상시켰으며; 녹색광 소자38, 39에서도, 전압을 저하시키고 효율을 향상시키는 효과를 나타내어, 본 발명 화합물의 우월성을 나타냈다.From the device example 36/37 and the device comparative example 2, it was found that when the organic EL device structure had the same other materials, CBP was substituted for the D-32 and D-39 compounds in the device comparison example 2, And the current efficiency was improved from 30 cd / A to 40 cd / A, the remarkable improvement effect was exhibited, and the working voltage was significantly lowered. From the device examples 33 to 35 and the device comparison example 1, it can be seen that when the other materials in the organic electroluminescent device structure are the same, 2-TNATA (C-10), C- ≪ / RTI > The operation voltage of the organic electroluminescent device in the red light element is remarkably lowered and the electric current of the organic electroluminescent element is reduced by replacing the NPB with B-8, B-6 and B-30 and replacing CBP with D-25, D- Improved efficiency; The green light elements 38 and 39 also exhibited the effect of lowering the voltage and improving the efficiency, thus showing superiority of the compound of the present invention.

위에서 본 발명의 바람직한 실시 수단을 상세하게 설명하였지만, 본 발명은 상기 실시 수단 중의 구체적인 세부 사항에 제한되지 않으며, 본 발명의 기술적 사상 범위 내에서, 본 발명의 기술 수단에 대하여 여러 가지 간단한 변형을 진행할 수 있고, 이러한 간단한 변형은 모두 본 발명의 보호 범위에 속한다.While the preferred embodiments of the present invention have been described in detail above, it is to be understood that the invention is not limited to the specific details thereof, and many modifications are possible in the technical scope of the invention And all such simple modifications fall within the scope of the present invention.

Claims (17)

벤조시클로옥타테트라엔디인돌 구조를 구비하고, 구조가 하기 일반식(Ⅰ)으로 표시되는 화합물,
Figure pct00118

상기 식에서, 고리A는
Figure pct00119
이며, 점선은 이어지는 위치이고;
Ar는 수소, C6 내지 C30인 아릴아미노기 또는 헤테로아릴아미노기, 치환 또는 비치환된 C6 내지 C30인 아릴기, 치환 또는 비치환된 C2 내지 C30인 헤테로아릴기이며, 두 개의 Ar는 동일하거나 상이할 수 있고,
R1 내지 R12는 각각 독립적으로 수소, 할로겐, C6 내지 C30인 아릴아미노기 또는 헤테로아릴아미노기, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C2 내지 C30 알케닐기, 치환 또는 비치환된 C2 내지 C30 알키닐기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C2 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C2 내지 C30 헤테로아릴기이며; 또는, R1 내지 R4 및/또는 R5 내지 R8은 각각 고리를 형성할 수 있음.
A benzocyclooctatetraendiindole structure, a compound represented by the following general formula (I)
Figure pct00118

Wherein ring A is
Figure pct00119
And the dotted line is the following position;
Ar is a group of hydrogen, C 6 to C 30 aryl group or a heteroaryl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 2 to C 30 is heteroaryl, the two Ar May be the same or different,
R 1 to R 12 are each independently hydrogen, halogen, an arylamino group or a heteroarylamino group having 6 to 30 carbon atoms, a substituted or unsubstituted C 1 to C 30 alkyl group, a substituted or unsubstituted C 2 to C 30 alkenyl group , A substituted or unsubstituted C 2 to C 30 alkynyl group, a substituted or unsubstituted C 3 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heterocycloalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 2 to C 30 heteroaryl group; Alternatively, R 1 to R 4 and / or R 5 to R 8 may each form a ring.
제1항에 있어서,
R1 내지 R12는 각각 독립적으로 수소, 치환 또는 비치환된 C6 내지 C30아릴기, 치환 또는 비치환된 C2 내지 C30헤테로아릴기, C6 내지 C30인 아릴아미노기 또는 헤테로아릴아미노기인 것을 특징으로 하는 화합물.
The method according to claim 1,
R 1 to R 12 are each independently selected from the group consisting of hydrogen, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 2 to C 30 heteroaryl group, a C 6 to C 30 arylamino group or a heteroarylamino group ≪ / RTI >
제1항에 있어서,
Ar, R1 내지 R12는 각각 독립적으로 페닐기, 바이페닐기, 터페닐기, 나프틸기, 안트릴기, 페난트릴기, 인데닐기, 플루오레닐기 및 이의 유도체, 플루오란테닐기, 트리페닐렌기, 피레닐기, 페릴렌기, 크리세닐기와 나프타센기, 푸라닐기, 티에닐기, 피롤릴기, 벤조푸라닐기, 벤조티에닐기, 이소벤조푸라닐기, 인돌릴기, 디벤조푸라닐기, 디벤조티에닐기, 카르바졸릴기 및 이의 유도체, 벤조디옥솔기, 피리딜기, 페닐피리딜기, 퀴놀릴기, 치환된 퀴놀릴기, 퀴나졸리닐기, 치환된 퀴나졸리닐기, 퀴녹살리닐기, 치환된 퀴녹살리닐기, 피리미디닐기, 치환된 피리미디닐기, o-페난트롤린기, 트리아지닐기, 치환된 트리아지닐기, 벤즈이미다졸릴기, 옥사졸릴기, 디페닐아미노기, 페닐나프틸아미노기, 4-트리페닐아미노기, 3-트리페닐아미노기, 4-[N-페닐-N-(디벤조푸란-3-일)]페닐아미노기, 4-[N-페닐-N-(디벤조티오펜-3-일)페닐아미노기로 이루어진 군에서 선택되는 적어도 하나의 기 또는 다수의 기가 단일 결합 또는 융합 결합에 의해 연결되는 조합이고, R1 내지 R4 및/또는 R5 내지 R8은 각각 고리를 형성할 수 있는 것을 특징으로 하는 화합물.
The method according to claim 1,
Ar, and R 1 to R 12 each independently represent a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, an anthryl group, a phenanthryl group, an indenyl group, a fluorenyl group and derivatives thereof, a fluoranthenyl group, A benzoyl group, a benzoyl group, a benzyl group, a benzyl group, a benzyl group, a benzyl group, a benzyl group, a benzyl group, a benzyl group, a benzyl group, And derivatives thereof, benzodioxolyl group, pyridyl group, phenylpyridyl group, quinolyl group, substituted quinolyl group, quinazolinyl group, substituted quinazolinyl group, quinoxalinyl group, substituted quinoxalinyl group, pyrimidinyl group, substituted A triphenylamino group, a 4-triphenylamino group, a 3-triphenylamino group, an imidazolyl group, an imidazolyl group, an imidazolyl group, a pyrimidinyl group, an o-phenanthroline group, a triazinyl group, a substituted triazinyl group, Amino group, 4- [N-phenyl-N- (dibenzofuran 3-yl)] phenylamino group and at least one group or a plurality of groups selected from the group consisting of 4- [N-phenyl-N- (dibenzothiophen-3-yl) And R 1 to R 4 and / or R 5 to R 8 are each a ring.
제1항에 있어서,
구조가 하기 일반식(II)으로 표시되는 화합물,
Figure pct00120

상기 식에서, Ar1, Ar2는 동일하거나 상이하며, 각각 독립적으로 C1 내지 C10알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C2 내지 C30 헤테로아릴기이고;
R1 내지 R12는 동일하거나 상이하며, 각각 독립적으로 수소, 할로겐, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C2 내지 C30 알케닐기, 치환 또는 비치환된 C2 내지 C30 알키닐기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C2 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C2 내지 C30 헤테로아릴기이며; 또는, R1 내지 R4는 동일하거나 상이하고, 인접한 기는 서로 고리를 이룰 수 있으며; R5 내지 R8은 동일하거나 상이하고, 인접한 기는 서로 고리를 이룰 수 있으며; R9 내지 R12는 동일하거나 상이하고, 인접한 기는 서로 고리를 이룰 수 있음.
The method according to claim 1,
A compound represented by the following general formula (II)
Figure pct00120

Wherein Ar 1 and Ar 2 are the same or different and each independently represents a C 1 to C 10 alkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 2 to C 30 heteroaryl group ego;
R 1 to R 12 are the same or different and each independently represents hydrogen, halogen, a substituted or unsubstituted C 1 to C 30 alkyl group, a substituted or unsubstituted C 2 to C 30 alkenyl group, a substituted or unsubstituted C 2 to C 30 alkynyl group, a substituted or unsubstituted C 3 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heterocycloalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 2 -C 30 heteroaryl group; Alternatively, R 1 to R 4 may be the same or different, and adjacent groups may form a ring with each other; R 5 to R 8 are the same or different, and adjacent groups may form a ring with each other; R 9 to R 12 are the same or different, and adjacent groups may form a ring with each other.
제1항에 있어서,
구조가 하기 일반식(III)으로 표시되는 화합물,
Figure pct00121

상기 식에서, Ar3, Ar4는 동일하거나 상이하고, 각각 독립적으로 C1 내지 C10 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C2 내지 C30 헤테로아릴기이며;
R13 내지 R24는 동일하거나 상이하고, 각각 독립적으로 수소, 할로겐, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C2 내지 C30 알케닐기, 치환 또는 비치환된 C2 내지 C30 알키닐기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C2 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C2 내지 C30 헤테로아릴기이며; 또는, R13 내지 R16은 동일하거나 상이하고, 인접한 기는 서로 고리를 이룰 수 있으며; R17 내지 R20은 동일하거나 상이하고, 인접한 기는 서로 고리를 이룰 수 있으며; R21 내지 R24는 동일하거나 상이하고, 인접한 기는 서로 고리를 이룰 수 있음.
The method according to claim 1,
A compound represented by the following general formula (III)
Figure pct00121

Wherein Ar 3 and Ar 4 are the same or different and each independently represents a C 1 to C 10 alkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 2 to C 30 heteroaryl group ;
R 13 to R 24 are the same or different and each independently represents hydrogen, halogen, a substituted or unsubstituted C 1 to C 30 alkyl group, a substituted or unsubstituted C 2 to C 30 alkenyl group, a substituted or unsubstituted C 2 to C 30 alkynyl group, a substituted or unsubstituted C 3 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heterocycloalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 2 -C 30 heteroaryl group; Or R 13 to R 16 are the same or different, and adjacent groups may form a ring with each other; R 17 to R 20 are the same or different, and adjacent groups may form a ring with each other; R 21 to R 24 are the same or different and adjacent groups may form a ring with each other.
제1항에 있어서,
Ar, R1 내지 R12는 수소 또는 페닐기, 톨릴기, 바이페닐기, 나프틸기, 페난트릴기, 트리페닐렌기, 플루오란테닐기, 크리세닐기, 플루오레닐기, 인데노플루오렌기로 이루어진 군에서 선택되는 기인 것을 특징으로 하는 화합물.
The method according to claim 1,
Ar, and R 1 to R 12 are hydrogen or a group selected from the group consisting of phenyl, tolyl, biphenyl, naphthyl, phenanthryl, triphenylene, fluoranthenyl, ≪ / RTI >
제5항에 있어서,
하기 A-1 내지 A-24의 화합물에서 선택되는 화합물.
Figure pct00122

Figure pct00123

Figure pct00124

Figure pct00125

Figure pct00126

Figure pct00127

Figure pct00128
6. The method of claim 5,
A compound selected from the following compounds A-1 to A-24.
Figure pct00122

Figure pct00123

Figure pct00124

Figure pct00125

Figure pct00126

Figure pct00127

Figure pct00128
제1항에 있어서,
Ar, R1 내지 R12는 수소 또는 카르바졸릴기, 디벤조푸라닐기, 디벤조티에닐기, 인돌로카르바졸릴기, 벤조푸라닐카르바졸릴기, 벤조티에노카르바졸릴기로 이루어진 군에서 선택되는 기인 것을 특징으로 하는 화합물.
The method according to claim 1,
Ar, R 1 to R 12 are hydrogen or a group selected from the group consisting of a carbazolyl group, a dibenzofuranyl group, a dibenzothienyl group, an indolocarbazolyl group, a benzofuranylcarbazolyl group and a benzothienocarbazolyl group ≪ / RTI >
제8항에 있어서,
이는 하기 B-1 내지 B-30의 화합물에서 선택되는 화합물.
Figure pct00129

Figure pct00130

Figure pct00131

Figure pct00132

Figure pct00133

Figure pct00134

Figure pct00135

Figure pct00136

Figure pct00137

Figure pct00138
9. The method of claim 8,
Which is selected from the following compounds B-1 to B-30.
Figure pct00129

Figure pct00130

Figure pct00131

Figure pct00132

Figure pct00133

Figure pct00134

Figure pct00135

Figure pct00136

Figure pct00137

Figure pct00138
제1항에 있어서,
Ar, R1 내지 R12는 수소 또는 C6 내지 C30인 아릴아미노기 또는 헤테로아릴아미노기인 것을 특징으로 하는 화합물.
The method according to claim 1,
Ar, R 1 to R 12 is a compound wherein the aryl group or heteroaryl group hydrogen or C 6 to C 30.
제10항에 있어서,
하기 C-1 내지 C-15의 화합물에서 선택되는 화합물.
Figure pct00139

Figure pct00140

Figure pct00141

Figure pct00142
11. The method of claim 10,
A compound selected from the following compounds C-1 to C-15.
Figure pct00139

Figure pct00140

Figure pct00141

Figure pct00142
제1항에 있어서,
Ar, R1 내지 R12는 수소 또는 피리딜기, 페닐피리딜기, 퀴놀릴기, 치환된 퀴놀릴기, 퀴나졸리닐기, 치환된 퀴나졸리닐기, 퀴녹살리닐기, 치환된 퀴녹살리닐기, 피리미디닐기, 치환된 피리미디닐기, o-페난트롤린기, 트리아지닐기, 치환된 트리아지닐기, 벤즈이미다졸릴기, 옥사졸릴기로 이루어진 군에서 선택되는 기인 것을 특징으로 하는 화합물.
The method according to claim 1,
Ar, R 1 to R 12 each represent a hydrogen atom or a pyridyl group, a phenylpyridyl group, a quinolyl group, a substituted quinolyl group, a quinazolinyl group, a substituted quinazolinyl group, a quinoxalinyl group, a substituted quinoxalinyl group, a pyrimidinyl group , A substituted pyrimidinyl group, an o-phenanthroline group, a triazinyl group, a substituted triazinyl group, a benzimidazolyl group, and an oxazolyl group.
제12항에 있어서,
하기 D-1 내지 D-39의 화합물에서 선택되는 화합물.
Figure pct00143

Figure pct00144

Figure pct00145

Figure pct00146

Figure pct00147

Figure pct00148

Figure pct00149

Figure pct00150

Figure pct00151

Figure pct00152
13. The method of claim 12,
A compound selected from the following compounds D-1 to D-39.
Figure pct00143

Figure pct00144

Figure pct00145

Figure pct00146

Figure pct00147

Figure pct00148

Figure pct00149

Figure pct00150

Figure pct00151

Figure pct00152
제1 전극, 제2 전극 및 상기 제1 전극과 상기 제2 전극 사이에 삽입되는 한층 또는 다층 유기층을 포함하고,
상기 유기층은 제1항 내지 제13항 중 어느 한 항에 따른 화합물을 포함하는 것을 특징으로 하는 유기 전계 발광 소자.
A first electrode, a second electrode, and a single-layer or multi-layer organic layer interposed between the first electrode and the second electrode,
Wherein the organic layer comprises the compound according to any one of claims 1 to 13.
제14항에 있어서,
상기 유기층은 정공 주입층을 포함하고, 상기 정공 주입층은 제1항 내지 제13항 중 어느 한 항에 따른 화합물을 포함하는 유기 전계 발광 소자.
15. The method of claim 14,
Wherein the organic layer comprises a hole injection layer and the hole injection layer comprises a compound according to any one of claims 1 to 13.
제14항에 있어서,
상기 유기층은 정공 수송층을 포함하고, 상기 정공 수송층은 제1항 내지 제13항 중 어느 한 항에 따른 화합물을 포함하는 유기 전계 발광 소자.
15. The method of claim 14,
Wherein the organic layer comprises a hole transporting layer and the hole transporting layer comprises a compound according to any one of claims 1 to 13.
제14항에 있어서,
상기 유기층은 발광층을 포함하고, 상기 발광층은 제1항 내지 제13항 중 어느 한 항에 따른 화합물을 포함하는 유기 전계 발광 소자.
15. The method of claim 14,
Wherein the organic layer comprises a light emitting layer, and the light emitting layer comprises a compound according to any one of claims 1 to 13.
KR1020177034684A 2015-08-04 2016-08-03 Compounds and organic electroluminescent devices KR102592175B1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201510472766.4 2015-08-04
CN201510472766.4A CN106433614B (en) 2015-08-04 2015-08-04 Organic electroluminescent compound, application thereof and organic electroluminescent device
CN201510472703.9A CN106432242B (en) 2015-08-04 2015-08-04 A kind of organic electroluminescent compounds and application thereof and organic electroluminescence device
CN201510472703.9 2015-08-04
PCT/CN2016/093026 WO2017020831A1 (en) 2015-08-04 2016-08-03 Compound and organic light-emitting device

Publications (2)

Publication Number Publication Date
KR20180032527A true KR20180032527A (en) 2018-03-30
KR102592175B1 KR102592175B1 (en) 2023-10-19

Family

ID=57942431

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020177034684A KR102592175B1 (en) 2015-08-04 2016-08-03 Compounds and organic electroluminescent devices

Country Status (3)

Country Link
JP (1) JP6765389B2 (en)
KR (1) KR102592175B1 (en)
WO (1) WO2017020831A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112876464A (en) * 2021-02-08 2021-06-01 北京燕化集联光电技术有限公司 Organic material with heterocyclic structure and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100137188A (en) * 2009-06-22 2010-12-30 다우어드밴스드디스플레이머티리얼 유한회사 Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR20140130637A (en) * 2014-09-02 2014-11-11 롬엔드하스전자재료코리아유한회사 Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR20150126283A (en) * 2014-05-02 2015-11-11 롬엔드하스전자재료코리아유한회사 Organic Electroluminescent Compounds and Organic Electroluminescent Device Comprising the Same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3389905B2 (en) * 1999-12-13 2003-03-24 日本電気株式会社 Organic electroluminescence device
JP4822687B2 (en) * 2003-11-21 2011-11-24 富士フイルム株式会社 Organic electroluminescence device
JP2006104133A (en) * 2004-10-06 2006-04-20 Ihara Chem Ind Co Ltd Indole tetramer and method for producing the same
WO2010114267A2 (en) * 2009-03-30 2010-10-07 덕산하이메탈(주) Organic electronic device, compounds for same, and terminal
KR20110041726A (en) * 2009-10-16 2011-04-22 에스에프씨 주식회사 Aromatic compound and organic electroluminescent device using the same
CN104513662A (en) * 2013-09-30 2015-04-15 北京鼎材科技有限公司 Organic light-emitting material and application thereof
CN104513247B (en) * 2013-09-30 2018-05-18 北京鼎材科技有限公司 A kind of benzo [ c ] benzo [ 3,4 ] carbazole and carbazole derivates and application
CN104513206B (en) * 2013-09-30 2019-07-19 北京鼎材科技有限公司 A kind of dianthranide radical derivative and its application
CN107722015A (en) * 2013-09-30 2018-02-23 北京鼎材科技有限公司 A kind of double carbazole derivates of anthra and its application
CN103880850A (en) * 2014-03-05 2014-06-25 南京邮电大学 Tetramer indole derivative material and preparation method and application thereof
CN104673276B (en) * 2014-12-31 2017-05-31 固安鼎材科技有限公司 A kind of luminous organic material and its application

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100137188A (en) * 2009-06-22 2010-12-30 다우어드밴스드디스플레이머티리얼 유한회사 Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR20150126283A (en) * 2014-05-02 2015-11-11 롬엔드하스전자재료코리아유한회사 Organic Electroluminescent Compounds and Organic Electroluminescent Device Comprising the Same
KR20140130637A (en) * 2014-09-02 2014-11-11 롬엔드하스전자재료코리아유한회사 Novel organic electroluminescent compounds and organic electroluminescent device using the same

Also Published As

Publication number Publication date
KR102592175B1 (en) 2023-10-19
JP2018523638A (en) 2018-08-23
JP6765389B2 (en) 2020-10-07
WO2017020831A1 (en) 2017-02-09

Similar Documents

Publication Publication Date Title
CN109251176B (en) Organic electroluminescent device
CN109020960B (en) Novel organic electroluminescent compounds and organic electroluminescent device using the same
CN107011248B (en) Compound and organic electronic device thereof
TWI706936B (en) Multicyclic compound including nitrogen and organic light emitting device using the same
KR20120116282A (en) Novel organic electroluminescence compounds and organic electroluminescence device using the same
CN113717058B (en) Triarylamine compound containing fluorene derivative group and organic electroluminescent device thereof
TWI641598B (en) Compound and organic electronic device using the same
CN114394929B (en) Carbazole-based triarylamine derivative and organic electroluminescent device thereof
TWI653211B (en) Compound and its organic electronic device
CN107840834B (en) Benzopyrene compound and application thereof
CN107108642B (en) Compound for organic photodiode, organic photodiode including the same, and display device
CN108727389B (en) Pyrene derivative and application thereof in organic luminescent material
CN111377905A (en) Organic electroluminescent material and device
CN111303113B (en) Organic compound, electronic device, and electronic apparatus
CN107778309B (en) Quinoline derivative and application thereof
CN112759524A (en) Aromatic amine derivative and organic electroluminescent device thereof
CN109836421B (en) A compound of general formula and its application
KR102012822B1 (en) Compound and organic electronic device using the same
KR102095632B1 (en) Blue luminescent compounds and organic electroluminescence element comprising the same and application thereof
JP5870346B2 (en) COMPOUND HAVING SUBSTITUTED ORTOTERPHENY STRUCTURE AND ORGANIC ELECTROLUMINESCENT DEVICE
KR102592175B1 (en) Compounds and organic electroluminescent devices
JP2015214491A (en) Compound having triphenylene ring structure, and organic electroluminescent element
WO2019240352A1 (en) Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device, and display device
CN107759527B (en) Compound, application thereof and organic electroluminescent device
TWI735783B (en) Compound and organic electronic device using the same

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant